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I. PRD RISK TITLE: RISK OF SPACEFLIGHT ASSOCIATED NEURO-OCULAR 
SYNDROME 
A subset of astronauts develop neuro-ocular structural and functional changes during 
prolonged periods of spaceflight that may lead to additional neurologic and ocular consequences 
upon return to Earth.  
 
II. EXECUTIVE SUMMARY 
Over the last 40 years, reports of visual acuity impairments associated with spaceflight 
have been identified through testing and anecdotal reports. Until recently, these changes were 
thought to be transient, but a comparison of pre and postflight orbital MRIs, axial length 
measurements, and cycloplegic refraction measurements (some of which were performed 10 
years after return from space) suggest a potential risk of permanent ocular changes largely as a 
result of globe flattening during spaceflight. The results of ocular testing show that a subset of 
crewmembers experience visual performance decrements and one or more of the following 
ocular findings: hyperopic shift, cotton-wool spots, choroidal folds, optic disc edema, optic nerve 
sheath distention, and posterior globe flattening with varying degrees of severity and 
permanence. These changes define Spaceflight Associated Neuro-ocular Syndrome (SANS). It is 
thought that the ocular structural and optic nerve changes are caused by events precipitated by 
the cephalad fluid shift crewmembers experience during long-duration spaceflight, and perhaps 
by additional spaceflight-related factors including the role of exercise or ambient CO2 levels on 
the ISS. It is believed that some crewmembers are more susceptible to these changes because of 
their genetic/anatomical predisposition or lifestyle (fitness) related factors. Three important 
systems – ocular, cardiovascular, and central nervous – will be evaluated to understand the risk 
of developing SANS. Several hypotheses have been proposed to explain the visual acuity and 
structural changes that are associated with spaceflight; these hypotheses include increased 
intracranial pressure (ICP), localized cerebrospinal fluid (CSF) pressure elevation within the 
orbital optic nerve sheath as a result of compartmentalization, decreased venous compliance, and 
alterations in CSF dynamics. Few data exist from which to determine the extent or cause of 
SANS, and the knowledge gap related to etiology of the changes and the postflight resolution 
suggests that more monitoring is required before, during, and after spaceflight to characterize the 
risk. It will be important to determine the risk of developing SANS, predict whether severity of 
symptoms will greater during long-duration exploration-class missions, and establish any 
prolonged consequences upon return to Earth. 
 
It was initially thought that intracranial hypertension leads to SANS, and the opening 
pressure at lumbar puncture was measured in some crewmembers who had postflight optic disc 
edema. However, no crewmembers have reported the type of headaches typically associated with 
elevated ICP or demonstrated other neurological disturbances that often occur in patients with 
intracranial hypertension. Recent invasive measurements of ICP during parabolic flight suggest 
ICP may not be pathologically elevated during weightlessness. Rather, the inability to reduce 
ICP, as typically occurs when transitioning between supine and upright posture on Earth, may 
lead to chronic low-level elevation of ICP throughout spaceflight. To date, no preflight or in-
flight invasive measures of ICP have been conducted on any astronaut.  
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An alternate theory proposes optic nerve (ON) sheath CSF pressure may rise as a result 
of compartmentalization within the orbit, and this could occur with or without a rise in ICP 
(Mader et al. 2011, 2015, 2016). In support of this theory, an astronaut who returned from long-
duration spaceflight with unilateral grade 1 disc edema had a normal lumbar puncture opening 
pressure of 18 cm H2O 8 days after the mission (Mader et al. 2013). During spaceflight, this 
astronaut also had unilateral loss of previously visible spontaneous venous pulsations (SVPs) in 
the eye with the disc swelling, which continued to be absent 21 months after he returned to 
Earth, suggesting a long-term rise in sheath pressure (Mader et al. 2015). Another more recent 
study documented the case of an astronaut with optic disc edema and globe asymmetry 6 months 
after a long-duration spaceflight who had lumbar puncture opening pressures of 22 cm and 16 
cm H2O at one week and one year post flight respectively (Mader et al. 2016). These lumbar 
puncture opening pressures are not believed to be high enough to cause or maintain disc edema. 
Thus, these findings suggest that increased ICP alone, at least in these astronauts, may not be the 
sole cause of the globe flattening or disc edema. 
 
III. HRP RISKS AND GAPS 
Below is a list of current knowledge gaps that will need to be closed to fully understand 
SANS and reduce the risk for exploration-class missions.  
 
Current knowledge gaps: 
• SANS1: What is the etiology of visual acuity and ocular structural and functional 
changes seen in-flight and postflight? 
• SANS3: Identify in-flight diagnostic tools to measure changes in ocular structure and 
function and/or ICP related to the SANS.  
• SANS12: What are the suitable ground-based analogs to study the SANS spaceflight-
associated phenomenon? 
• SANS13: What are the safe and effective countermeasures (CMs) to mitigate changes in 
ocular structure and function and intracranial hypertension for spaceflight? 
 
IV. INTRODUCTION 
As of 2016, 24 long-duration crewmembers had experienced in-flight and/or postflight 
visual acuity and ocular anatomical changes that included optic disc edema, globe flattening, 
choroidal folds, cotton wool spot, or hyperopic shifts. NASA has termed the risk of developing 
these symptoms and physiologic ocular changes during or after long-duration spaceflight as the 
Spaceflight Associated Neuro-ocular Syndrome (SANS) (previously this was termed Visual 
Impairment and Intracranial Pressure, VIIP). Initially, SANS incidence was classified using a 
Clinical Practice Guideline (CPG) score that grouped findings together. However, as our 
understanding of SANS has evolved, the medical, research, and occupational surveillance groups 
have moved away from the CPG classification system and now report crewmember incidence on 
the basis of each ocular finding. Figure 1 depicts this new representation of findings, including 
the number of crewmembers tested for each finding, which varies. Because the Medical 
Operations group has identified optic disc edema as the primary metric for SANS, the overall 
incidence of SANS is considered to be 16%. However, 24 crewmembers have been identified as 
having one or more of the constellation of symptoms, and because of the variability in the total 
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number of crewmembers tested for each finding, 38% to 51% of long-duration crewmembers 
have developed one or more findings associated with SANS. 
 
After returning from a space mission, some crewmembers experienced transient ocular 
changes; whereas, for others these changes persisted with varying degrees of severity. While the 
underlying etiology of these changes is unknown at this time, the NASA medical community 
suspects that the microgravity-induced cephalad fluid shift and associated changes in physiology 
play a significant role in the development of SANS. The Human Health and Performance 
Directorate has assembled a SANS project team to address this issue using a comprehensive 
project plan that covers operations and research.  
 
Though the clinical findings were important by themselves, the retrospective analysis of 
questionnaires given to 300 crewmembers who participated in long- or short-duration missions 
furthered our understanding of the phenomenon and indicated that these spaceflight-induced 
vision changes are not unique to long-duration fliers. Changes in visual acuity are not 
uncommon in astronauts, although there appears to be a higher prevalence among crewmembers 
who participate in long-duration missions. Specifically, 29% of crewmembers who participated 
in a short-duration Shuttle spaceflight and 60% of crewmembers who participated in long-
duration spaceflight onboard the International Space Station (ISS) reported degradation of 
distance or near-visual acuity, which in some cases did not resolve in the years after a long 
duration ISS mission. Yet, only 9 of 47 astronauts (19%) tested following long-duration 
missions demonstrated refractive error changes ≥0.75D. In the initial 7 ISS astronaut case 
studies, which are presented below, preflight eye examinations were normal but most astronauts 
reported diminished visual acuity in flight that persisted after the mission. 
 
V. SPACEFLIGHT AND ANALOG EVIDENCE 
A. Summary of Existing Spaceflight Data 
1. Overview 
Alterations in visual acuity associated with spaceflight have been identified over the last 
40 years by medical tests, research, and anecdotal reports. In 2011, the seminal report by Mader 
et al. (Mader et al. 2011) provided case studies of 7 ISS long-duration astronauts who underwent 
extensive postflight medical examinations in response to reports of changes in visual acuity. Of 
these 7 astronauts, 5 had disc edema, 5 had globe flattening, 6 had nerve fiber layer (NFL) 
thickening by optical coherence tomography (OCT), 7 had decrements in near vision, 5 had 
choroidal folds, and 3 had cotton-wool spots. Five of the 7 astronauts who reported altered near 
vision had hyperopic shift pre to post-mission that was equal to or greater than +0.50 diopters 
(D) spherical equivalent refraction in one or both eyes (range +0.50 D to +1.50 D). Five of the 7 
had globe flattening that was identified by MRI. Lumbar punctures performed in 4 astronauts 
who had disc edema had opening pressures of 22, 21, 28, and 28.5 cm H2O performed at 60, 19, 
12 and 57 days post-mission, respectively. A summary of findings from these crewmembers is 
presented in Appendix A. 
 
Additional cases of altered visual acuity have been reported since, including an astronaut 
with a transient scotoma (visual field defect) who had to tilt his head 15 degrees to view 
instruments and read procedures.  
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To better characterize the signs and symptoms that have been related to SANS, Figure 1 
shows the number of individuals who have presented with each sign and symptom of SANS, 
along with the total number of individuals that have been tested through Expedition 48. This 
chart does not capture whether an astronaut has developed signs on more than 1 spaceflight, in a 
single eye or both eyes, or whether differences in these variables exist between sexes. Because 
the Medical Operations group has identified optic disc edema as a finding that has the potential 
to be medically treated, optic disc edema has been used as the metric for quantifying SANS and 
indicates a prevalence of 16%. However, if the total number of subjects that have presented any 
of these findings are used to quantify the prevalence of SANS, the percentage of affected United 
States Orbital Segment (USOS) crewmembers (excludes Russian cosmonauts) ranges from 
37.5% to 51%. 
 
2. Seminal Report 
The first U.S. case of vision changes observed during spaceflight was reported by an  
astronaut (C1) who noticed a marked decrease in near-visual acuity throughout his long-duration 
mission onboard the ISS but at no time reported headaches, transient visual obscurations, 
pulsatile tinnitus, or diplopia. His postflight fundus examination (Figure 2) revealed choroidal 
folds inferior to the optic disc and a single cotton-wool spot in the inferior arcade of the right 
eye. The acquired choroidal folds gradually improved but were still present 3 years after he 
returned from space. Intraocular pressure (IOP) measured by applanation revealed a 5 mmHg 
drop from before flight in both eyes. The left eye examination was normal. There was no 
Figure 1 Total number of USOS individual crewmembers that have been tested (blue) and demonstrated presence of 
each SANS finding (orange) from Expedition 1-48. In total, 24 separate crewmembers demonstrated findings in one 
or more categories. Disc edema: Modified Frisen scale grade 1 or greater at first postflight eye exam (fundoscopy); 
Cotton wool spot: Observed during or after flight (fundoscopy); Choroidal folds: New or worsened relative to 
preflight (OCT); Globe flattening: A change relative to preflight (MRI or ultrasound); Refractive error: Change in 
cycloplegic (spherical) refraction ≥0.75D from before flight to first postflight eye exam. Courtesy of the Lifetime 
Surveillance of Astronaut Health. 
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documented evidence of optic disc edema in either eye. Brain MRI, lumbar puncture, and OCT 
were not performed before or after flight on this astronaut. 
 
The second case of visual changes was reported approximately 3 months after launch 
when an ISS astronaut (C2) noticed that he could now only see the Earth clearly while looking 
through his reading glasses. This change persisted for the remainder of the mission without 
noticeable improvement or progression. The astronaut did not complain of transient visual 
obscurations, headaches, diplopia, pulsatile tinnitus, or visual changes during eye movement. 
Postflight fundoscopic images revealed choroidal folds and a cotton wool spot (Figure 3). In the 
years since the mission his vision has been stable with optical correction but has not returned to 
his pre-mission refractive status. 
 
Fluorescein angiography confirmed the choroidal folds in astronaut C2. A magnetic 
resonance angiography (MRA) and magnetic resonance venogram (MRV) were normal. An 
OCT confirmed the increased retinal NFL thickening consistent with optic disc edema nasally 
and demonstrated a normal macula. A lumbar puncture, 2 months after astronaut C2 returned to 
Earth, documented an opening pressure of 22 cm H2O with normal CSF composition. The 
astronaut had additional postflight lumbar punctures with documented opening pressures of 26, 
22, and 23 cm H2O at 17, 19, and 60 months, respectively. No improvement in visual acuity 
occurred during these 60 months. 
 
Figure 2 Fundus examination of first case of vision changes from long-duration spaceflight. Fundus examination 
revealed choroidal folds inferior to the optic disc (right-pointing arrow) and a single cotton-wool spot (left-pointing 
arrow) in the inferior arcade of the right eye. 
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Figure 3 Fundus examination of the second individual who reported visual acuity and ocular changes related to 
long-duration spaceflight. Fundoscopic images showing choroidal folds (white arrows) in the papillomacular 
bundle area in the right eye and left eye and a cotton-wool spot (bottom arrow) at the inferior arcade in the left eye. 
Both optic discs show grade 1 disc edema. 
The third case of visual changes secondary to spaceflight onboard the ISS presented 
asymptomatically with no changes in visual acuity reported during the mission and no 
complaints of headaches, transient visual obscurations, diplopia, or pulsatile tinnitus. Upon 
return to Earth, no eye issues were reported by the astronaut (C3) at landing. Fundus 
examination of astronaut C3 revealed bilateral, asymmetrical disc edema (OD: grade 3 on the 
Frisén scale; OS: grade 1) (Figure 4). There was no evidence of choroidal folds or cotton-wool 
spots. A small hemorrhage was observed inferior to the optic disc in the right eye. Astronaut C3 
had the most pronounced optic disc edema of all the astronauts reported to date, with a 0.5-D 
hyperopic shift in the right eye, and a 0.25-D hyperopic shift in the left eye. No choroidal folds, 
or globe flattening were noted. At 10 days post landing, an MRI of the brain and orbits showed 
a mild increase in CSF signal around the right optic nerve, but was otherwise normal. An MRV 
showed no evidence for cerebral venous sinus thrombosis. An OCT showed marked nerve fiber 
layer thickening consistent with optic disc edema and was thicker in the right eye than the left 
(Figure 5). A lumbar puncture performed 19 days after return to Earth documented an opening 
pressure of 21 cm H2O with normal CSF composition.  
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Figure 4 Fundoscopic images of the right and left optic disc of the third case showing profound grade 3 edema at 
the right optic disc and grade 1 edema at the left optic disc. Adapted from Mader TH et al. (2011) with permission 
from Elsevier, obtained via Copyright Clearance Center, Inc. 
The fourth case of visual changes on orbit was significant because the individual (C4) 
had previously undergone transsphenoidal hypophysectomy surgery for macroadenoma. 
Postoperative imaging showed no residual or recurrent disease. About 2 months into the ISS 
mission the astronaut noticed a progressive decrease in near-visual acuity in his right eye and a 
Figure 5 OCT examination of third case of visual changes from long-duration spaceflight. Postflight Zeiss Stratus 
OCT scans show significant NFL thickening (black line upper panel) consistent with the observed bilateral optic 
disc edema (OD>OS). Retinal Nerve Fiber Layer (RNFL) Thickness Profile – The black line indicates the thickness 
values of the patient’s scan around the optic disc from temporal, superior, nasal, inferior to temporal (TSNIT). 
Colors indicate comparison versus normative database. Green: Within normal limits, with values inside the 95% 
normal range. Yellow: Borderline, with values outside 95% but within 99% confidence interval of the normal 
distribution (.01 < P < .05). Red: Outside normal limits, with values outside 99% confidence interval of the normal 
distribution. 
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scotoma in his right temporal field of vision. He described the scotoma as fixed and translucent; 
he could not read 12-point font through the scotoma and he described it as the “shape of a 
football” held upright at arm’s length. Astronaut C4 reported no transient visual obscurations, 
headaches, diplopia, pulsatile tinnitus, or vision changes during eye movement. During the 
mission the astronaut used a topical corticosteroid and oral ketoconazole for a facial rash, 
occasionally took vitamin D supplements, and took promethazine to treat symptoms of space 
adaptation syndrome. He had never used tetracycline or nalidixic acid. He participated in two 
extravehicular activities (EVAs or space walks) during the mission and was not exposed to any 
toxic fumes. 
 
Preflight eye examination of astronaut C4 revealed a cycloplegic refraction of -0.75-0.50 
× 100 on the right and plano -0.50 × 090 on the left, correctable in each eye to 20/15. He had a 
reading add of +2.00 OU. Ten days after he returned from space, astronaut C4 had a visual 
acuity that was correctable to 20/15 with a cycloplegic refraction of +0.75-0.50 × 105 on the 
right and to +0.75-0.75 × 090 on the left. He never experienced losses in subjective best-
corrected acuity, color vision, or stereopsis. Fundus examination revealed mild, nasal disc 
edema (grade 1 Frisén scale) of the right eye with choroidal folds extending from the disc into 
the macula. Preflight to postflight IOP fell 4.0 mmHg OD, and 3 mmHg OS. 
 
Three weeks into the same ISS mission as astronaut C4, another astronaut (C5) reported 
the fifth case of decreased near-visual acuity. Carbon dioxide (CO2), cabin pressure, and oxygen 
(O2) were reported to be within the allowable levels during all missions and none of the 
astronauts were exposed to any toxic fumes.  
 
NASA consulted external experts to evaluate the data and the experts concluded that 
“the data seem to point to an eye/orbit-centered problem, and intracranial hypertension as the 
mechanism seems less likely, although it cannot be completely ruled out at this point in time.” 
In-flight ocular ultrasound exams were performed on astronauts C4 and C5 to rule out increased 
optic nerve sheath diameter (ONSD), posterior globe flattening, detached retina, 
chorioretinopathy, or raised optic disc, and to confirm normal anterior eye anatomy. Ocular 
ultrasound was used because previous studies had validated the procedure and a nonexpert had 
successfully performed ultrasound examination of the eye onboard the ISS with guidance from 
ground support teams. The remotely guided ultrasound eye examinations of astronauts C4 and 
C5 demonstrated posterior flattening of the globe, dilated optic nerve sheaths, bilaterally 
distended jugular veins, and a raised right optic disc in the astronaut C4 (Figure 6 and Figure 7). 
Image files of a near and far acuity chart and an Amsler grid were uploaded and printed on 
orbit. Both astronauts reported decrements in near-visual acuity.  
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Figure 7 On-orbit ultrasound of optic nerves of the fourth case of visual changes from long-duration spaceflight. In-
flight ultrasound shows proximal kinking and increased ONSD of approximately 12 mm that is consistent with 
raised ICPs. Optic nerve shown in purple and the ONSD in green. 
 
Three weeks after the ultrasound examination and Amlser grid testing, reading glasses 
(2.5 D and 3.25 D) were delivered to the ISS via the Space Shuttle and one astronaut reported 
that the 3.25 D glasses worked best. A video-ophthalmoscope system was also delivered to the 
ISS from the Shuttle, and remotely-guided dilated fundoscopic exams (Figure 8) were 
performed on both astronauts during their presleep period so that visual acuity loss from 
Elevation of optic disc 
Figure 6 On-orbit ultrasound of posterior orbit of the fourth case of visual changes from long-duration spaceflight. 
In-flight ultrasound image of the right eye showing posterior globe flattening and a raised optic disc consistent with 
optic disc edema and raised ICP. 
 
D S 
   
12 mm 
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Tropicamide drops would not impact other activities. The astronauts took turns being the 
operator and subject during these examinations and were given their preflight fundoscopic 
images to use as references. The fundoscopic video and captured images were downloaded from 
the ISS and sent to neuro-ophthalmological consultants who thought that the temporal location 
and shape of the reported scotoma in astronaut C4 was consistent with disc edema and an 
enlarged blind spot. The fundoscopic exam was normal for astronaut C5. Consultants agreed 
that no treatment was indicated at that time and that these images would serve as a baseline for  
follow up examinations throughout the rest of the mission. The inability to measure IOP on the 
ISS was also a factor in deferring any pharmacological interventions. Monthly remotely-guided 
ocular ultrasound, dilated video fundoscopic, and visual acuity exams were performed for the 
duration of the mission. These images allowed experts on the ground to make a diagnosis of 
mild optic disc edema in the right eye. Postflight fundus examination revealed mild, nasal optic 
disc edema (Frisen grade 1) of the right eye with choroidal folds extending from the disc into 
the macula. Postflight OCT confirmed optic disc edema and choroidal folds (Figure 8 and 
Figure 9). 
 
 
Figure 8 Fundus images from the ISS of astronaut C4 who had a case of visual changes resulting from long-
duration spaceflight. (Top) Preflight optic nerve head photography. (Bottom left) In-flight (ISS) photography of the 
right optic disc obtained by remote guidance showing “C” halo associated with Grade 1 edema. (Bottom right) 
Postflight (R+10) image shows the “C” halo edema effect in greater detail with subtle nerve fiber glutting beyond 
the border of the edematous disc (arrows).  Adapted from Mader TH et al. with permission from Elsevier, obtained 
via Copyright Clearance Center, Inc. 
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Following their long-duration mission, astronaut C4 and C5 immediately returned to 
Johnson Space Center, allowing for 3-Tesla MRI images of the eye to be obtained within 3 
days of landing. Previously, astronauts recovered in Star City, Russia for 21 days after landing 
and 3-Tesla MRI facilities were not available for these individuals.  Because no preflight 3-
Tesla head and orbit MRIs were collected on crewmembers C4 and C5, the standard 1.5-Tesla 
head MRI, MRA, and MRV obtained upon their selection into the ISS training flow (several 
years before mission assignment) were used to confirm that increased ONSD or posterior globe 
flattening were not present before the mission. 
 
The MRI of the brain and orbits was repeated on astronaut C4 30 days after return from 
space, and documented bilateral, severely dilated optic nerve sheaths (right greater than left), 
bilateral flattening of the posterior globe (right greater than left), and thickened tortuous optic 
nerves (Figure 10, Figure 11, and Figure 12). However, flight surgeons have since reported that 
a brain MRI from astronaut C4, taken years prior to the spaceflight, showed similar optic nerve 
tortuosity, suggesting this finding existed in the astronaut before the mission. An intracranial 
MRV and MRA obtained from astronaut C4 showed no abnormalities, and a lumbar puncture, 
performed 57 days after return to Earth, documented an opening pressure of 28.5 cm H2O with 
normal CSF composition.  
 
 
Figure 9 OCT of astronaut C4 who had vision changes resulting from long-duration spaceflight (right). Preflight 
Zeiss Stratus OCT showing the right and left NFL ‘TSNIT’ curve (left). Postflight Zeiss Cirrus OCT showing 
increased thickness of nerve fiber layer ‘TSNIT’ due to disc edema. Greater increase is noted in the right eye 
inferior sector consistent with postflight optic disc photography. 
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Figure 10 MRI (R+30 days) of the fourth case of vision changes resulting from long-duration spaceflight (a). 
Bilateral optic sheath dilatation remained. The right optic sheath diameter measures 10 to 11 mm (b and c); and the 
left optic sheath diameter measured 8 mm. These numbers are similar to the R+3 examination. Evidence of optic 
disc edema was seen on the right eye only. There was residual flattening of the posterior globes. The optic nerve 
remained thickened bilaterally measuring up to 5 mm on the right and 4 mm on the left. Bilateral tortuosity of the 
optic nerve sheaths also remained, with the kink at the optic nerve sheath approximately 1.1 cm behind the posterior 
margin of the globe. More recent discussions with flight surgeons indicate this tortuosity has been seen on MRI 
taken prior to the spaceflight. Red arrow depicts the optic disc edema, blue arrows show the flattened globe and the 
yellow arrows illustrate the distended optic nerve sheath.  Reproduced from Mader TH et al. with permission from 
Elsevier, obtained via Copyright Clearance Center, Inc. 
 
 
Figure 11 MRI (R+30 days) of the fourth case of vision changes resulting from long-duration spaceflight. There is 
prominence of central T2-hyperintensity of the optic nerves bilaterally, right greater than left approximately 10 to 
12 mm posterior to the globe (arrow) that represents an element of optic nerve congestion. 
a b 
c 
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Astronaut C5 noticed vision changes 3 weeks into his ISS mission. This change 
continued for the remainder of the mission without noticeable improvement or progression. He 
never complained of headaches, transient visual obscurations, diplopia, pulsatile tinnitus, or 
other vision changes.  
 
The preflight eye examination of astronaut C5 revealed a cycloplegic refraction of -5.75-
1.25 × 010 on the right, and -5.00-1.50 × 180 on the left, correctable in each eye to 20/20 with a 
reading add of +1.75 OU. Dilated eye examination and fundus photos of astronaut C5 were 
normal. Upon return to Earth he noted the vision changes persisted. Postflight visual acuity was 
correctable to 20/20 OU with a manifest and cycloplegic refraction of -5.00-1.50 × 015 on the 
right and -4.75-1.75 × 170 on the left, and a reading add of +2.25 OU. He never experienced 
losses in subjective best-corrected acuity, color vision, or stereopsis. His fundus examination 
was normal with no evidence of disc edema or choroidal folds. However, an MRI of the brain 
and orbits, and ultrasound of the globes performed 3 and 8 days after landing respectively, 
revealed that astronaut C5 had bilateral posterior globe flattening, distended optic nerve sheaths, 
and tortuous optic nerves. OCT showed significant NFL thickening relative to preflight values 
and a normal macula ( 
 
Figure 13). A lumbar puncture was not performed. This case is interesting because the 
astronaut did not have disc edema or choroidal folds but was documented to have NFL 
thickening, globe flattening, a hyperopic shift, and subjective complaints of loss of near vision.  
 
 
 
 
 
Figure 12 MRI (R+30 days) of the fourth case of vision changes resulting from long-duration spaceflight. Tortuous 
optic nerve and kink on left (arrow). MRI of opposite orbit on right. 
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Figure 13 Preflight (left) and postflight (R+13 days, right) Zeiss Cirrus OCT of the fifth case of vision changes 
resulting  from long-duration spaceflight showing right and left NFL ‘TSNIT’. Postflight Zeiss Cirrus OCT shows 
increased thickness of the nasal (red arrow) NFL. Greater increase is noted in the right eye in the nasal quadrant 
NFL thickness; 42 μm preflight to 70 μm postflight. Fundus and optic disc imaging did not show presence of 
observable disc edema. 
 
The sixth case of vision changes was reported after the ISS astronaut (C6) returned 
from a 6-month mission; he noticed that his far vision was clearer through his reading glasses. 
A fundus examination performed 3 weeks postflight documented mild (grade 1) nasal optic 
disc edema in the right eye only. There was no evidence of disc edema in the left eye or 
choroidal folds in either eye (Figure 14). MRI of the brain and orbits, performed 46 days after 
return, revealed bilateral flattening of the posterior globe, right greater than left, and a mildly 
distended right optic nerve sheath. There was also evidence of optic disc edema in the right 
eye.  
 
Fundus examination and OCT (Figure 15), performed 60 days postflight, documented 
that astronaut C6 had mild disc edema and a “new onset” cotton-wool spot in the left eye 2 disc 
diameters superior temporal to the disc, just inside the superior arcade. This cotton wool spot 
was not observed in the fundus photographs taken 3 weeks postflight. 
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Figure 14 Fundus examination of the sixth astronaut who reported vision changes resulting from long-duration 
spaceflight. Preflight images of normal optic disc. Postflight right and left optic disc showed grade 1 (superior and 
nasal) edema at the right optic disc. 
  
 
Figure 15 OCT of sixth case of vision changes resulting from long-duration spaceflight. Preflight Zeiss Stratus OCT 
showing the NFL ‘TSNIT’ curve. Postflight Zeiss Cirrus OCT showing a 50 µ increase in thickness (50% increase) 
of the nerve fiber layer at the superior and inferior poles (red arrow) consistent with changes seen in postflight optic 
nerve head photography. Choroidal folds are also visible (white arrow).  
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The seventh case of vision changes associated with spaceflight is significant in that it was 
eventually treated postflight. Astronaut C7’s preflight cycloplegic refraction was +1.25 sphere in 
both eyes and his fundus exam was normal. Approximately 2 months into the ISS mission 
astronaut C7 reported a progressive decrease in his near and far visual acuity in both eyes, which 
persisted for the remainder of the mission. Approximately 3 to 4 months into the 6-month 
mission he noticed that his normal “Earth” prescription progressive glasses were no longer 
strong enough for near tasks, at which time he began using his stronger “Space Anticipation 
Glasses” (+1.25 D greater). He never complained of transient visual obscurations, headaches, 
diplopia, pulsatile tinnitus, or vision changes during eye movement. The ISS cabin pressure, 
CO2, and O2 levels were normal during the mission (of note, the CO2 levels on the ISS are 
nominally between 2.3 and 5.3 mmHg, equal to 10-20 times the normal terrestrial atmospheric 
level, which is 0.23 mmHg). Astronaut C7 was not exposed to any toxic substances. Three days 
after his return to Earth his visual acuity was correctable to 20/20 OU with a cycloplegic 
refraction of +2.75 sphere on the right, and +2.50 sphere on the left. He never experienced losses 
in subjective best-corrected acuity, color vision, or stereopsis. A fundus examination revealed 
that astronaut C7 had mild bilateral optic disc edema (grade 1), and choroidal folds (Figure 16 
and Figure 17). 
 
 
Figure 16 Preflight images of astronaut C7’s right and left optic discs (upper). Postflight images of the ONH (lower) 
show more detail of the extent of the edematous optic disc margins and glutting of the superior and inferior nerve 
fiber layer axons and choroidal folds OD and OS (arrows). 
 
Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS) 
22 
 
   
An OCT confirmed that astronaut C7 had optic disc edema and choroidal folds. An MRI 
of the brain and orbits performed 6 days postflight documented bilateral flattening of the 
posterior globes, distended optic nerve sheaths and optic disc edema. A lumbar puncture, 12 days 
after return to Earth, documented an elevated opening pressure of 28 cm H2O with normal CSF 
composition.  
 
Astronaut C7 was the only individual who was treated following a long duration 
spaceflight because by this time NASA Space Medicine had a developed treatment plan. The 
astronaut received acetazolamide (Diamox Sequel) 500 mg for 6 weeks, then 250 mg for another 
2 weeks (total of 2 months). Over that time the lumbar puncture opening pressure decreased from 
28 (pre-treatment) to 19 cm H2O, and further treatment was deemed of questionable benefit. It is 
also noted that in this one case the individual's urinary creatinine rose from normal to 1.7, thus 
enhancing the desire to discontinue the medication. 
 
The disc edema, posterior globe flattening, choroidal folds, and hyperopic shift seen in 
astronauts C2, C4, C6, and C7 appear consistent with findings of increased intracranial 
hypertension. Astronauts C2, C4, C6, and C7 presented with optic nerve sheath distention and 
posterior globe flattening as documented by MRIs taken 23, 30, 46, 6, and 7 days post-mission, 
respectively. Additionally, astronauts C4 and C7 had lumbar puncture opening pressures of 28.5 
and 28 cm H2O at 57 days and 12 days, respectively after returning to Earth. CSF opening 
pressures were measured in astronaut C2 66 days after he returned from space and for astronaut 
C3 pressures were measured 19 days after return; pressures were not dramatically elevated, but 
they were above the upper range of normal of approximately 20 cm H2O for normal healthy 
individuals (Edsbagge et al. 2004; Berdahl et al. 2008a; b; Ren et al. 2010; Qvarlander et al. 
2013; Petersen et al. 2016; Eklund et al. 2016; Lawley et al. 2017). While these values appear 
elevated compared to normal healthy populations, no astronaut has had a reference lumbar 
puncture before spaceflight to determine whether postflight values are elevated or values are 
actually normal for that individual. Furthermore, it is not known how a postflight ICP value 
compares to ICP values in weightlessness during long-duration spaceflight.  
 
Figure 17 Red-free fundus photography of astronaut C7 taken 30 days after return from an ISS 
mission highlighting the extent of the horizontal choroidal and retinal folds in the posterior 
fundus (OD>OS). Adapted from Mader TH et al. with permission from Elsevier, obtained via 
Copyright Clearance Center, Inc. 
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In summary, although a definitive etiology for these findings is unknown, it has been 
hypothesized that venous congestion in the brain and/or eye, brought about by cephalad fluid 
shifts and which may have exacerbated choroidal volume changes, may be a unifying 
pathologic mechanism. In light of the observations of vision change, optic disc edema, 
choroidal folds, and changes in the ocular ultrasound, head and orbit MRI, increased ICP, and 
fundoscopic image changes, NASA has initiated an enhanced occupational monitoring program 
for all active astronauts that includes enhanced attention to signs and symptoms related to ICP.  
 
Interestingly, similar findings have previously been reported among Russian cosmonauts 
who flew long-duration missions on the Orbital Space Station Mir (the station was operational 
until 2001). The findings, published by Myasnikov and Stepanova in 2008 (Mayasnikov and 
Stepanova 2008), were part of a study that evaluated the retina by ophthalmoscopy, linear 
velocity of blood flow in the straight venous sinus of the brain by transcranial Doppler, and 
structural changes in the brain by MRI, under the premise that psychological difficulties reported 
during  long-duration spaceflight could be caused by impaired in-flight cerebral hemodynamics. 
The study included 16 cosmonauts, of which 8 were found to have mild to moderate optic disc 
edema on landing day, corresponding to NASA’s CPG class 3 and 4. In addition to optic disc 
edema, transcranial Doppler confirmed elevation of linear velocity of blood flow in the straight 
venous sinus of the brain in 9 of 13 crewmembers who underwent Doppler testing; flow 
velocities ranged from 30 to 47 cm/sec (normal range 14-28 cm/sec). MRI of the brain was 
obtained from 10 of the crewmembers, and 1 crewmember exhibited “signs of moderate 
intracranial hypertension” although the signs themselves are not described. This crewmember 
had congenital low-lying cerebellar tonsils, which were thought to have impeded CSF outflow 
from the cranium into the spinal canal. A second MRI obtained from this individual 3 months 
postflight reported resolution of the signs of intracranial hypertension. Of note, the spaceflight 
environment of the Mir was very similar to that of the ISS, including exposure to both 
microgravity and high levels of CO2.         
3. Case reports 
One of the original 7 crewmembers reported by Mader (Mader et al. 2011) completed a 
second long-duration spaceflight 9 years later. During his initial flight he developed choroidal 
folds and a single cotton wool spot in the right eye; during his second flight there was a 
recurrence of more widespread choroidal folds and he presented with optic disc edema, which 
was also in the right eye (Mader et al. 2013). This crewmember’s near-visual acuity in-flight was 
not different from preflight, and postflight cycloplegic refraction did not change after the second 
flight. Postflight OCT imaging revealed thickening of the RNFL in the right, but not the left eye. 
Clinical impression of the MRI revealed bilateral globe flattening. Fundus and OCT imaging 
taken 52 days following the second flight documented a normal optic disc in both eyes and 
normal RNFL thickness. The authors of this case report speculated that ocular effects resulting 
from spaceflight may be cumulative and the changes that developed during the first mission may 
have predisposed this astronaut to additional ocular changes during the next spaceflight. 
 
A follow-up Letter to the Editor described unilateral loss of SVPs in this same astronaut 
following his second mission (Mader et al. 2015). Prior to the second mission SVPs were present 
bilaterally on ophthalmoscope inspection, but were no longer present in the fundoscopy video 
obtained in the right eye, in which optic disc swelling was present, 5 months into the spaceflight 
mission. SVPs remained prominent in the left eye and the fundus was normal. A postflight MRI 
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obtained 6 days after return from space revealed bilateral globe flattening, and a repeat MRI 
showed that this flattening was still present 7 months later. The opening pressure of a lumbar 
puncture performed 8 days after landing was 18 cm H2O. By 52 days after return from space the 
optic disc swelling in the right eye had resolved, yet 21 months after the mission SVPs remained 
absent and choroidal folds persisted in the right eye.  
 
A more recent report describes an ISS crewmember (C8) who presented with asymmetric 
optic disc swelling, globe flattening, and choroidal folds (Mader et al. 2017). Optical coherence 
tomography 90 days into the mission suggested optic disc edema and choroidal folds were 
present in the right eye, with only minimal swelling and a normal optic disc in the left eye. Mild 
optic disc swelling and moderate choroidal folds persisted in the right eye 4 days after this 
individual returned to Earth and were still visible on retinal photography 90 days after landing. 
Lumbar puncture performed 7 days and 1 year after landing recorded opening pressures of 22 cm 
H2O and 16 cm H2O, respectively. Twenty-two months after landing the visual field was normal. 
 
While the reports of optic disc edema and globe flattening presented in the seminal paper 
(Mader et al. 2011) led to the hypothesis of a pathology resulting from elevated ICP, authors of 
this more recent case study suggest this cause is less likely for a number of reasons. The 
postflight lumbar puncture opening pressures suggest that ICP was not high enough to result in 
optic disc edema. More than 90% of terrestrial patients with idiopathic intracranial hypertension 
report severe headache and most present with bilateral optic disc edema, yet  astronaut C8 only 
reported occasional mild headaches and had asymmetric unilateral optic disc swelling. An 
alternative mechanism resulting from compartmentalization and sequestration of cerebral spinal 
fluid in the orbital subarachnoid space was proposed. This hypothesis points to alterations in 
CSF absorption within the orbit due to impaired venous and lymphatic drainage in 
weightlessness, leading to a locally elevated pressure within the optic nerve sheath and the 
possible accumulation of toxic substances. 
 
The majority of the medical data published on SANS stems from data collected on U.S. 
astronauts and NASA’s partner agencies (European Space Agency, Canadian Space Agency, and 
Japan Aerospace Exploration Agency); however, Russian cosmonauts have also spent a 
significant amount of time in weightlessness, yet they have not reported similar symptoms of 
SANS. A recent editorial (Bogomolov et al. 2015) suggested that Russian countermeasures 
including lower-body negative pressure (Chibis device) may provide them protection that  
astronauts from other agencies do not have. The Russian authors reported no significant 
deterioration of visual function in any Russian cosmonauts returning from missions that lasted up 
to 437 days on the Salyut or Mir space station. Furthermore, they reported that none of the 
cosmonauts showed optic disc edema (based on ophthalmoscopy) during the postflight period, 
yet they also stated that a slight or transient peripapillary edema developed during the first 3-4 
days of rehabilitation on Earth. This edema was also seen in cosmonauts after they returned from 
short-duration spaceflights. The authors suggested this transient edema resulted from 
transversely-loaded G-forces upon re-entry aboard the Soyuz spacecraft. Whether Russian 
cosmonauts are truly protected from developing SANS remains unconfirmed. Some Russian 
crewmembers have volunteered to participate in NASA research experiments and this may begin 
to provide the first in-flight evidence that may help elucidate whether Russian cosmonauts truly 
are protected from SANS. 
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4. Intracranial Pressure (ICP) in a Macaque Monkey During Spaceflight 
In 1994 a Russian publication provided evidence of ICP measurements during short-
duration spaceflight in a Macaque monkey named Krosh on the biosatellite Cosmos-2229 
(Krotov et al. 1994). A surgically implanted pressure sensor was placed in contact with the dura 
mater 25-30 days before launch. ICP was measured during seven 5-minute sessions throughout 
the 20 hours before launch, continuously for 2 hours starting 21 minutes after entering 
weightlessness, and then for 5 minutes every 2 hours throughout the duration of the flight. 
Before launch, while in the rocket on the launch pad, ICP in the “physical mid-position” (head 
and legs at the same level) averaged 10.23 ± 0.12 mmHg (range: 8.5 – 12.1 mmHg). During the 
final 2 hours before flight the average ICP was 11.66 ± 0.09 mmHg. Twenty-two minutes after 
entering weightlessness ICP was 13.78 mmHg and continued to increase to ~15 mmHg over the 
first few hours. By flight days 3 to 5 ICP reached an average of 14 mmHg, driven in large part by 
increased ICP during the night. Conversely, from flight days 6 to 9 ICP was higher during the 
day than at night and the average ICP returned to values that were similar to preflight baseline. 
Disruption in the sleep-wake cycle throughout the mission led to the changes in the circadian 
pressure rhythm such that ICP was higher at night than during the day on flight day 8 and 9. The 
ICP pulse also demonstrated changes during weightlessness, with a decrease in amplitude of the 
arterial component and an increase in amplitude of the venous component. This also tended to 
return toward preflight morphology during flight days 5 to 9. In comparison to the 4 mmHg 
change in ICP observed from preflight to weightlessness, posture changes on Earth (moving the 
monkey from upright to supine) increased ICP by 10 mmHg. 
 
5. Medical Operations Testing 
NASA’s Space and Clinical Operations Division, in collaboration with the SANS 
project, has implemented an expanded set of medical tests before, during and after spaceflight to 
determine the existence and degree of alterations in the structure and function of the eye. The 
tests relating to eye health are captured in the Medical Requirements Integration Document 
(MRID) in section MedB 1.10 (“MedB 1.10 Pre and Postflight Physical”, rev 3.4, 2016). The 
suite of tests provides information on eye and brain health for flight qualification prior to a 
mission, aids in monitoring astronauts for the development of SANS-related signs and 
symptoms during flight, and allows monitoring of recovery after flight.  
 
A 3-Tesla MRI of the brain and orbits is performed 21 to 18 months before a mission, 
and within the first three days of returning from space. The brain anatomy is evaluated against 
standard clinical criteria for the presence of abnormalities in the white and grey matter, CSF 
spaces, and vasculature. Attention is paid to signs of elevated ICP such as enlarged ventricles, 
compression of the pituitary gland, or changes in the configuration of the sella turcica. Orbital 
images are assessed for optic nerve sheath diameter, optic disc elevation, globe flattening, and 
optic nerve tortuosity − all findings that may indicate the onset of SANS. If any of the above 
signs of elevated intracranial or ON sheath pressure are documented, the MRI is repeated as 
clinically indicated.   
 
Ocular ultrasound is conducted 9 to 6 months before flight, in-flight, and during the first 
3 days postflight to document globe flattening, ONSD distension, and optic nerve sheath 
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tortuosity. Subjects are supine during ground testing. During flight, measurements are made on 
flight days 30 and 90, and on R-30 (30 days before returning to Earth). In-flight sessions are 
remotely guided by sonographers in mission control via real-time cabin video and ultrasound 
feed from the ISS. The astronauts onboard the ISS acquire the images on one another while 
receiving expert guidance from mission control.  
 
Vision testing is performed 21 to 9 months before launch and again 6 to 9 months prior to 
launch. In the postflight period, testing is completed during the first three days upon return to 
Earth and as clinically indicated. The ground portion of vision testing consists of the following:  
 
 Vision questionnaire 
 Visual acuity (distance and near) 
 Refraction (manifest and cycloplegic) 
 Amsler grid 
 Contrast sensitivity 
 Pupil reflexes 
 Extraocular muscle balance 
 Biomicroscopy (slit lamp) 
 Dilated fundus examination 
 Applanation tonometry (Goldmann, Tonopen) 
 Optical coherence tomography (high resolution)  
 Threshold automated visual fields 
 High resolution retinal photography 
 Optical biometry (axial length) 
 Magnetic resonance imaging (brain and orbits) 
 
During flight, far visual acuity is tested for each eye with and without a corrective lens 
using a software application loaded onto the OCT laptop that provides a screen shot of a standard 
logMAR Snellen chart. The astronaut is positioned 15 feet away from the OCT laptop and 
ground-support personnel control the software application by remotely accessing the OCT 
laptop. The software is also used for Amsler grid testing during each session for both the right 
and left eyes. Any changes to the appearance of the grid (wavy, blurred, or missing lines) 
indicate a positive for this test. Near visual acuity is tested for each eye with and without a 
corrective lens using a paper-based eye chart located 16 inches from the astronaut on the wall of 
the laboratory module of the ISS. Laptop-based contrast sensitivity testing is not routinely 
performed during flight, but is available for “as clinically indicated” situations.  
 
OCT is a diagnostic imaging technique that is based on analysis of the reflection of low-
coherence infrared light from the tissue under examination. It involves measurements of retinal 
thickness, volume, and retinal nerve fiber layer (RNFL) thickness using a method of quantitative 
cross sectional analysis. OCT is conducted before, during, and after spaceflight to identify and 
detect changes in key posterior ocular areas, especially the optic disc, retinal nerve fiber layer 
(RNFL), retinal pigment epithelium (RPE), and the vascular choroid. The OCT scans are 
performed with the subject placing their chin on a chin rest while the device performs a scan of 
the eyes. 
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Dilated fundoscopy is performed on the right and left eye to obtain images of the retinal 
surface and optic disc. All in-flight exams are remotely guided using the current fundoscope and 
desktop streaming software technology. Still images and short video clips are recorded and 
downlinked. 
 
The in-flight vision questionnaire asks if the crewmember has noticed any change in his 
or her vision since launch or the last in-flight exam. Respondents rate any change as mild (does 
not affect daily activities), moderate (crewmember had to make changes to accommodate, but 
completion of all activities was achieved), or severe (changes significantly affected or interfered 
with completion of daily activities). The vision change questionnaire includes questions about 
distortion, vision in dim light, fluctuation in visual acuity, depth perception, double vision, 
transient vision loss, and change in near, intermediate, and distance vision. Additional questions 
include type of eyewear used, i.e., progressive lenses, bifocal lenses, reading glasses or 
adjustable eyewear. The crewmember is also asked is they have any of the following symptoms: 
headaches, tinnitus, nausea, or impairment in cognition. If present, he or she is asked to rate the 
intensity as mild, moderate, or severe. 
 
Refractive error is a measurement of the lens power needed to correctly focus light on the 
retina of the eye. Two types of refraction tests, manifest and cycloplegic, are used to measure 
refractive error. In manifest refraction, refractive errors are measured while the eyes own 
crystalline lens is able to accommodate. During manifest refraction, subjects may “over-use” 
their accommodative ability while trying to read a line of letters. This must be controlled to 
properly determine the refractive error and prescribe the appropriate correction. Cycloplegic 
refraction determines the total refractive error while the muscles that aid in focusing the eye are 
temporarily paralyzed. Cycloplegic eye drops are used to temporarily relax the cilliary body, the 
focusing muscle of the lens.  
 
Standard automated visual field testing (Zeiss Humphrey SITA standard) is conducted on 
astronauts before and after their spaceflight missions to screen for changes in central and 
peripheral vision. Humphrey’s automated static threshold visual field is used to simultaneously 
test different locations throughout the visual field. A SITA standard 30-2 is used to test the 
central 30 degrees of the visual field by displaying a dim light at a particular location. If the 
astronaut does not see the light, it is gradually made brighter until it is seen. The minimum 
brightness required for the detection of a light stimulus is the "threshold" sensitivity level for that 
location. This procedure is then repeated at several other locations until the entire visual field is 
tested. The 30 degree test is used to assess 76 individual points that are separated by 6 degrees.   
 
Additional testing conducted pre- and postflight includes pupillary reflexes, extraocular 
muscle balance, biomicroscopy, and optical biometry. Retinal photography is conducted before, 
during, and after the mission. 
 
6. Optic Nerve Sheath Diameter (ONSD) 
Since the initial hypothesis suggested that elevated ICP was a precipitating factor in the 
development of changes to the structure and function of the eye, NASA’s Medical Operations 
group used ultrasound imaging of the optic nerve and optic nerve sheath in an attempt to 
noninvasively assess and longitudinally track signs of elevated ICP. With increasing ICP, the 
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local compartment of the CSF, predominantly in the retrobulbar portion of the optic nerve, is 
distended by hydrostatic transmittance of CSF pressure within the subarachnoid space (SAS). As 
noted above, it is also possible that the increase in optic nerve sheath pressure and resultant 
distension may occur as a localized compartment syndrome even in the presence of non-elevated 
ICP. This can result in an increase in the local ONSD, even before edema appears at the optic 
disc, which may reflect the accommodative capacity of the retrobulbar space. Although a number 
of studies have demonstrated a relationship between ONSD and ICP, a large range of ICP values 
are required to achieve statistically significant correlations. Because ultrasound assesses ONSD 
noninvasively, ONSD measurements are conducted pre-, in-, and postflight to track any changes 
immediately posterior to the globe; pre- and postflight analysis of MRI data also provide 
assessment of ONSD. 
 
MRI data collected from 27 astronauts after they returned from long-duration spaceflight 
was used to measure ONSD; 8 of these individuals subsequently flew a second short-duration 
mission and had a second MRI available for review (Kramer et al. 2012). The ONSD of the 8 
subjects did not change after their short-duration spaceflight relative to their ONSD after a 
previous long-duration mission. After long-duration spaceflight, 20 astronauts who did not 
present with globe flattening had an average ONSD of 5.8 ± 0.6 mmHg, while 7 astronauts with 
globe flattening had an ONSD of 7.2 ± 1.5 mmHg. When grouped by presence of nerve kinking, 
those with nerve kinking (n=4) had a greater ONSD than those without (n=23) (7.5 ± 1.1 vs. 5.9 
± 0.8 mmHg, respectively). 
 
7. Intraocular Pressure 
In light of the relationship between IOP, glaucoma, and RNFL pathology, assessment and 
longitudinal tracking of IOP during prolonged spaceflight was also a priority for the Medical 
Operations group. Preliminary data have shown that IOP is elevated above ground-based values 
upon initial exposure to weightlessness (Draeger et al. 1995). Because there are no valves in the 
veins in the eye or the brain, there is no venous pump, as there is in the legs, to facilitate blood 
return to the heart. Thus, in weightlessness, where no venous pump or gravity exist, blood flow 
may stagnate and accumulate in the veins, contributing to the distended facial and neck veins 
noted in astronauts. In addition, a cephalad redistribution of fluids is known to occur with 
exposure to weightlessness, which has been recorded as changes in leg girth, facial edema, and 
verbal reports of head fullness and nasal congestion. Venous engorgement elevates the cerebral 
post-capillary venous pressure. This rise in venous pressure affects the episcleral veins as well as 
the choroid space within the eye. Congestion in the venous system will cause a concomitant rise 
in pressure in the episcleral vessels of the eye and will increase the resistance to aqueous-humor 
outflow, leading to a rise in IOP (Mader et al. 1993). However, the aqueous-humor outflow 
system is slow and would not account for the sudden spike in IOP documented in head-down and 
parabolic flight studies. Therefore, sudden choroidal expansion within the eye is a more likely 
explanation for the rise in IOP. Since the choroid is drained by the vortex vein system and lacks 
autoregulation, a sudden rise in venous pressure from cephalad fluid shifts could inhibit 
choroidal drainage causing sudden choroidal expansion and a concomitant IOP spike. Indeed, 
modeling work suggests ocular hemodynamics governs the response of IOP to acute 
gravitational changes (Nelson et al. 2017). 
 
Draeger (Draeger et al. 1995) reported an initial 20% to 25% increase in IOP 44 minutes 
Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS) 
29 
 
into a Space Shuttle flight that was measured using a hand-held applanation tonometer. In a 
subsequent experiment, IOP in 2 cosmonauts onboard a Soyuz vehicle bound for the Mir Space 
Station increased 92% 16 minutes after reaching weightlessness (Draeger et al. 1993). In a 
follow-up 6-day experiment onboard STS-55 (the German D2 mission) diurnal IOP was recorded 
and a 114% increase in IOP was noted 16 minutes after crewmembers reached microgravity 
(Draeger et al. 1994). 
  
Tonometry data collected as part of the medical testing requirements uses the gold 
standard Goldman applanation tonometry pre- and postflight on subjects while seated, and the 
handheld Tonopen is used by crewmembers on each other during spaceflight. Preliminary data 
supplied by the Lifetime Surveillance of Astronaut Health for 15 subjects suggest there is no 
change in IOP for the group as a whole on flight day 30 and 30 days prior to return to Earth (R-
30) compared to pre- or postflight (Figure 18). The subjects who demonstrated optic disc edema 
on fundoscopy (red symbols) upon return to Earth do not appear different from the remaining 13 
crewmembers (Figure 19).  
Figure 18 IOP values for eleven subjects before, during (non-shaded region), and after six Shuttle missions. FD= 
flight day 
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8. Magnetic Resonance Imaging 
MRI of the eye is acquired before and after long-duration space missions as part of the 
astronauts’ medical monitoring. In 2012 Kramer et al. reported the prevalence of globe flattening 
and ONSD distension after short- and long-duration spaceflight as measured by MRI, and the 
authors suggested these findings were similar to terrestrial IIH patients (Kramer et al. 2012). 
Although limitations exist in translating postflight findings into speculation about occurrences 
during spaceflight, quantification of CSF flow dynamics may provide insight into changes in ICP 
during spaceflight. In dogs, experimentally induced intracranial hypertension above 27.2 cm H2O 
results in down-regulation of CSF production (Miller et al. 1986). This led to the hypothesis that 
the combination of a headward fluid shift, intracranial volume expansion, and resulting 
modulation of CSF hydrodynamics may occur in astronauts during prolonged weightlessness. 
Kramer, et al. (Kramer et al. 2015) graded the degree of globe flattening from pre- and postflight 
MRIs obtained from 14 astronauts (7 long-duration fliers and 7 short-duration fliers), 13 of 
whom had previous spaceflight exposure. Two astronauts (one short- and one long-duration flier) 
had optic disc protrusion after their mission, and there was an increased incidence and severity of 
globe flattening in the long- (n=4) vs short-duration (n=2) fliers. Postflight CSF production rate 
was significantly higher postflight than preflight in the subgroup who had globe flattening, 
whereas CSF production rate was not significantly changed for the group that did not have globe 
flattening; no reports were provided for the effect of flight duration on CSF production rate. 
Conversely, astronauts that did not have globe flattening had a significant increase in CSF 
maximum systolic velocity, and those with globe flattening did not. These results suggest that 
spaceflight induces a down regulation of CSF production in response to the cephalad fluid shift. 
Upon return to the 1g environment on Earth the reversal of the cephalad fluid shift causes a drop 
in ICP and a compensatory upregulation of CSF production. Kramer et al. further speculate that 
the CSF maximum systolic velocity represents a marker of compensatory reserve and increased 
Figure 19 Intraocular pressure averaged between right and left eyes collected with Goldman Applanation 
tonometry (circles) or Tonopen (squares). Red symbols (n=2) are subjects who demonstrated optic disc edema in 
one or both eyes during postflight fundoscopy exam. Black symbols (n=13) are subjects without signs of optic disc 
edema. Pre, preflight; FD30, flight day 30; R-30, 30 days prior to return; Post, postflight. Provided by NASA 
Lifetime Surveillance of Astronaut Health. 
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craniospinal compliance. If the astronauts with greater CSF maximum systolic velocity had 
anatomical differences in their spinal canal, thecal sac, or compression of the epidural venous 
plexus that allowed them to maintain a greater capacity to blunt increases in ICP, this could 
explain why they did not develop globe flattening and this warrants further investigation. 
Furthermore, it remains unknown if ICP during spaceflight needs to be pathologically elevated to 
cause the observed ocular changes, or whether the lack of diurnal variation in ICP typical of 
upright and supine posture on Earth is sufficient to alter CSF production rates. 
 
9. Choroidal Folds 
If the retrobulbar pressure becomes elevated beyond physiologic levels, the pressure may 
compress the posterior globe causing posterior sclera flattening thereby moving the macula 
anteriorly. Hence, posterior globe compression or sclera flattening may be a secondary 
mechanism contributing to the hyperopic shift. Scleral flattening may also contribute to 
choroidal fold development by decreasing the surface area that supports the choroidal 
vasculature. As a consequence, the choroidal vessels become compressed, precipitating folding.   
 
Although not typically associated with the development of optic disc edema, choroidal 
folds have been reported in 11 of 47 (23.4%) crewmembers as demonstrated by either 
fundoscopy or OCT imaging. The anatomical location and presentation of these folds varies 
between individuals, with some folds appearing in a circular pattern around the optic disc and 
others appearing as horizontal folds between the disc and macula. Currently, choroidal folds 
visualized on fundoscopy or OCT are evaluated and graded on the following scale: clear (0), 
trace (1), mild (2), moderate (3), or severe (4). The pathophysiology surrounding this finding 
remains unknown at this time.  
 
Choroidal folds usually involve Bruch’s membrane and the adjacent RPE, but they may 
also be associated with retinal folding (Mader et al. 2017). The absence of vision changes with 
the occurrence of choroidal and retinal folding suggests that these folds have not been of 
sufficient magnitude, so far, to cause vision distortions. Any factor causing globe flattening or 
congestion within the choriocapillaris may lead to folding.  
 
10. Summary 
The constellation of ocular signs and symptoms reported during and after long-duration 
spaceflight, including optic disc edema, globe flattening, choroidal folds, enlargement of the 
subarachnoid space detected from ONSD distension, and a hyperopic shift are similar to those 
described in idiopathic intracranial hypertension. This led to the initial primary hypothesis that 
SANS resulted from elevated ICP. In contrast, more recent case reports suggest an alternative 
hypothesis that does not rely on pathologically elevated intracranial pressure for the development 
of SANS. This alternative hypothesis proposes that a localized rise in optic nerve sheath pressure 
within the orbit could occur even without a rise in ICP. Furthermore, invasive measurement of 
ICP during brief periods of weightlessness in parabolic flight (see below) support the notion that 
the acute headward fluid shift does not result in pathologically elevated ICP. Although the 
etiology remains unknown, it is proposed that SANS findings may represent manifestations of a 
pathologic process related to, but not limited to, the eye and the optic nerve, the brain, and the 
vascular system including venous congestion experienced during prolonged weightlessness.  
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B. Analog Evidence 
1. Parabolic Flight, Effects on ICP and IOP 
No invasive direct measurements of ICP have been conducted during spaceflight, but 
many of the risks and considerations that would require resolution before attempting an ICP 
measurement during weightlessness have been reviewed (Barr 2014). Recent work by Lawley et 
al. (Lawley et al. 2017) utilized patients that had implanted Ommaya reservoirs for central 
nervous system chemotherapy administration, but were asymptomatic for at least 1 year, to 
directly measure ICP during ~20-second periods of weightlessness achieved during parabolic 
flight and referenced to both seated and supine positions. A fluid-filled 25 gauge needle was 
inserted into the Ommaya reservoir and attached to a pressure transducer to continuously 
measure ICP during posture changes and weightlessness during parabolic flight. ICP was 4 ± 1 
mmHg while seated and increased to 15 ± 2 mmHg after stabilization in the supine position. In a 
separate experiment, these same subjects were in the supine position throughout parabolic flight 
and ICP decreased by 3.8 ± 2.9 mmHg after transitioning from 1g to 0g. This indicated that ICP 
during weightlessness falls to levels between seated and supine values on Earth. These data led 
the authors to conclude that removal of the gravitational vector does not raise ICP to 
pathologically elevated levels. 
 
Some have hypothesized that resistance exercise conducted as a countermeasure to 
muscle and bone loss during long-duration spaceflight may lead to periodic spikes in ICP and 
thus contribute to SANS signs and symptoms. The same patients with Ommaya reservoirs 
performed leg-press exercises during head down tilt (n=4) and during the weightlessness phase 
of parabolic flight (n=8) while conducting Valsalva and Mueller maneuvers (Lawley et al. 2017). 
Because of the slight increase in ambient CO2 on the ISS these subjects were also exposed to 
0.7% CO2 during exercise and throughout 24 hours of 6° head-down tilt. Leg press exercise 
performed during weightlessness in parabolic flight with uncontrolled Valsalva significantly 
lowered ICP by a few mmHg compared to the ICP pressures in supine position in 1g. In the 
supine and 6-degree head down tilt posture (after 5 min and 25 hr) central venous pressure and 
ICP increased during Valsalva with leg press contraction. During the Muller maneuver, the 
reduced intrathoracic pressure and central venous pressure during leg extension attenuated the 
magnitude of change of ICP.  
 
Two groups of investigators have reported IOP increases during parabolic flight. Draeger 
and colleagues documented a mean 5 mm increase in IOP during the free-fall phase of parabolic 
flight using a hand-held applanation tonometer, which has been superseded by more accurate 
instruments (Draeger and Hanke 1986). Mader et al. (Mader et al. 1993) also measured IOP 
during parabolic flight using a TonoPen. They found that IOP increased 7 mmHg on average, 
from a mean baseline value of 12 mmHg to an in-flight mean of 19 mmHg (n = 11).  
 
Recently IOP values obtained during parabolic flight were compared to IOP values 
during posture changes in a 1g environment (Anderson et al. 2016). Not only does IOP increase 
when moving from seated to supine, but a further increase occurs when subjects are positioned 
face down in the prone posture; during brief periods of weightlessness experienced in parabolic 
flight, IOP falls between the supine and prone values. 
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During weightlessness the loss in the gravitational vector that drains blood flow through 
the internal jugular vein may contribute to venous congestion and impair cerebral venous and 
lymphatic drainage from the skull. Noninvasive estimates of internal jugular venous pressure 
(IJVP) recently conducted during periods of weightlessness in parabolic flight using compression 
sonography in 11 healthy subjects (8 female) in a seated position indicate that IJVP during 
weightlessness (23.9 ± 5.6 mmHg) is greater than IJVP during seated posture at 1g (9.9 ± 5.1 
mmHg) (Martin et al. 2016). Furthermore, when intrathoracic pressure is increased to 10 and 20 
mmHg at 0g by having subjects perform a Valsalva maneuver, IJVP increases 10 and 20 mmHg, 
respectively.  
 
In some cases of idiopathic intracranial hypertension (IIH), choroidal folds have been 
found to precede the development of optic disc edema. In others, choroidal folds have been the 
only presenting sign of raised ICP from any source (that is, pseudotumor cerebri, venous sinus 
thrombosis, or intracranial mass). This suggests that either elevated intrasheath pressure and 
indentation of the globe, or elevated venous pressures transmitted to the choroid may cause 
choroidal folds before the onset of optic disc edema. It may be possible that variation of elastic 
properties of the sclera in different individuals could have some influence on how readily globe 
flattening occurs. If ICP is raised, but doesn’t reach a critical level to cause axoplasmic stasis for 
that individual, it may cause retrolaminar ONS enlargement and posterior globe flattening 
without causing obvious ONH swelling.  
 
The inter-individual variability of the elastic properties of the ONS has been 
demonstrated by Hansen et al. (Hansen et al. 2011), while Lavinsky et al. (Lavinsky et al. 2007) 
showed variability among subjects in scleral rigidity as a determinant of the visible effects of the 
transmission of an increased ICP to the globe. In their study, they described the most frequent 
sonographic findings in IIH cases: flattening of the posterior ocular wall, thickening of the 
retinochoroid layer, and distension of the ONS. It is likely that in some individuals, retrobulbar 
pressure becomes great enough to cause some globe flattening, but not so high as to cause 
axoplasmic stasis. Even if the choroid is engorged due to ICP elevation, the sheath and lamina 
are likely flexible enough to minimize axonal compression, maintain axoplasmic flow, and help 
prevent swelling and disc edema. 
 
2. Head-down Tilt, Effects on ICP and IOP 
Direct invasive assessment of ICP in healthy subjects has not been performed during 
prolonged bed rest, but multiple studies have investigated the magnitude of change in ICP during 
various tilting postures. Table 1 presents a list of studies in which ICP was invasively measured 
in “healthy” control subjects via lumbar puncture, Ommaya reservoir, or a tip-transducer catheter 
passed into the brain parenchyma or the frontal horn of the right lateral ventricle (Edsbagge et al. 
2004; Qvarlander et al. 2013; Petersen et al. 2016; Eklund et al. 2016; Lawley et al. 2017). We 
applied a random-effects meta-analysis to the data reported in these studies (number of subjects, 
mean, and standard deviation) and estimated an overall mean of 16.0 cm H2O and a 95% 
confidence interval of 14.9 to 17.2 cm H2O for healthy subjects in the supine position. However, 
the range for the mean ICP across these studies is 12.8 to 20.4 cm H2O. In a subset of these 
studies, subjects were positioned at 6, 9, 10, or 20-degrees head-down tilt to measure the effect 
of a headward fluid shift on ICP. Using the same Ommaya reservoir patients that underwent 
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parabolic flight experiments, Lawley et al. (Lawley et al. 2017) measured ICP throughout 24 
hours of 6° head-down tilt and found it was the same as ICP measured while supine before tilting 
(Lawley et al. 2017). Eklund et al. tilted subjects at a 9-degrees head-down tilt and ICP increased 
from 14.3 to 21.5 cm H2O while the subjects were supine (Eklund et al. 2016). Petersen et al. 
who reported the lowest supine ICP of 12.8 cm H2O tilted subjects to 10- and 20-degrees head-
down tilt, which resulted in ICP increasing to 14.3 and 19 cm H2O, respectively (Petersen et al. 
2016). 
 
Table 1 Publications reporting invasive measurements of ICP in healthy subjects. n = number of subjects. AJPR, 
American Journal of Physiology, Regulatory, Integrative and Comparative Physiology; IOVS, Investigative 
Ophthalmology & Visual Science; JAP, Journal of Applied Physiology; NTG, normal tension glaucoma; OHT, 
ocular hypertension; POAG, primary open angle glaucoma. Note: Eklund et al. (2016) used 2 controls groups for 
appropriate matching to 2 disease populations. 
Publication Position n Mean (SD), 
mmHg 
Mean (SD), 
cm H2O 
Subject Population 
Eklund, Ann 
Neurol, (2016) 
80:269-276 
Supine 11 10.5 (1.5) 14.3 (2.0) Healthy adults 
Supine 11 11.5 (0.8) 15.6 (1.1) Healthy adults 
Berdahl, IOVS, 
(2008) 49:5412-18 
Supine 68 12.7 (3.9) 17.3 (5.3) Age-matched control subjects for 
POAG and NTG (> 55 yrs) 
Supine 39 11.5 (3.3) 15.6 (4.5) Age-matched control subjects for 
OHT (30-70 yrs) 
Berdahl, 
Ophthalmology, 
(2008) 115:763-68 
Supine 49 13.0 (4.2) 17.7 (5.7) Non-POAG 
Ren, 
Ophthalmology, 
(2010) 117:259-66 
Supine 71 12.9 (1.9) 17.5 (2.6) Non-Glaucoma 
Petersen, AJPR, 
(2016) 310:R100-4 
Supine 9 9.4 (3.8) 12.8 (5.2) Patients: non-surgical candidates, 
18-70 yrs 
Qvarlander, JAP, 
(2013) 115:1474-80 
Supine 27 11 (2.1) 15.0 (2.9) Patients: investigation for 
suspected normal pressure 
hydrocephalus 
Edsbagge, AJPR, 
(2004) 287:R1450-5 
Supine 34 10 (2.3) 13.6 (3.1) Healthy medical or dental students. 
ICP Range: 9.2-19.1 cm H20 
Lawley, J Physiol, 
(2017) 595:2115-
2127 
Supine 8 15 (2) 20.4 (2.7) Former cancer patient free of 
disease for > 1yr 
 
While it remains unknown whether ICP would increase during more prolonged periods of 
head-down tilt, the lack of gross ocular changes after up to 70-days of head-down tilt bed rest 
suggests that bed rest does not increase ICP, or some other factor may occur that leads to a 
different response during prolonged bed rest than occurs during prolonged spaceflight. Lawley et 
al. suggested that the pillow that is placed under all bed rest subjects’ heads may provide enough 
of a gravitational vector for blood and CSF to drain from the head and prevent an elevated ICP. 
In fact, ICP in supine subjects was reduced by an average of 4 mmHg when the head was lifted 
onto a pillow (14 ± 2 mmHg [without pillow] and 10 ± 2 mmHg [with pillow]). However, subtle 
increases in peripapillary retinal thickness (+4.67 µm ≤ mean delta +12.17 µm) in the inner 
sectors of the Early Treatment Diabetic Retinopathy Study (ETDRS) grid did develop after 70 
days of head-down tilt bed rest (Taibbi et al. 2017). This thickening decreased with increasing 
distance from the optic disc such that average retinal nerve fiber layer thickness increased by just 
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+1.33 µm after bed rest and there were no differences between the control and exercise groups in 
any ocular measures. 
 
Similar to the effects of posture change on ICP, IOP is also influenced by changes in 
body posture (Weinreb et al. 1984; Friberg and Weinreb 1985; Draeger and Hanke 1986; Mader 
et al. 1990; Liu et al. 1998, 2002, 2003a; Chiquet et al. 2003; Xu et al. 2010), the most common 
of which is the transition from the upright position to the supine posture. Using a noncontact 
tonometer, Chiquet et al. (Chiquet et al. 2003) measured IOP in 25 healthy female subjects who 
were seated as well as 1, 3, and 10 minutes after laying flat. After 1 minute in the supine 
position, their IOP had increased by 2 mmHg relative to sitting and then remained stable 
throughout the 10 minutes of monitoring. This observation of an elevation in IOP while supine is 
consistent with results from other studies (Wilson et al. 1993; Liu et al. 1998, 2002). 
 
The first known study to examine the effects of prolonged simulated microgravity on 
ocular structure and function was reported in 1970 by Drozdova and Nesterenko (Drozdova and 
Nesterenko 1970). Sixteen healthy subjects were studied before, during, and after 70 days of bed 
rest. The specific conditions studied, which the authors refer to as “hypodynamia”, were not 
clearly delineated in this report, but after 45 days of hypodynamia, visual acuity had decreased 
by 21%, the visual field decreased by 11 degrees, and the near point of clear vision had been 
extended by 3.5 cm. Interestingly, the authors reported that IOP decreased by 3 mmHg from a 
prestudy level of 20 mmHg. The authors reported that visual function had decreased further after 
67 days of hypodynamia; the visual field decreasing by 15 degrees and the near point of clear 
vision had been extended by 12.5 cm relative to the prestudy measurement. The authors failed to 
indicate the timing of their ophthalmic examinations relative to the study timeline, but they 
reported that changes in visual function appeared to be coupled with structural changes within 
the eye. The optic disc appeared to have faded and the temporal borders were indistinct. 
Additionally, both the veins and the arteries of the eye appeared to be enlarged. In particular, the 
authors noted that the veins were distended and exhibited a deeper coloration. Encouragingly, the 
changes in the visual function and structure after 70 days of hypodynamia in the study by 
Drozdova and Nesterenko recovered somewhat when subjects resumed their normal activities 
(Drozdova and Nesterenko 1970). Twenty days after the end of the hypodynamia condition, 
ophthalmic examination revealed that the arteries of the eye had returned to their normal size, the 
veins were less distended, and the optic disk was pink with sharp boundaries. Concomitantly, 
visual acuity and the size of the visual field had recovered to some extent after 20 days but these 
were not at the prestudy baseline. Unfortunately, it appears that no follow-up examinations were 
completed beyond the 20 days post hypodynamia; therefore, this study does not provide any 
clues to whether these observed changes in vision and ocular structure were long lasting or 
permanent. While it is difficult to correlate these changes with spaceflight-induced alterations in 
vision with any certainty, it is relevant to note that vision changes in astronauts do not 
consistently resolve after long-duration spaceflight either (Mader et al. 2011). 
 
In a study of 4 male subjects exposed to 120 days of horizontal bed rest, Kuzmin 
(Kuz’min 1973) found that IOP increased to 28 to 30 mmHg. In 2 of the subjects, the increase in 
IOP was accompanied by visual disorders in the form of clouding of vision and a decrease in 
visual acuity. Kuzmin proposed that impaired regulation of IOP was occurring under prolonged 
bed rest, and that subjects over 45 years of age and those with autonomic dysfunction could be at 
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increased risk of increased IOP. Similar changes in IOP were noted by Kuzmin et al. in a 62-day 
horizontal bed rest study (Kuz’min 1973).  
 
The cephalad fluid shift during the transition from an upright to a head-down posture 
would be expected to result in even greater elevations in IOP compared to the transition to supine 
posture because the hydrostatic gradients are reversed compared to gradients when standing or 
sitting. In an extreme illustration, Draeger et al. (Draeger and Hanke 1986) observed that IOP, 
measured with the same hand-held applanation tonometer as the one used during spaceflight 
studies, almost tripled in 20 healthy volunteers when they moved from the +90° head-up position 
(~12 mmHg) to the -90° head-down position (~34 mmHg) in increments of 45°. Similar 
increases were observed by other investigators (Weinreb et al. 1984; Friberg and Weinreb 1985). 
As had been observed, IOP increases when subjects move from the head-up to supine posture, 
but the elevation in IOP was more dramatic once subjects progressed beyond the supine posture 
to head-down positions. The influence of the respective height of the hydrostatic column relative 
to the gravity vector is clear when measuring local pressure changes during posture transitions; 
changes in leg arterial pressures appear to be concurrent and inversely related to the alterations in 
IOP (Draeger and Hanke 1986). It must be noted, however, that acute radical tilts do not reflect a 
spaceflight analog condition and these results should be taken for their own relevance.  
 
Therefore, because spaceflight conditions are not simulated by such extreme postures as 
inversion, it seems more reasonable to explore IOP effects during a more moderate head-down 
position. Draeger et al. (Draeger and Hanke 1986) examined 10 men during 90 minutes of 10-
degree head down tilt (HDT). There was an immediate elevation of IOP with HDT that reached a 
maximum (~24 mmHg) after 15 minutes. IOP decreased somewhat by 45 minutes of HDT and 
was stable through the end of the tilt, although still higher than the level observed during the 
seated posture. Draeger et al. also observed that IOP decreased during lower body negative 
pressure used to reverse the cephalad fluid shift, and the pressure was restored when the 
decompression of the lower body was released. The effects of HDT on IOP were also present, 
although attenuated, when subjects were dehydrated by a sauna exposure that reduced their body 
weight by 2% before tilt. In this spaceflight model of induced plasma volume loss, the initial 
elevation of IOP was less severe and the peak pressure was acquired and resolved in a shorter 
time when subjects were dehydrated, but the pattern of intraocular responses to tilt remained. 
Also, using the 10-degree HDT model, Shinojima et al. measured subfoveal choroidal thickness 
and foveal retinal thickness. They hypothesized that elevated ophthalmic vein pressure during 
simulated microgravity increases subfoveal choroidal thickness via enlargement of the choroidal 
vasculature and greater choroidal blood volume. Subfoveal choroidal thickness and IOP were 
increased by HDT during simulated microgravity, although no change in foveal retinal thickness 
was observed (Shinojima et al. 2012).   
 
Xu et al. (Xu et al. 2010) evaluated IOP in 65 males, with a mean age of 22.5 years, 
during 21 minutes of 15-degree HDT to assess whether myopic individuals were more sensitive 
to cephalad fluid shifts than emmetropes and low myopic subjects. Baseline mean values of IOP 
in the low myopic eyes and emmetropic eyes were similar (15.09 ± 3.20 mmHg and 14.71 ± 3.07 
mmHg, respectively) while those in the moderate myopic eyes appeared slightly higher (16.59 ± 
3.50 mmHg). During the 15-degree HDT, the mean value of IOP was increased in all subjects at 
every test point when compared to their respective baseline values. The IOP in the moderate 
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myopic group was higher than the IOP in the emmetropic and low myopic groups at 1, 6, and 11 
minutes after the initiation of the 15-degree HDT test (P, 0.05), and reached a peak of 21 mmHg 
at 6 minutes. The results suggested that IOP in the moderate myopia group was more sensitive to 
postural change. 
 
Mader et al. (Mader et al. 1990) examined IOP and visual acuity in 9 men aged 19 to 29 
years during 48 hours of 10-degree HDT. The subjects showed a diurnal variation in IOP, with 
values lowest early in the morning and highest at noon. Baseline IOP was 11.2 mmHg while 
seated, and rose to 17.9 mmHg within seconds of subjects assuming the head-down position. 
When they sat up 48 hours later, IOP had decreased 6.7 mmHg on average. Because these two 
IOPs were significantly different, the authors concluded that a greater volume of blood was 
displaced at the end of the 48 hours than at time zero. In a companion study of the same subjects 
during this 10-degree HDT period, Frey et al. (Frey et al. 1993) reported a 4% increase in the 
size of the optic disc. Retinal artery and vein diameters were greater and IOPs were lower during 
the seated rest period before the subjects assumed the HDT posture, but no change occurred 
during bed rest. Additionally, as bed rest progressed, thoracic fluid volume decreased in these 
subjects along with a tendency for middle cerebral artery velocity to decrease. The decrease in 
middle cerebral artery velocities was inversely correlated with the change in retinal vasculature 
caliber. This observation agrees with reports from Friberg and Weinreb (Friberg and Weinreb 
1985) of subjects during total body inversion (hanging upside-down). Chiquet et al. (Chiquet et 
al. 2003) measured IOP and corneal thickness in 8 women during and after 7 days of 6-degree 
HDT bed rest. In these subjects, IOP measured in the HDT position progressively decreased 
through the course of bed rest, becoming significantly lower than pre-bed rest values after 5 days 
of bed rest. IOP recovered to pre-bed rest levels after 2 days of normal activity. 
 
Mader et al. (Mader et al. 2011) noted that an increase in episcleral venous pressure 
would elevate IOP due to backflow resistance. However, because aqueous flow is less than or 
equal to 3 µL/min (Goel et al. 2010), such a large increase in IOP would take several minutes to 
occur if it was purely a result of impaired aqueous humor outflow and would not lead to the 
observed rapid spike in IOP. This could, however, be explained by an engorgement of 
intraocular uveal tissue, principally the choroid, secondary to cephalad fluid shift. Normally, 
blood in the choroid is drained through the vortex veins. When the head remains in the 
recumbent position, venous blood may pool in the choroid owing to the effects of gravity. As the 
choroidal blood flow lacks autoregulation, there is little resistance to fluid accumulation aside 
from the tamponade effect of rising IOP. Total body inversion causes a sudden rise in choroidal 
blood volume of only 20 μL, which may result in an immediate rise in IOP of more than 20 
mmHg (Smith and Lewis 1985). While the choroidal circulation is not autoregulated, the retinal 
circulation is believed to be autoregulated and is mainly influenced by local factors (Delaey and 
Van De Voorde 2000). Therefore, small fluctuations in choroidal blood volume during positional 
changes may cause sudden and significant increases in IOP.  
 
Recent work investigating 3.5 hours exposure to tilt angles of 6°, 12°, and 18° HDT 
found that relative to the supine position, IOP increased 2.2 mmHg and 3.4 mmHg during 12° 
HDT and 18° HDT, respectively. Furthermore, application of 40 mmHg lower body negative 
pressure returned IOP to baseline values after each of these tilt angles (Marshall-Goebel et al. 
2017a). 
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Although the cephalad fluid shift during transient changes in posture and the resulting 
influence on IOP is not unexpected, chronic head-down bed rest as a ground-based analog of 
weightlessness may be more relevant for determining effects in astronauts onboard ISS. The 
well-recognized diuresis secondary to HDT might modify or attenuate IOP during the course of 
bed rest, although the continued hydrostatic gradient may cause the choroidal vessels to fill and 
increase episcleral pressures (Draeger and Hanke 1986). The 6-degree head-down tilt bed rest 
model has been used as a ground-based analog for weightlessness, replicating many of the 
cardiovascular, muscle, and bone changes seen during spaceflight. After the seminal report of 
ocular structural and functional changes in astronauts, NASA implemented similar ocular 
assessments in subjects participating in prolonged bed rest studies. A case study of a 24 year old 
Caucasian male who spent 30 days in head-down tilt bed rest demonstrated a 28% decrease in 
intraocular pressure and a 17.4 and 21.4 micron increase in peripapillary retinal thickness in the 
right and left eye, respectively, compared to pre-bed rest values (Taibbi et al. 2013). Imaging 
taken 6 months after bed rest showed that thickness returned to pre-bed rest levels. IOP 
monitoring of bed rest subjects in 6-degree HDT for 14 days revealed that IOP increased from 
baseline by an average of 2.17 mmHg (right eye) and 2.06 mmHg (left eye) after 3 days of bed 
rest, and by 2.13 mmHg (right eye) and 1.74 mmHg (left eye) after 10 days of bed rest. After 2 
days of bed rest, IOP was not different from pre-bed rest values (Taibbi et al. 2014). When IOP 
data were evaluated after 14-day (+1.4 mmHg) and 70-day (+1.8 mmHg) bed rest studies (Taibbi 
et al. 2016) the change appeared physiologically insignificant and called into question the effects 
of bed rest on IOP. This study also found a significantly greater increase in peripapillary retinal 
thickness following 70-days compared to 14-days of bed rest in the superior (+11.50 µm vs 
+4.69 µm), nasal (11.46 µm vs 4. 63 µm), and inferior (10.08 µm vs 4.34 µm) quadrants. Optic 
disc edema, choroidal folds, cotton wool spots, globe flattening, and changes in refractive error 
did not develop during these bed rest studies. 
 
Taibbi et al. (Taibbi et al. 2014) evaluated best-corrected visual acuity (BCVA), spherical 
equivalent, IOP, spectral-domain OCT, retinal nerve fiber layer thickness (RNFLT), optic disc 
and macular parameters in 16 subjects (12 men and 4 women) before, during, and after 14 days 
of HDT bed rest. Equivalency tests revealed that nearly all post-bed rest changes were within 
predefined clinically relevant thresholds, suggesting that the experimental conditions did not 
significantly affect participants’ visual function. However, there were small changes in the 
following parameters: BCVA (pre/post-BR mean difference: -0.06 logMAR), spherical 
equivalent (-0.30 D), IOP (+3.03 mmHg) and OCT (+1.14 µm), temporal inferior (+1.58 µm) 
and nasal-inferior RNFLT (+3.48 µm). In general, HDT bed rest resulted in a small non-
progressive IOP elevation, which returned to baseline levels post-bed rest. 
 
A short report by Mekjavic et al. (Mekjavic et al. 2002) examined the effects of longer 
bed rest on IOP and vision and reported no changes in visual function in any of the 10 subjects 
who participated in 35 days of horizontal bed rest. Unfortunately, the authors did not report 
whether IOP changed during this protocol, although they stated it was measured. However, 
interpretation of these results relative to other studies is hampered by two important factors. 
First, the measurements were not made until the second or third day after bed rest, during which 
time some recovery from bed rest may have occurred. Second, this was a horizontal bed rest, 
which acute studies have suggested does not have as dramatic an effect on IOP. 
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In conclusion, it is apparent that IOP is transiently elevated above the seated and supine 
pressures upon the assumption of the head-down posture; this change in posture models 
conditions of initial insertion into weightless in space. The rapid increase in IOP, concomitant 
with a cephalad fluid shift, has also been observed during the brief periods of weightlessness that 
are experienced in parabolic flight (Mader et al. 1993). However, available bed rest data suggest 
that elevated IOP resolves over time. 
 
3. Modeling 
Strain, stress, and stiffness of ocular tissues may play a role in the biomechanics of the 
optic nerve head. Ocular geometry and tissue material properties contribute to strain and stress of 
posterior ocular structures, for example at the ONH and the lamina cribrosa (LC).  Both IOP and 
ICP can contribute to these tissue strains and stresses (Feola et al. 2016). Some factors that 
contribute to the ONH biomechanics are size and shape of the scleral canal, scleral thickness, 
regional laminar density, and collagen beam orientation. Therefore, eyes with identical IOPs may 
exhibit different strain fields because of differences in their structural stiffness (Bellezza et al. 
2000). Recent work characterized the mechanical behavior of porcine optic nerve sheaths 
through inflation and axial loading that allowed for unconfined lengthening, twisting, and 
circumferential distension (Raykin et al. 2017). They reported a “cross-over point” in the 
pressure-diameter curves under varying axial loads and suggested this represented a protective 
behavior to prevent optic nerve compression. 
  
Three primary tissue types are found in the ONH: load-bearing connective tissues of the 
peripapillary structures (sclera, scleral canal wall, and LC), axonal tissues (retinal ganglion cell 
axons), and cellular elements (astrocytes, glial cells, endothelial cells, and pericytes along with 
their basement membranes) (Bellezza et al. 2000). 
 
Finite element modeling suggests that structural deformations at the vitreoretinal 
interface may not correspond with those at the anterior surface of the LC. In addition, scleral and 
laminar compliance may contribute more to average strains within the LC than compliance of 
neural and pia matter tissues (Sigal et al. 2004). Finite element modeling demonstrates that sclera 
stiffness has a large influence on ONH biomechanics (Sigal et al. 2005). The sclera is the 
primary load-bearing tissue of the eye, and less compliant than other ONH tissues. Alterations in 
scleral tissue properties can modify how the sclera responds to IOP or other pressures at the 
posterior of the eye, and therefore the less compliant structures at the ONH can be modified as 
well. High or heterogenous scleral strains may translate and impact tissues at the ONH, for 
example causing alterations in LC structure, compression of axons, and/or reduction in ONH 
microvascular blood and interstitial fluid flow (Downs et al. 2003). Indeed, modeling work 
suggests CSF pressure impacts the strain distribution within the LC and the retrolaminar neural 
tissue (Feola et al. 2017). Understanding how these models translate over longer periods of time 
will be necessary since certain ocular parameters appear to respond to changes in the 
gravitational vector over the course of 60 min (Anderson et al. 2017). 
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C. Consequences 
1. During Spaceflight 
Although 24 individual crewmembers have demonstrated one or more structural or 
functional change consistent with SANS, none of these changes have been severe enough to 
endanger mission success. Many crewmembers alter the prescription of reading glasses during 
spaceflight, but additional ‘consequences’ of SANS remain absent. 
 
2. Following Spaceflight 
Prolonged optic disc edema may lead to long-term deleterious consequences for the optic 
nerve as has been seen in IIH patients. For example, evidence from IIH patients presenting with 
symptoms varying in duration from 1-30 months and a median CSF pressure of 34 cm H2O 
(range 10.9-61.2) suggests that those who regained normal disc appearance (50% of patients) 
following Diamox (acetazolamide) administration had a shorter duration of disease (median=4 
months) and had better visual outcomes compared with those whose symptoms persisted longer 
(median=12 months). When followed for a median of 49 months, patients with chronic disc 
changes and higher grades of disc edema had an enlarged blind spot that was nearly 2 times 
larger than the area of the blind spot of patients who had lower grades of disc edema and who 
regained normal disc appearance over the follow-up period (Figure 20) (Sørensen et al. 1988). 
 
 
Additionally, in a study of 22 IIH patients with mild papilledema, a mean Frisen grade of 
2 (range 1-3), a mean CSF pressure of 35 cm H2O (range 25.5-45), and a mean age of 40 years 
(Rebolleda and Muñoz-Negrete 2009), visual field (VF) perimetry testing at 1-year follow-up 
revealed that 66% had normal VF, 18% had an enlarged blind spot, and 16% had an irreversible 
Figure 20 Blindspot enlargement in IIH patients with optic disc edema treated with acetazolamide. 
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VF loss. On OCT, 10 subjects had an RNFL that was thinner than normal (3 of those had VF 
constriction, 3 had inferonasal defects, 1 had a scotoma). 
 
VF assessment conducted within the first 3 days after astronauts return from space can 
identify whether optic disc edema contributes to an enlarged blind spot. Follow-up testing of 
OCT RNFL thickness should be conducted to identify whether the chronic optic disc edema 
during spaceflight leads to RNFL thinning during the years following spaceflight. VF testing 
should be done in conjunction with OCT imaging to identify whether functional deficits develop 
along with any structural changes.  
 
VI. HYPOTHESIZED CONTRIBUTING FACTORS 
The original leading hypothesis for the ocular changes documented in the astronauts 
affected by SANS was that the cephalad fluid shift caused by spaceflight exposure results in a 
prolonged increase in ICP. The symptoms (choroidal folds, globe flattening, cotton wool spot, 
hyperopic shift, and optic disc edema) seen in affected astronauts after long-duration spaceflight 
are similar to those seen in the terrestrial idiopathic intracranial hypertension (IIH) condition 
(Friedman 2007), yet the astronauts do not display all of the classic IIH symptoms such as 
chronic headaches, diplopia, transient visual obscurations, or pulse-synchronous tinnitus. 
Various hypotheses for the etiology of SANS signs and symptoms are discussed below.  
A. Intracranial Pressure 
The pressure-volume relationship between ICP, volume of CSF, blood, and brain tissue, 
is known as the Monro-Kellie doctrine (Mokri 2001). The cranium’s constituents (blood, CSF, 
and brain tissue) maintain a homeostasis, such that any increase in volume of one of the cranial 
constituents must be compensated by a decrease in volume of another. However, a small 
buffering capacity exists for increases in intracranial volume primarily by the volume of CSF and 
to a lesser extent, the volume of venous blood. These buffers respond to increases in volume of 
the remaining intracranial constituents. For example, in a head trauma patient with an expanding 
epidural hematoma the increased mass will be compensated by the displacement of CSF and 
venous blood out of the cranium (Mokri 2001). 
 
Intracranial pressure can be measured with direct insertion of a pressure transducer into 
the lateral ventricle of the brain, but it is often assessed via lumbar puncture while patients are 
positioned horizontally on their side. Because of the invasiveness required to access and measure 
ICP, few reports have provided measures in truly healthy populations, however, a pressure of 10-
20 cm H2O is considered normal (Johanson et al. 2008) which agrees with the studies highlighted 
in Table 1.  
 
1. Similarities to IIH 
Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a 
condition characterized by increased ICP without clinical, laboratory, or radiologic evidence of 
an intracranial space-occupying lesion, meningeal inflammation, or venous outflow obstruction. 
This increased ICP can lead to optic disc swelling (papilledema) caused by high CSF pressure in 
the distal optic nerve sheath, elevation of the pressure in the central retinal vein, and impaired 
perfusion of the neurons as their axons traverse the lamina cribrosa (LC) (Brazis and Lee 1998). 
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That astronauts have demonstrated globe flattening, ONSD distension, and optic disc edema 
highlights similarities with IIH patients. However, the fact that astronauts have not manifested 
other findings typically associated with IIH, including headaches, symmetric presentation of 
ocular findings, diplopia, and transient visual obscuration, supports the possibility of an 
alternative etiology.  
 
2. Hydrostatic Fluid Redistribution 
In a 1g environment, acceleration due to gravity creates a downward force that acts on the 
body’s fluids. As a consequence, a hydrostatic pressure gradient exists across the body’s axis, 
resulting in a higher pressure in the most dependent regions and lower pressure at the head. This 
is most evident in the standing position. The arterial pressure in a standing male of average 
height has been estimated to be 200 mmHg at the foot, and only 70 mmHg at the head (Hargens 
and Richardson 2009) (Figure 21). The venous blood is also subject to the hydrostatic gradient, 
and gravity assists cerebral venous drainage from the head, preventing cerebral venous 
congestion and elevations in ICP. Upon exposure to weightlessness and loss of the hydrostatic 
gradient, there is a cephalad fluid shift of 1-2 liters from the lower body. Consequently, arterial 
pressure across the body’s axis equalizes so that pressure at the foot and the head is ~100 mmHg. 
Interestingly, Rowell reported that arterial pressure was approximately 98 mmHg at the foot and 
99 mmHg at the head when supine (Rowell and Blackmon 1988). Thus, vascular, interstitial, and 
cerebral spinal fluids moves from the dependent regions to the abdomen, thorax, and head on a 
daily basis on Earth when a person assumes a supine position during sleep. Importantly, but 
often ignored, the CSF also shifts  
 
 
An indication of the changes in central and cerebral hemodynamics that occur as a result 
of fluid shifts during spaceflight may be illustrated by the terrestrial work of Chapman et al. 
(Chapman et al. 1990) and Hirvonen et al. (Hirvonen et al. 1995). Chapman (Chapman et al. 
1990) inserted intraventricular catheters in a group of normal subjects and measured ICP while 
Figure 21 Loss of hydrostatic pressure gradient drainage and cerebral venous congestion. Adapted from Hargens 
AR, et al. 2009, with permission of Elsevier BV, obtained via Copyright Clearance Center, Inc. 
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tilting subjects at multiple angles. Similarly, Hirvonen and Kauko (Hirvonen et al. 1995) 
measured central venous pressure (CVP) in normal subjects at similar tilt angles. In the upright 
position (0 degree), ICP in a representative subject was found to be -2.3 mmHg (-3.1 cm H2O), 
while Hirvonen and Kauko found the CVP to be 0 mmHg. In the supine position (90 degrees), 
ICP increased by 11.5 mmHg (15.6 cm H2O) from -2.3 mmHg (-3.1 cm H2O) to 9.2 mmHg (12.5 
cm H2O), and correspondingly, CVP in the same position increased from 0 to 5 mmHg. When 
subjects were placed in HDT (-30 degrees) ICP increased an additional 14.8 mmHg (20.1 cm 
H2O) from the supine position to 24.0 mmHg (32.6 cm H2O), while CVP in a similarly tilted 
subject increased to 9 mmHg. These invasive experiments document how cephalad fluid shifts 
affect CVP and ICP. In the case of ICP, the acute effect of cerebral venous engorgement is an 
increase in blood volume within the cranium. As the cranium is rigid and not expandable, 
pressure increases modestly, and within the normal limits of ICP (10 to 15 mmHg or 13 to 20 cm 
H2O). However, in these experiments, subjects were tilted for brief periods lasting no longer than 
5 to 15 minutes. In the case of the ISS astronauts, the fluid shift exposure is constant for 
approximately 5 to 6 months. 
 
Upon entry into microgravity, the loss of the hydrostatic gradient results in a 
redistribution of fluid pressures across the body’s axis causing an increase in venous pressures 
above the right atrium relative to standing in 1g. As described earlier, Hirvonen and Kauko 
(Hirvonen et al. 1995) showed an increase in CVP with fluid shift from standing to supine in 
terrestrial subjects, and Gisolf et al. (Gisolf et al. 2004) reported an increase in venous pressures 
from standing to supine of approximately 40 mmHg from -20 mmHg standing to 15 to 20 mmHg 
supine. The shift in venous volume to the cranium is at least partially responsible for the acute 
change in ICP, as demonstrated by Chapman (Chapman et al. 1990) and is illustrated by the 
equation for ICP: 
 
ICP=CSF out flow resistance x CSF formation+Superior Sagittal Sinus Pressure  
 
Although increases in CSF outflow resistance will increase ICP, the most immediate 
increase will be venous volume shift into the dural venous sinuses. Underappreciated, however, 
is the shift of CSF from the spinal compartment into the cranium that likely occurs when the 
head to foot gravitational vector is removed during spaceflight. Evidence from MRI suggests 
cerebral ventricular volume increases from before to after spaceflight (Roberts et al. 2017). 
Whether this outcome is in response to the headward shift of CSF during spaceflight is unknown.  
 
3. Changes in CSF Regulation 
It has been proposed that alterations in the regulation of CSF contribute to changes in ICP 
during spaceflight, yet limited data exist in astronauts, all of which come from the postflight 
period when measurements may reflect processes responding to the re-adaptation to a 1g 
environment. Rats exposed to weightlessness during short-duration spaceflight provide some 
evidence of alterations in CSF production during weightlessness, but there is no evidence from 
long-duration spaceflight. While a complete review of CSF regulation is beyond the scope of this 
report, a recent review of CSF dynamics may be of help to the reader (Lawley et al. 2016). 
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The total volume of CSF in humans is estimated to be 150 to 270 mL, but because it is 
produced at a high rate of 0.3 to 0.6 mL/min, 500 to 600 mL of CSF is produced daily and is 
sufficient to completely replace the entire volume 3 to 4 times per day (Redzic and Segal 2004). 
 
The pulsatile flow of CSF exits into the spinal and subarachnoid spaces through the 
fourth ventricle before passing into the cervical lymphatic system and draining into the venous 
blood. Normal CSF pressure in humans is approximately 10 to 20 cm H2O, which is greater than 
the venous pressure in the dural sinuses (Johanson et al. 2008), and drives the flow of CSF out of 
the brain and into the systemic vasculature. For example, in the supine position, CSF pressure 
may be 10 to 12 mmHg (13.6 to 16.3 cm H2O), whereas superior sagittal sinus pressure (SSP) 
may be 5 to 7 mmHg yielding a driving pressure of 3 to 5 mmHg for CSF reabsorption. Thus, an 
increase in the venous pressure of just a few mmHg could alter the diffusion gradient and inhibit 
CSF reabsorption. As a result of venous congestion and the associated increase in venous 
pressure, CSF reabsorption could be decreased causing an accumulation of intracranial CSF. 
However, the arachnoid granulations are now thought to have a role in regulating CSF drainage 
in times of increased pressure (Eklund et al. 2007; Johanson et al. 2008; Andersson et al. 2008). 
 
The choroid plexus, located in the lateral, third and fourth ventricles, comprises cells that 
are specialized in the secretion of CSF and are regulated by multiple mechanisms, including 
protein expression and regulatory hormones. The apical membrane of choroidal epithelial cells 
contains aquaporin proteins and Na+/K+ ATPase pumps, which facilitate fluid transport in the 
choroid plexus and support CSF production, as well as receptors for atrial natriuretic protein 
(ANP) and arginine vasopressin (AVP), which regulate volume.  
 
Short-duration spaceflight and analog models have been used to study the effects of 
weightlessness on choroid plexus, aquaporin-1 (AQP1) channels, and hormonal regulation of 
CSF production (Gabrion et al. 1995, 1996; Mani-Ponset et al. 1997; Davet et al. 1998; Carcenac 
et al. 1999). During the Space Life Sciences-2 experiments aboard the STS-58 mission, rats 
sacrificed on flight day 13 of a 14-day mission demonstrated a modified structure of apical 
microvilli of the choroid plexus (Gabrion et al. 1996), indicating structural changes to cells 
important in regulating CSF production. Additionally, the ratio of AQP1 concentration to the 
total choroidal surface area (AQP1/ChT) was decreased in rats dissected 6 to 8 hours after return 
to Earth (9.2 ± 0.9) compared to ground control animals (25.5 ± 1.7), suggesting a likely 
decrease in CSF production (Masseguin et al. 2000). Hormonal regulation of CSF also appears to 
be altered by spaceflight. ANP receptors at the choroid plexus of the lateral and third ventricles 
increased after rats returned from short-duration spaceflight (Herbuté et al. 1994), and pituitary 
concentrations of AVP decreased after return from spaceflights of 7 to 14 days, relative to values 
in vivarium control rats (6.3 ± 0.3 vs. 8.3 ± 0.5 µg/mg tissue (Wade and Keil 1998). Because 
ANP blunts water permeability of AQP1 (Patil et al. 1997) and AVP stimulates AQP1-dependent 
water transport and increases choroidal CSF secretion (Patil et al. 1997), these data support the 
hypothesis that CSF production is down-regulated during short-duration spaceflight. 
Additionally, immunodetection of carbonic anhydrase II in the cytoplasm of choroidal cells was 
reduced in the flight animals, which would result in a down-regulation of CSF formation. 
 
Interestingly, animals dissected 48 hours after return to Earth demonstrated a 48.4% 
overshoot of AQP1 expression, (37.8 ± 4.5 AQP1/ChT, p<0.04) when compared to values in 
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control animals (AQP1/ChT = 25.5 ± 1.7) (Masseguin et al. 2000) and recovery of microvilli 
structural changes at the apical surface of choroidal cell membranes (Davet et al. 1998). These 
data indicate that the rebound and overshoot of factors regulating CSF production occur during 
the first few days upon return to a 1g environment and may play a role in the elevated lumbar 
puncture opening pressures observed in a number of U.S astronauts > 2 days after returning from 
a long-duration spaceflight.  
 
To date, 10 U.S. astronauts have developed disc edema during flight. Five of these 
astronauts had mildly elevated postflight CSF lumbar puncture opening pressures despite 
removal from the precipitating environment. We hypothesize that the flight animals and 
astronauts develop an elevated ICP setpoint secondary to prolonged weightlessness exposure. 
Upon return to the 1g environment and re-exposure to a hydrostatic gradient, sagittal sinus 
pressure (SSP) is suddenly reduced and ICP falls, thus causing an upregulation of CSF 
formation. This is supported by the histological and biochemical changes in the flight animals 
that cause an overshoot of CSF production in comparison to baseline and could explain the 
mildly elevated CSF pressure detected in 5 US astronauts during their re-adaptation to a 1g 
environment. Therefore, astronauts may be at risk for persistently elevated ICP in the postflight 
period.  
 
4. Venous Congestion 
The superior ophthalmic vein and the much smaller inferior ophthalmic vein merge to 
drain into the cavernous sinus and drain fluid from the eye. Because the venous system from the 
eye has no valves, impaired venous outflow or even retrograde flow may occur in the face of 
elevated pressures transmitted from the cavernous sinus. Elevated ICP and venous pressures can 
be transmitted to the eye via the ophthalmic vein along 3 pathways. The most significant is via 
the choroidal veins that drain blood from the choroid, a rich vascular network that lies between 
the outer sclera of the eye and the inner retina. The choroidal veins drain into the vortex veins 
that subsequently drain into the superior and inferior ophthalmic veins. Almost the entire blood 
supply of the eye comes from the choroidal vessels. Thus, relatively large shifts in volume can 
occur and thereby alter IOP. According to Smith and Lewis (Smith and Lewis 1985), 20 µL of 
additional blood volume in the choroid can increase IOP up to 20 mmHg.  
 
The second pathway is via the episcleral veins that lie within the sclera and drain the 
percolated aqueous humor from the anterior chamber after it passes through the trabecular 
meshwork. The episcleral veins drain both indirectly into the vortex veins via the anterior ciliary 
veins, and directly into the vortex veins, which drain into the superior and inferior ophthalmic 
veins. It is well known from the study of glaucoma that elevations in episcleral venous pressure 
cause a direct rise in IOP due to the decreased facility (outflow) of aqueous humor via the 
trabecular meshwork, thereby increasing the pressure within the anterior chamber of the eye 
(Craven 2008). As noted previously, this is a slow process that can take 20 minutes or more to 
occur.  In contrast, choroidal engorgement may cause a spike in IOP within seconds. In 
summary, episcleral venous pressure is influenced by venous drainage pressure in the 
superior/inferior ophthalmic veins, cavernous sinus, and even internal and external jugular veins, 
a contributing mechanism for rising IOP in the supine position (Liu et al. 1998). Thus, any 
abnormality leading to increased venous pressure in the venous drainage system downstream 
from the eye can lead to elevated IOP if the episcleral venous pressure is increased as occurs in 
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jugular vein obstruction, superior vena cava obstruction and cavernous sinus thrombosis (Craven 
2008).  
 
The third and most minimal route of transmission of elevated venous pressure and ICP is 
via the central retinal vein (CRV). The effect of CRV engorgement on IOP is likely minimal; 
however, rising retinal vein pressures can cause retinal hemorrhages. The CRV drains venous 
blood from the retina. The CRV exits the eye alongside the retinal artery through the optic nerve 
before exiting the subarachnoid space and the optic nerve sheath. Beyond that point, it has 
several anatomical variations and may join the superior or sometimes the inferior ophthalmic 
vein, or less often the cavernous sinus directly (Hayreh 2006). The CRV is also directly 
influenced by ICP during its course through the subarachnoid space within the optic nerve 
sheath. 
 
To identify how elevated superior vena cava pressure may affect ICP and ONSD, 
Nusbaum et al. developed a juvenile piglet model of elevated superior vena cava pressure 
(SVCP) by increasing SVCP to 20 and 40 mmHg for 1 hour each by inflating a balloon catheter 
placed within the super vena cava (Nusbaum et al. 2013). Serial measurements of ICP 
(interventricular drain catheter placed 4mm later and rostral to the bregma through a 
craniotomy), internal and external jugular pressure (IJP, EJP, respectively; venous catheter) were 
made hourly for 3 h, and ONSD of the right eye was measured hourly by ultrasound (US). Naive 
piglets were maintained at baseline pressure levels for 3 h and measurements of dynamic ICP 
were made continuously for the entire period in a similar fashion to the SVCP occlusion group. 
In the naive piglets, ONSD did not change significantly over time. Interestingly, there was a 
significant linear correlation between IJP and ICP (slope: 0.9614 ± 0.0038, r =0.9683). 
Moreover, with increasing SVCP, resulting ONSD was also correlated with ICP (slope: 0.0958 ± 
0.0061, r = 0.7841), suggesting that for every 1 mmHg increase in ICP there was a 0.1 mm 
increase in ONSD. Sensitivity and specificity for ONSD in diagnosing elevated ICP were 92% 
and 91%, respectively, for a cutoff of 5.45 mm. However, external validation of these findings in 
humans is required to understand the physiological significance of these relationships across the 
range of ICP values that likely occur during weightlessness. 
 
5. Cerebral Edema 
The Starling-Landis equation describes the net balance of hydrostatic and oncotic 
pressures within the intravascular and extravascular fluid at the level of the capillaries, which are 
known as Starling forces (Hargens and Richardson 2009). An increase in venous pressure due to 
venous congestion will alter this balance of pressures by increasing transcapillary pressure and 
result in net filtration of fluid to the brain parenchyma. If this occurs, brain parenchyma swells 
and in turn increases sinus venous pressure. This phenomenon underlies the development of high 
altitude cerebral edema (Wilson et al. 2009). In addition to potential changes in Starling forces 
during exposure to weightlessness, changes in the integrity of the blood-brain barrier, based on 
the tightness of the endothelial cell-cell tight junctions in the walls of the intracranial capillary 
vessels, could also contribute to cerebral edema. While there is no direct evidence of alterations 
in tight junctions in astronauts, rats subjected to hindlimb suspension for 30 and 180 minutes 
demonstrated no change in tight junctions found between choroid plexus epithelial cells and that 
tight junction structure and protein composition were unaltered, as confirmed by freeze-fracture 
and conventional electron microscopy, and immunohistochemistry for typical tight junction 
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proteins, respectively (Masseguin et al. 2001). Further assessment of tight junction permeability 
was confirmed by showing that cytochrome C injected into the blood circulation did not cross 
the blood-CSF barrier at the level of the choroid plexus. Whether the hindlimb-unloading model 
in rats for up to 3 hr can be extrapolated to human exposure to the weightlessness environment of 
spaceflight for up to 6 months is unknown. In-flight investigations of fluid distribution and 
postflight MRI targeting extravascular fluid are needed to definitively determine if fluid 
accumulates during long-duration spaceflight.  While gravitational unloading of body tissues and 
fluids, one of the most pervasive changes caused by weightlessness during spaceflight, may have 
an ability to alter the integrity of the blood-brain barrier, exposure to higher levels of radiation in 
space may also affect the biology of endothelial cells in a way that will reduce the integrity of the 
tight junctions. The effect of radiation exposure similar to that on the ISS on blood-brain barrier 
function remains poorly studied. 
 
6. Optic Disc Edema 
Optic disc edema is often associated with an increase in ICP (in which case it is referred 
to as papilledema), and is characterized by deformation of the ONH and swelling of the optic 
disc, which often protrudes into the eye globe. Optic disc edema has been observed in 10 
American and US-partnered astronauts manifesting visual alterations after return from long-
duration missions.  
 
If the ICP rises because of an increase of cerebrospinal fluid volume, the pressure 
gradient will point unidirectionally from the chiasmal cistern to the subarachnoid space of the 
optic nerve in the manner of a hydraulic pump, building up pressure in the small compartment 
that ends blindly behind the globe. Intracranial CSF reaches the orbital subarachnoid space 
(SAS) in a “cul-de-sac” anatomy at the optic nerve head (Figure 22). The SAS contains a 
complex system of arachnoid trabeculae and septa that divide the SAS into different segments 
and thus the hydrodynamics of the CSF within the SAS may not simply reflect a continuum of 
pressure along a tube (Killer et al. 2003). Structurally, the immediate retrobulbar space is more 
distensible due to the absence of pillars and septae found in the less distensible intraorbital and 
canalicular portions of the optic nerve sheath. These features are believed to be important for 
pressure homeostasis. This arrangement facilitates the flow of CSF within the optic nerve SAS 
allowing a buildup of physiologic pressure within the retrobulbar space and thereby facilitating 
periodic reverse flow and thus circulation of CSF. 
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Measurements of decreasing pressure along the optic nerve SAS in a proximal to distal 
direction (Liu and Kahn 1993), suggest that the subarachnoid space may not have a pressure 
equivalent to that of the ventricles, the cisterns, and the cranial subarachnoid spaces. Thus, while, 
correlations between ICP in IIH patients and ONSD provide evidence that elevated pressure is 
transmitted to the SAS, this relationship and exact influence in the development of optic disc 
edema remains incompletely understood. Furthermore, it is unknown if increases in ICP are 
transmitted to the ONH during weightlessness to the same degree as occurs in a 1g environment. 
Yet, measures of ONSD from MRI provide the opportunity to assess the effects of HDT on this 
ocular parameter and possible countermeasures. After 4.5 hours of 12° HDT ONSD increased 
significantly compared to the supine position, but lower body negative pressure of 20 mmHg 
during HDT prevented this increase (Marshall-Goebel et al. 2017c). Data collected from this 
same study (Marshall-Goebel et al. 2017b) suggested that DTI-derived diffusivity parameters 
and fractional anisotropy were enhanced during various degrees of HDT compared to the supine 
position, suggesting alterations in CSF hydrodynamics and increased CSF volume within the 
optic nerve sheath (Gerlach et al. 2017). 
 
ICP can affect the ONH in diseases such as pseudotumor cerebri, a condition in which the 
ICP is greater than IOP, resulting in swelling of the ONH. In addition to this protrusion, local 
edema within the optic papilla may develop due to tissue ischemia, an increased pressure 
gradient between the SAS and the vitreous of the globe with resultant transarachnoid 
transudation of fluid, and/or the extravasation of fluid secondary to this pressure gradient 
(Jinkins 1987). A significant factor in the proximate cause of early edema is stagnant axonal 
transport (stasis) with added vascular congestion, leakage, and ischemia leading to disc swelling 
(Tso and Hayreh 1977). When severe swelling or edema occurs within the SAS occurs, neural 
and vascular structures become compressed and distorted to varying degrees, and venous 
drainage is believed to be compromised, thus leading to stasis. Several investigators report that 
the demonstrated axonal swelling is a response to the increased pressure gradient and axoplasmic 
stasis (Jinkins 1987; Berdahl and Allingham 2010). Preliminary data analyzed from eyes 
Figure 22 Schematic drawing of the optic nerve demonstrating the microanatomy of the ONS complex. 
Reproduced from Killer HE, et al. Ophthalmol, 2003 with permission from BMJ Publishing Group Ltd. 
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obtained from female 10 to 12 week-old BALB/Cj mice following short-duration spaceflight 
suggest upregulation of genes associated with oxidative stress in the retina and optic nerve 
(Zanello et al. 2013). Swelling of the ONH can also occur in ocular hypotony, which occurs due 
to a low IOP rather than elevated ICP. In both conditions ONH changes are caused by an 
increase in translaminar pressure. Investigating optic nerve biomechanics to understand the stress 
(force/cross-sectional area) and strain (local deformation) on the ONH (Burgoyne et al. 2005; 
Sigal et al. 2005) may yield clues as to the determinants of axonal, glial, and vascular 
dysfunction in the pathogenesis and progression of glaucoma and optic disc edema. 
 
An important question is the relationship between the increase in ICP and the degree of 
distention of the ONS. Hansen and Helmke performed a study in twelve patients undergoing 
neurological testing that involved CSF absorption (Hansen and Helmke 1997). The ONSD was 
evaluated by serial B-mode ultrasound scans of the anterior optic nerve near its entry into the 
globe. The linear relationship between ONSD and ICP was only present within a certain CSF 
pressure interval. This interval differed between patients. ONSD dilation commenced at pressure 
thresholds between 15 mmHg (20.4 cm H2O) and 30 mmHg (40.8 cm H2O) and, in some 
patients, saturation of the response (constant ONS diameter) occurred between 30 mmHg (40.8 
cm H2O) and 40 mmHg (54.4 cm H2O). Because of the variable pressure-diameter relationship, 
at higher CSF pressure levels the ONS may lose its ability for further dilation. Trabecular fibers 
and sheath collagen structure may determine this aspect of the sheath response. In Hansen’s 
study, this certain threshold CSF pressure was, on average, 22 mmHg (30 cm H2O) in all 
patients. The largest diameters were observed in the subgroup with the highest ICP readings (6.5 
mm ONS diameter equivalent to 30 to 55 mmHg ICP or 40.8 to 74.8 cm H2O). 
 
Thus, the clinical relevance of this study relies on the demonstration of pathologically 
enlarged sheaths or ongoing enlargement on serial ultrasonography studies. This study also 
points to a possible threshold ICP before which changes in ONSD may not occur, or may not 
reflect ICP. At higher pressure, ONS distension reaches a saturation level at which the other 
papilledema-like features begin to manifest. Whether ICP has reached this threshold or surpassed 
a saturation point in astronauts is not clear and makes it challenging to interpret ONSD 
measurements in a meaningful way.  
 
In their more recent work, Hansen et al. (Hansen et al. 2011) showed that prolonged 
dysregulation of ICP led to persisting dilatation of the CSF compartment surrounding the optic 
nerve. As with any nonelastic behavior, ONSD returned to baseline only when SAS pressures did 
not exceed 35 mmHg (47.5 cm H2O). When decompression occurred from higher pressure levels 
(45 mmHg or 61.2 cm H2O and above), a clear residual dilatation remained (above 0.34 mm). 
Thus, after exposure to pathologically elevated pressures within the SAS, there is a limited 
capability for retraction of the optic nerve sheath after pressure normalization. When 
deformation due to over-distension occurs, a pressure-dependent structural remodeling in the 
trabecular tissue and ⁄or the dural elements takes place, reducing the retraction of the ONS to 
baseline levels when pressures are elevated above a certain threshold value and length of time. 
According to this study, direct correlation between distension and pressure exists for pressure 
values between 5 and 45 mmHg (6.8 to 61.2 cm H2O). 
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Jinkins (Jinkins 1987) examined 20 subjects with increased ICP and papilledema, and 
found bulging of the optic sheath in the SAS in 18 of them, regardless of the cause of ICP. It was 
determined that dilatation of the sheath surrounding the optic nerve resulted in a “ballooning” of 
the ONH, causing it to protrude into the globe. This resulted in an increased pressure gradient 
between the SAS and the vitreous with resultant transarachnoid transudation of fluid secondary 
to the pressure gradient, possibly into the optic disc and the vitreous of the globe. Thus, a 
significant factor in early disc swelling or papilledema is papillary protrusion. Of note, Jinkins 
reported that protrusion precedes any obvious arterial abnormality in the optic disc and that such 
changes in the pressure gradient manifest rapidly, appearing within the first 24 hours of 
increased ICP. Thus, data collection close to the 24-hour mark of entry into weightlessness may 
be an important benchmark. Conversely, 4 ISS astronauts have manifested a refractive change 
≥0.75 D in at least one eye, yet had no evidence of optic disc edema. 
 
7. Globe Flattening 
Determination of globe flattening in astronauts is currently limited to subjective analysis 
of globe morphology during the clinical read of the ocular MRI. While this rudimentary 
approach has provided insight into globe flattening prevalence following long-duration 
spaceflight, quantitative assessment of globe flattening may provide greater sensitivity and 
reliability in determining the development and progression or regression of SANS signs. 
 
Alperin et al. (Alperin et al. 2013) have developed a quantitative assessment of globe 
flattening, nerve protrusion, and maximal deformation by creating a 2-dimensional (2D) map of 
the distances from the globe center to the posterior wall. The proposed automated method 
transforms the 3D globe geometry into a 2D color-coded quantitative distance map of the sclera 
in the posterior globe. This provides a distinctive advantage over scrolling through individual 
magnetic resonance (MR) images along different planes to appreciate 3D globe deformation.  
 
The automated method for quantifying the 3D geometry of the posterior sclera involved 
the following steps: 1) segmentation, 2) identification of a reference point (center of globe), and 
3) generating a 2D map of the distances from the globe center to the posterior wall. The centers 
of mass of the globe and the lens are identified and are used to define an orthogonal coordinate 
system in which the x axis (optical axis) is the posterior-anterior orientation, and the y-axis is 
oriented laterally from left to right. 
 
Each point on the globe posterior wall is identified by use of 3 parameters: d, the distance 
in millimeters from the globe center; θ, the azimuth angle (in the xy plane); and ϕ, the elevation 
angle (in the xz plane), where θ and ϕ range from -90° to +90°. Color mapping is used to indicate 
shorter distances from the center and longer distances at the periphery. A 2D map of a perfectly 
spherical hemisphere will have a uniform color with a distance equal to its radius. 
 
Three measures of globe deformation are calculated by using the distance map: 1) nerve 
protrusion (NP), depicting the extent of the nerve head protrusion; 2) globe flatness (GF), 
depicting the degree of flattening of the posterior wall, and 3) maximal deformation (MD), 
depicting the combined deformation due to the flattening and the nerve protrusion. Each measure 
is defined as the ratio of the mean distances within a central and a peripheral region in the 2D 
distance map.  
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Seven IIH patients with a mean CSF opening pressure of 36.9 ± 7.8 cm H2O (range, 26–
47 cm H2O) and bilateral papilledema (mean grade of 2.0) and 6 age- and sex-matched control 
subjects were examined for MRI evidence of GF. Compared to control subjects, mean values of 
the 3 deformation measures were significantly poorer in the IIH group, with nerve protrusion 
demonstrating the strongest difference (P = .0002). Nerve protrusion was most strongly 
associated with papilledema grade (P=.01) and maximal deformation was negatively associated 
with CSF opening pressure (R=0.86, P =.0001). Although both the NP and the GF measures 
were significantly worse in the IIH cohort, the NP measure more strongly separated the patients 
with IIH from the healthy control subjects. 
 
The NP measure was also the one that was significantly associated with the clinical 
papilledema grading. On the basis of these observations and results, optic nerve protrusion may 
be a more clinically relevant marker for the risk of papilledema in IIH (Alperin et al. 2013) and a 
potential objective measure of papilledema severity compared with the subjective Frisen scale. 
 
Analysis of globe distance maps for a subgroup of IIH patients treated with 
acetazolamide demonstrated reversal of the eye globe deformation. After only 2 weeks of 
treatment, there was a significant improvement in NP from 0.91 to 0.94, p=0.036 (Alperin et al. 
2013).  
 
There was also a significant correlation between the deformation measures and the CSF 
opening pressure. This is expected because the primary cause for the globe deformation in this 
population was increased CSF pressure transmitted to the globe through the increased CSF 
volume within the subarachnoid space and optic nerve sheath. This is consistent with the fact that 
MD, the combined deformation caused by NP and GF, demonstrated the strongest negative 
correlation with the CSF opening pressure, with an R value of 0.86. 
The relationship demonstrated in Figure 23 represents an encouraging step towards 
quantification of globe deformation and the potential to improve the grading of SANS cases. Yet, 
Figure 23 Scatterplot of the relationships between MD (y-axis) and CSF opening pressure (x-axis). 
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because no astronauts have had a lumbar puncture opening pressure greater than 29 cm H2O, it is 
unclear whether this technique has the sensitivity to detect the degree of globe deformation 
present in astronauts, which may be less than that occurring in the IIH patients studied by 
Alperin. 
 
8. Headache 
Since the Apollo Program missions, anecdotal reports of headaches due to cephalad fluid 
shifts have been documented. Indeed, a feeling of “fullness” of the head, or facial edema lasting 
for the duration of the flight were reported by all Apollo astronauts. Several crewmembers 
complained of symptoms such as headaches, congested sinuses, head pressure, pressure on the 
eyeballs, awareness of neck pulse, and distended veins in the forehead and neck (Hoffler and 
Johnson 1975). One Apollo astronaut described the fluid shifts as “the eye sockets themselves 
become a little puffy, the face a little rounder and a little redder, veins in the neck and forehead 
become distended and one's sinuses feel congested.” The headaches were reported as frontal and 
occipital, and ranged in intensity from moderate, severe, to “one of the worst ever experienced.” 
The headaches began as soon as crewmembers started moving about the cabin and ranged in 
duration from 3-4 days to mission duration. For instance, one crewmember reported that the 
“eyes gradually cleared but the congested sinuses, while not too bothersome, were always there.” 
(Hoffler and Johnson 1975). 
  
A more recent study found that headaches are still commonly reported among astronauts. 
Vein et al. (Vein et al. 2009) evaluated headache severity and incidence at 4 time points: (1) 
launch (period between the launch of space vehicle and docking to the space station), (2) stay at 
the space station, (3) activity outside the space station (extravehicular activity [EVA]) and (4) 
landing (between undocking from the space station and landing) in short duration (n=9; up to 2 
weeks; mean 10.9 days; range 8–14 days) and long-duration (n=8; mean 201.7 days; range 150–
366 days) astronauts. Vein et al. found that of the 16 male and one female astronauts who 
participated in the survey, 12 (71%) reported having experienced at least one headache episode 
while in space, whereas they had not suffered from headache when on Earth. There were in total 
21 space headache episodes reported, of moderate to severe intensity in 71%. In 2 astronauts 
(12%) the headache and associated symptoms would match the ICHD-II criteria for migraine and 
in 3 astronauts (18%) for tension-type headache; in 12 astronauts (70%) the headache was non-
specific. The vast majority of headache episodes (76%) were not associated with symptoms of 
space motion sickness (SMS). The 12 astronauts with headache reported a total of 21 headache 
episodes: 9 during launch, 9 during the stay at the space station, 1 during EVA and 2 during the 
landing. Headache severity ranged from mild to severe, with mild intensity in 29% and moderate 
to severe intensity in 71%, but was usually reported as moderate (65%). In 77% of the episodes, 
the headache was described as “exploding” and/or as “a heavy feeling” by 8 out of 9 astronauts 
during the launch, by 7 out of nine during the stay at the space station, by 1 astronaut during the 
EVA and by 2 out of 2 during the landing. When each independent headache episode was 
assessed, 16 (76%) demonstrated no association with the main symptoms of SMS, such as 
nausea, vomiting, or vertigo suggesting an etiology other than SMS.  
 
Several non-pharmacological and pharmacological interventions have been used to 
mitigate headaches. For example, Apollo astronauts noted the effects of exercise, diet, and 
diurnal variation: “We always felt a lot better for about a half hour to 2 hours after we exercised 
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on the bicycle.” The effectiveness of exercise in drawing blood away from the head was noted in 
Skylab missions, where a half inch increase in calf circumference was noted immediately 
following exercise (Johnston and Dietlein 1976). This strongly suggests the caudal movement of 
blood into the larger muscles of the lower limbs alleviating cerebral venous congestion. 
Additional reports indicated that symptoms of headache and head fullness were lessened 
following meals. Again, this suggests increased splanchnic blood flow alleviated venous 
congestion. The last effect is associated with the time of day. “As on Earth, if one is bothered by 
something, it typically feels worse toward the end of the day; the same was true up there with the 
sensation of head fullness” (Hoffler and Johnson 1975). In Apollo missions, several crewmen 
took Actifed to relieve nasal congestion at various times throughout the flight, whereas 64% of 
short- and long-duration astronauts reported taking analgesics for headaches (Hoffler and 
Johnson 1975). 
 
9. Noninvasive Assessment of ICP 
Owing to the hypothesis that elevated ICP may be a contributing factor for SANS, over 
the past few years a number of noninvasive devices have been investigated by NASA and others 
to estimate ICP in astronauts aboard the ISS, as well as during ground-based analogs such as 
head-down tilt.  
 
The Cochlear and Cerebral Fluid Pressure (CCFP) Analyzer is currently onboard the ISS 
and is used to collect data as part of the Fluid Shifts experiment during weightlessness and 
during use of the Russian lower-body negative pressure device known as Chibis. Since the 
perilymphatic fluid of the inner ear communicates with the CSF of the brain, alterations in CSF 
pressure are transmitted to the perilymphatic fluid and affect tympanic membrane displacement 
in response to a loud tone. The CCFP device quantifies tympanic membrane displacement 
(Samuel et al. 1998a; b) to estimate changes in ICP, but does not provide an absolute pressure 
value. Before and after long-duration spaceflight, astronauts are studied in the seated, supine, and 
15° HDT positions, while in-flight measures occur early and late in-flight, with and without 
application of lower-body negative pressure. The CCFP was recently used in a ground based 
study to demonstrate that 15° HDT posture induces a headward fluid shift and elevation of ICP 
which is reversed by 28% and 38% using 25 and 50 mmHg lower body negative pressure, 
respectively (Watkins et al. 2017). 
 
The otoacoustic emission (OAE) technique is also based on the notion that the CSF 
communicates with the inner ear perilymphatic fluids. Alterations in CSF pressure alter oval 
window stiffness, which can be detected through alterations in acoustic signals emitted by 
oscillation of the inner ear auditory apparatus in response to different audible tones. Repeatable 
changes in distortion product OAE magnitudes, phase shifts, and power reflectance when 
subjects are tilted to 45° HDT, which presumably increases their ICP (Voss et al. 2010). 
Distortion product OAE was used to assess changes in ICP in patients undergoing diagnostic 
CSF infusion testing where ICP was increased in steps of 3 mmHg (Williams et al. 2016). 
Distortion product OAE detected significant changes in angle, and to a lesser degree magnitude, 
when ICP was ≥ 12 mmHg above baseline supine values. 
 
The Vittamed two-depth transcranial Doppler device has shown promise in providing a 
noninvasive quantitative measure of ICP. The technology is based on simultaneously measuring 
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the blood flow velocity waveform in the intracranial and extracranial portions of the ophthalmic 
artery (OA) before, during, and after discrete increases in pressure applied to the closed eye. The 
pressure surrounding the intracranial portion of the OA is equal to ICP, whereas the extracranial 
portion of the OA lies outside of the cranial vault, in the orbit, and therefore is subjected to 
orbital tissue pressure. The device relies on the assumption that applied external pressure at 
which the waveforms of the internal and external OA match is equivalent to ICP (Ragauskas et 
al. 2005). Direct assessment of ICP in neurological patients undergoing lumbar puncture and 
simultaneous assessment with the Vittamed device resulted in 98% limits of agreement between 
the two methods spanning -4.0 to +4.0 mmHg when the mean opening pressure was 13.18 
mmHg (± 2.99) with a range of 4.14 to 24.26 mmHg (Ragauskas et al. 2008). However, more 
recent work funded by the National Space Biomedical Research Institute in support of NASA 
produced much larger 95% limits of agreement between the two methods of -10.5 to +11.0 
mmHg (Bershad et al. 2016). The mean LP opening pressure was 20.9 mmHg (9.8 to 28.6 
mmHg) and some of the subjects were suspected of having IIH. The authors concluded that the 
wide limits of agreement indicated that the device should not serve as the only method of 
determining ICP in a given patient. 
 
While not a direct measure of ICP, the sensitivity of optical coherence tomography has 
shown promise in detected changes in ICP. Patients undergoing lumbar puncture had a fall in 
ICP from 34.3 ± 11.8 cm H2O to 11.6 ± 3.3 cm H2O after removal of CSF. Concurrently, there 
was a decrease in the retinal pigment epithelium/Bruch’s membrane angle in all subjects and a 
decrease in papillary height in 3 out of 5 subjects (Anand et al. 2016). Whether or not structural 
changes from OCT taken during spaceflight are sensitive enough to track smaller changes in ICP 
remains to be determined. 
 
B. Intraocular Pressure 
Intraocular pressure is determined by the production, circulation and drainage of ocular 
aqueous humor and is described by the equation: 
 
IOP= F/C+PV 
 
where F=aqueous fluid formation rate, C = aqueous outflow rate, and PV = episcleral 
venous pressure. 
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In the general population, IOP ranges between 10 and 20 mmHg with an average of 15.5 
mmHg (Liu et al. 1998). Diurnal variation for normal eyes is between 3 and 6 mmHg, with a 
nocturnal peak independent of body position change (Figure 24) (Liu et al. 1998, 2003a; Mosaed 
et al. 2005). Besides circadian variation, IOP has been shown to increase by 3 to 4 mmHg in both 
normal and glaucomatous patients lying supine, regardless of the time of the day (Liu et al. 
2003b). Tilting to 15° head-down tilt also increases IOP, while application of lower body 
negative pressure significantly reduces it towards supine levels (Macias et al. 2015). 
 
Twenty-four hour assessment in glaucoma and sleep studies (Mosaed et al. 2005) 
evidenced that IOP peaks roughly around 5:00 to 5:30 in the morning (during sleep period), and 
aging has a shifting effect delaying the peak post awakening (Mansouri et al. 2012). Aqueous 
humor flow also demonstrates a circadian rhythm, peaking in the morning at ~2.3 to 3.0 µl/min 
and dropping to 1.1 to 1.5 µl/min at night (Sit et al. 2008; Goel et al. 2010; Nau et al. 2013). 
There are two drainage routes for aqueous humor. The majority (up to 80%) is through the 
trabecular meshwork consisting of the uveal and corneoscleral meshwork, the endothelial lining 
of Schlemm’s canal, and the collecting channels and aqueous veins. After having passed through 
the trabecular outflow pathways, aqueous humor drains into the episcleral venous system. The 
second drainage route is via the uveoscleral outflow pathway that is less defined and understood. 
Fluid in this pathway ultimately drains into the lymphatic system. Compared to 20-30 year old 
subjects, those older than 60 years have reduced aqueous humor production and uveoscleral 
outflow (Toris et al. 1999).  
 
Episcleral venous pressure in healthy humans is in the range of 7 to 14 mmHg with 
values between 9 to 10 mmHg typically (Phelps and Armaly 1978). This is the only component 
of aqueous humor dynamics that is affected by body position. Episcleral venous pressure 
increases by 3.6 mmHg by changing body position from seated to supine. Any increase in 
episcleral venous pressure results in decreased trabecular meshwork aqueous outflow and a 
Figure 24 Correlation between office and peak nocturnal IOP in healthy subjects and glaucoma patients. 
Reproduced from Mosaed S, Liu JHK, Weinreb RN, with permission from Elsevier, obtained via Copyright 
Clearance Center, Inc. 
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corresponding increase in IOP. In fact, a change in episcleral venous pressure of 0.8 mmHg 
corresponds to a change in IOP of 1 mmHg. Moreover, trabecular and uveoscleral outflow is 
reduced in ocular hypertension.  
 
Ocular hypertension, generally considered as an IOP greater than 21 mmHg, is the most 
important risk for glaucoma. The Ocular Hypertension Treatment Study showed that the 
incidence of glaucomatous damage in subjects with ocular hypertension was up to 3% for IOPs 
of 21 to 25 mmHg, up to 26% for IOPs of 26 to 30 mmHg, and approximately 42% for subjects 
with an IOP higher than 30 mmHg (Gordon et al. 2002). Age greater than 40 years is a risk 
factor for the development of both ocular hypertension and primary open-angle glaucoma. 
However, while in-flight monitoring of IOP using Tonopen had occurred as a part of routine 
medical monitoring on all astronauts, the relatively high variability in measurements and general 
lack of IOP values suggestive of ocular hypertension led to the cessation of acquiring this 
measurement. Currently, in-flight measurements of IOP occur as part of certain research 
experiments and as clinically indicated.  
 
1. Translaminar Pressure Difference 
In a 1-G environment under normal physiologic conditions, the difference between IOP 
and the retrolaminar CSF is the translaminar pressure difference (TLPD) that generates both a 
net posterior force on the surface of the lamina cribrosa (LC) and a hydrostatic pressure gradient 
within the neural and connective tissues of the prelaminar and laminar regions. The clinical 
importance of TLPD has gained in importance both in patients with elevated ICP and glaucoma 
patients with elevated IOP. 
 
Jonas et al. (Jonas et al. 2004) suggested that the border between the high pressure 
intraocular space and lower pressure retrobulbar space produces a translaminar pressure gradient 
which can play a role in ocular disease if either pressure becomes abnormally high or abnormally 
low (Morgan et al. 1998, 2002). The TLPD depends on the difference in pressure and the 
thickness of the LC, thus Jonas et al. suggested one may infer that the reduced thickness of the 
LC in highly myopic eyes might be the histologic correlate of an increased susceptibility to 
glaucoma.  
 
The TLPD is dynamic and not a static pressure difference, for example both IOP and ICP 
are altered during postural adjustments. In addition, both the IOP and ICP contain characteristic 
pulse pressure waveforms corresponding to the cardiac cycle. To accurately estimate the TLPD, 
both IOP and ICP should be measured with subjects in the same position, yet clinical 
assessments of ICP typically occur with patients in the supine or lateral side lying position, while 
IOP is typically measured in the seated upright position. Recent work by Eklund et al. in 11 
healthy subjects demonstrated that both ICP and IOP change during posture changes, resulting in 
TLPD differences of 19.8 mmHg while seated, 12.3 mmHg while supine, and 6.6 mmHg while 
in the 9° head-down tilt position (Eklund et al. 2016). By assuming 16 hours of upright posture 
and 8 hours of supine posture per day, these authors estimated a 24 hr average TLPD of 17.3 
mmHg. Conversely, estimates of TLPD during weightlessness when all hydrostatic pressures are 
removed suggest that during spaceflight TLPD is 6.7 mmHg, a decrease over a 24 hr period 
relative to pressures that occur on Earth.  
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Potentially, one could utilize the TLPD to guide treatment of optic disc edema by 
monitoring and modulating IOP and ICP. Pharmaceutical treatments aimed at ICP and IOP could 
rebalance the TLPD gradient thereby reversing axonal compression and edema formation. 
However, at present there is no validated method of noninvasively measuring ICP during 
spaceflight or providing such a countermeasure. 
 
2. Lamina Cribrosa 
Nerve fiber bundles from the optic nerve pass through the lamina cribrosa (LC) before 
entering the posterior pole of the eye. The LC is a porous, collagenous cylindrical structure at the 
bottom of the intrapapillary region (Figure 25 (Burgoyne et al. 2005)) and is composed of type-1, 
III, IV, V, and VI collagen, and elastin (Hernandez et al. 1987; Goldbaum et al. 1989). The 
human lamina cribrosa marks an important anatomical transition zone where axonal bundles 
anterior to the disc are not myelinated, but as they cross into the retrolaminar region become 
myelinated (Tso and Hayreh 1977; Hayreh 2016). This transition zone includes non-myelinated 
axons, therefore this tissue may be particularly susceptible to abnormal translaminar pressure 
differences and associated mechanical forces.  
 
The LC shows regional variations. Pore size increases with increasing distance from the 
center of the LC (Figure 25); the largest pores are located close to the lamina margin, with the 
least amount of inner pore connective tissue in the inferior, superior, and temporal disc regions, 
and higher retinal nerve fiber count in the inferior and superior disc regions. In addition, the 
central portion of the lamina cribrosa tends to have a slight anterior elevation at the site were the 
central retinal vessel passes. There is evidence that high myopia is associated with a thinner and 
elongated LC (Jonas et al. 2004) and variations in the thickness of the LC and surrounding tissue 
has been hypothesized to increase stresses and strains from the higher translaminar pressure 
gradient (Sigal et al. 2004). During aging, weakening of the collagen within the LC alters its 
mechanical behavior, compromising the support of nerve axons that pass through it, and likely 
increasing the susceptibility of retinal ganglion cell axons to damage (Albon et al. 1995, 2000; 
Karwatowski et al. 1995). The change in mechanical compliance appears to be most marked after 
40 to 50 years, the age at which the incidence of primary open angle glaucoma (POAG) is 
increased. This corresponds with the age range for astronauts affected with SANS.  
 
Anatomical regional strain and stress distribution about the lamina cribrosa exist (Roberts 
et al. 2010) and alterations in these fields may be associated with quadrant based changes in 
Figure 25 Left: Optic nerve and ONH X-Section. Reproduced with permission from Vaughan DW. Right: Anterior 
view LC. Reproduced from Burgoyne CF, et al., with permission of Pergamon, obtained via Copyright Clearance 
Center, Inc. 
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RNFL. While direct experimental measures of lamina cribrosa are limited, future advances in 
OCT imaging may provide future data to monitor lamina cribrosa structure. Because the stress 
on the ocular tissue of the globe, and thus at the LC, is related to the radius, larger eyes may have 
a greater cupping of the LC and thus greater stress on that tissue. As such, individuals with a 
large globe diameter may be at greater risk for damage to the LC and/or glaucomatous damage. 
 
C. Genetic 
1. 1-Carbon Metabolism 
Smith, Zwart, and others have put forward the theory that the incidence of ophthalmic 
issues is genetically predisposed (Zwart et al. 2017). This is based on initial findings related to 
differences in 1-carbon pathway biochemistry between crewmembers. In their initial paper, 
Zwart et al. (Zwart et al. 2012) identified differences in circulating concentrations of the folate 
and B12-dependent 1-carbon metabolic pathway between astronauts on ISS missions of 48–215 
d with (n = 5) and without (n = 15) ophthalmic changes. They found that serum homocysteine 
(Hcy), cystathionine, 2-methylcitric acid (2MCA), and methylmalonic acid concentrations were 
25-45% higher (P < 0.001) in astronauts with ophthalmic changes than in those without them, 
and that these differences were present before, during, and after flight. Moreover, preflight serum 
concentrations of Hcy and cystathionine, and mean in-flight serum folate, were correlated with 
change (postflight relative to preflight) in cycloplegic refraction (P < 0.05). Zwart and colleagues 
hypothesized that the higher Hcy may be caused by single-nucleotide polymorphisms of 
enzymes involved in folate- and vitamin B-12 dependent 1-carbon metabolism (Zwart et al. 
2012). In a follow-on investigation, Zwart et al. (Zwart et al. 2016) examined whether genetic 
variations in 1-carbon metabolism genes (methionine synthase reductase (MTRR), 
methylenetetrahydrofolate reductase (MTHFR), serine hydroxymethyltransferase (SHMT), and 
cystathionine β-synthase (CBS)) contributed to susceptibility to ophthalmic changes in 49 
astronauts (48 ± 4 yrs; 58-382 days in space). Results indicated that B-vitamin status and the 
number of risk alleles of the genes studied were significant predictors of many of the ophthalmic 
outcomes. Astronauts with the recessive G MTRR 66 allele had a higher risk of choroidal folds 
and cotton wool spots, and those with the SHMT 1420 C allele had a higher risk of optic disc 
edema after spaceflight. Additionally, preflight dehydroepiandrosterone was positively 
associated with cotton wool spots, and serum testosterone response during flight was associated 
with refractive change. Altered 1-carbon metabolism is likely one of many factors during 
spaceflight that contribute to endothelial dysfunction and vascular permeability that can increase 
an individual’s susceptibility during flight. Mild hyperhomocysteinemia has been shown to 
increase arterial permeability and rigidity in animal models, and with a 
methylenetetrahydrofolate reductase (MTHFR) polymorphism, the blood concentration of folate 
is lower, promoting an increase in vascular permeability (Symons et al. 2006; Mullick et al. 
2006), and ultimately potentially increasing ICP. Studies are currently underway to investigate a 
wider array of single nucleotide polymorphisms in the 1-carbon metabolic pathway. In addition, 
a terrestrial clinical population was identified as having similar characteristics to astronauts with 
ophthalmic issues, and a full characterization of that population is currently being conducted, 
with the hope that this may provide a terrestrial analog population in which to study astronaut 
ophthalmic issues. Whether these genotypes and resulting biochemical and physiological 
differences are associated with the mechanisms leading to astronaut ophthalmic issues or 
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whether they constitute genetic markers for other potential genetic associations is unknown and 
requires further investigation. 
 
2. Biomarkers 
There are several potential biomarkers in CSF and possibly in blood or other body fluids 
that may in the future be used for early detection of SANS or to identify astronauts with 
increased risk for developing the syndrome. The Panel members of the 2010 Visual Impairment 
Summit suggested several biomarkers as potential candidates including S-100, platelet count, 
albumin, CRP/inflammation markers, insulin-like growth factor, somatostatin, tet-transactivator 
(TTA), myelin basic protein, immunoglobin G index, oligo-clonal bands, atrial naturetic peptide, 
vasopressin, and aquaporin. In addition, gene expression profiling, epigenetic modifications of 
gene expression, proteomics, metabolomics, CO2 retaining variants, single nucleotide 
polymorphisms, and copy number variants should be expanded to better characterize the 
individual susceptibility to develop SANS. As the etiology of the symptoms is more clearly 
defined the appropriate biomarkers will be evaluated. 
 
D. Spaceflight Exposures 
1. Exercise 
Exercise is an important countermeasure used to maintain muscle, bone, and cardiac 
health during spaceflight. Historically, Russian scientists have used a variety of exercise 
hardware and in-flight exercise protocols during long-duration spaceflight (up to and beyond 1 
year) onboard the Mir space station. On the ISS, a combination of resistive and aerobic exercise 
is used. For missions to the moon, establishment of a lunar base, and interplanetary travel to 
Mars or to an asteroid, the functional requirements for physical human performance during each 
specific phase of these missions have not been sufficiently defined to determine whether 
currently developed exercise countermeasures are adequate. Long-duration missions and 
exploration missions with several transitions between gravitational environments present the 
greatest challenges to risk mitigation and to development of countermeasures of proven efficacy. 
 
Despite its benefits on skeletal morphology and function, the effects of resistive exercise 
on the development of elevated ICP remain controversial. Recent work by Lawley, et al. 
demonstrated an acute increase in ICP during resistive exercise in weightlessness of parabolic 
flight (Lawley et al. 2017). When the subject simultaneously exercised and performed a Valsalva 
maneuver there was a concomitant increase in arterial blood pressure, central venous pressure, 
and ICP. Conversely, performance of a Mueller maneuver reduced central venous pressure and 
ICP to a similar magnitude during the resistive exercise task. Haykowsky et al. invasively 
examined ICP in fully cooperative, alert, and clinically stable patients who received a ventricular 
drain as part of their surgical procedure and postoperative care. They reported that resistive 
exercise without a Valsalva maneuver resulted in no change in peak systolic pressure or ICP 
(Haykowsky et al. 2003).  
 
The effects of resistive exercise on IOP are less controversial. Resistive exercise training 
induces an increase in IOP (Lempert et al. 1967). A significant increase in IOP was also reported 
immediately after a static squat done until voluntary termination (Movaffaghy et al. 1998), and 
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during bench press (Vieira et al. 2006). A dramatic increase in IOP (115%) was observed in 
experienced strength trained subjects during a maximal static muscle contraction combined with 
Valsalva maneuver (Dickerman et al. 1999). However, IOP was decreased after static muscular 
actions, such as handgrip exercise in subjects with normal IOP values (Marcus et al. 1974). After 
exercising, IOP declined to 14% less than the pre-exercise values (Movaffaghy et al. 1998). The 
only study that incorporated dynamic muscular contractions reported that IOP was reduced 40% 
after a series of isokinetic muscular actions in subjects with normal IOP (Avunduk et al. 1999). 
More recently, Chromiak et al. demonstrated that IOP decreases after one or more sets of chest 
press and leg press performed at moderate intensity (Chromiak et al. 2003). Consequently, it 
appears as though resistance exercise performed without a Valsalva maneuver will not elevate 
ICP or IOP during exercise, and may even decrease ocular and cranial pressures post exercise. 
 
In contrast to numerous investigations examining the effects of resistive exercise on 
cranial pressures, there is a dearth of information regarding the consequences of aerobic exercise 
on ICP. To our knowledge the only study to examine ICP during aerobic exercise invasively 
measured ICP in patients with normal and increased ICP (Brimioulle et al. 1997). The 
researchers found that exercise tended to decrease ICP both in patients with intracranial 
hypertension and in those with normal ICP. They suggested that because aerobic exercise is 
generally conducted without Valsalva maneuvers, it is unlikely that ICP will increase during 
such exercise. However, other studies have demonstrated that in both animals and humans global 
brain blood flow increases 20% to 30% during the transition from rest to moderate exercise 
(Kashimada et al. 1995; Delp et al. 2001). Interestingly, more recent work has shown that an 
increase in exercise intensity up to ~60% VO2max results in an increase in CBF, after which 
CBF decreases toward baseline values (sometimes decreasing below baseline values) with 
increasing exercise intensity (Jørgensen et al. 1992b; a; Moraine et al. 1993; Hellström et al. 
1996). These findings suggest that high intensity exercise may be a key countermeasure to 
decrease CBF and thus potentially ICP.  
 
It is well established that IOP decreases transiently with aerobic exercise in proportion to 
intensity and duration (Figure 26) (Harris et al. 1994). For example, sedentary subjects’ IOP 
reduced 28% immediately after cycling at a low intensity for 1 hour (Qureshi 1996), and 
individuals with elevated IOP (18 mmHg or greater) had a reduced IOP after a single bout of 
Figure 26 Impact of aerobic exercise on IOP. Reproduced from Harris A, and others, with permission of the 
Association for Research in Vision and Ophthalmology, obtained via Copyright Clearance Center, Inc.  
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aerobic exercise (Qureshi 1996) and in individuals with elevated IOP (18 mmHg or greater) it 
was reduced after a single bout of aerobic exercise (Qureshi 1995). Another investigation 
demonstrated that IOP was decreased by 30% after an incremental cycle test to exhaustion in 
subjects with IOP values of 22 mmHg or greater (Passo et al. 1991). A ground-based study 
currently underway is assessing IOP during and immediately following high intensity resistive 
exercise and aerobic exercise during HDT.  
 
2. Carbon Dioxide 
a) Elevated CO2 on ISS 
Carbon dioxide constitutes just 0.04% by volume of Earth’s atmosphere, resulting in a 
partial pressure of CO2 (PCO2) of 0.3 mmHg at sea level. As a byproduct of metabolic 
respiration, humans expire CO2 with each breath, which increases ambient PCO2 in closed or 
poorly-ventilated environments if not adequately removed. As a result, indoor levels of CO2 on 
Earth are typically elevated to ~1 mmHg. The Occupational Safety and Health Administration 
sets the maximum daily exposure limit for an 8-h work day to a time-weighted average of 0.5% 
(3.5 mmHg) (NIOSH 2007) despite the fact that the Environmental Protection Agency 
recognizes no acute effects for indefinite exposures of up to 1% CO2 (7.5 mmHg) (Compressed 
Gas Association 1990). The Spaceflight Maximum Allowable Concentration (SMAC) for 
ambient CO2 is set to 5 mmHg, although recent concerns related to reports of crewmember 
symptoms has led NASA to target levels equal to or below 4 mmHg (Law et al. 2014).  
 
Elevated arterial PCO2 leads to vasodilation of cerebral arteries to effectively “wash out” 
CO2 from the brain, while augmented ventilation expels CO2 from the body (Battisti-Charbonney 
et al. 2011). Despite these acute ventilatory and cardiovascular responses designed to rid the 
body of excess CO2, it is unknown if chronic exposure to a mildly elevated CO2 environment, 
combined with the headward fluid shift induced by weightlessness, contributes to the structural 
and functional changes characteristic of SANS. Ambient levels of CO2 are elevated on ISS 
because of poor air convection, variability in CO2 production from up to 6 crewmembers in an 
enclosed environment, and limitations with currently available CO2 removal hardware. One 
hypothesis for the lack of SANS symptoms developing in ground analogs of spaceflight is that 
these models lack the elevated ambient CO2 that is present on the ISS. Negative sequelae 
normally associated with high levels of CO2 may result from the strong vasodilating effect of 
CO2 include headaches, blurred vision, lethargy, irritability, and neurocognitive deficits. While 
these symptoms typically manifest in environments on Earth with high levels of CO2 (typically 
greater than 5.0% inspired) (Henning et al. 1990; Law et al. 2014), it is unknown if the chronic 
exposure to mildly elevated CO2 (currently ISS is <0.5% CO2 inspired) experienced by 
crewmembers on ISS in combination with weightlessness or other spaceflight factors contributes 
to SANS or contributes to other negative impacts on crew performance, such as reductions in 
cognitive function (Manzey and Lorenz 1998a; b) or sleep (Barger et al. 2014). 
 
b) Localized Pockets 
Because air convection is significantly reduced in microgravity, local pockets of CO2 
may develop around the nose and mouth. A computational fluid dynamics analysis revealed that 
without adequate ventilation, PCO2 could rise above 9 mmHg within 10 minutes around a 
Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS) 
62 
 
sleeping astronaut’s mouth and chin (Son et al. 2002). Fans built into the sleep quarters and 
directed at the astronaut’s face are in place to prevent this buildup of CO2. 
 
Few investigations to date have measured true CO2 exposures during spaceflight. The 
Major Constituent Analyzer (MCA) draws air from fixed locations that may not necessarily 
reflect local CO2 levels around astronauts as they move throughout the ISS. Even the portable 
CO2 monitors (CDMs) are generally placed on cabin walls and not directly next to the crew. In 
other words, CDM data may not be representative of what the crew truly experiences throughout 
their day. Portable wearable CO2 monitors were recently launched to the ISS in 2016 and will 
hopefully provide more precise insight into the true CO2 exposure of astronauts. 
 
All in all, more data are needed to further the understanding of individual and 
environmental factors that contribute to CO2-related symptoms in microgravity. It may be that 
certain individuals or one sex is more susceptible to CO2 retention and increased ICP, but until 
true exposure data are available to correlate symptoms and ppCO2, no conclusion can be drawn 
at this time about CO2 susceptibility in spaceflight. 
 
c) Acute CO2 Exposure with Head-down Tilt 
Recent investigations into the combined effects of a headward fluid shift induced by 
HDT combined with elevated inspired PCO2 provide evidence of acute exposures similar to what 
crewmembers may experience during prolonged spaceflight. Subjects who breathed 1% CO2 for 
up to 60 min in the 6-degree HDT position had a small, but statistically significant increase in 
end-tidal PCO2 as compared to values obtained when they breathed room air (42.1 mmHg vs. 
40.4 mmHg, respectively). This increase was likely physiologically insignificant as there was no 
difference in mean blood flow velocity through the middle cerebral artery or noninvasively 
estimated ICP (Laurie et al. 2017). Similarly, using a double-blind cross-over design, blood flow 
through the internal carotid arteries measured using MRI was not different after 26.5 hours of 12-
degree HDT breathing either room air or 0.5% CO2 (Kramer et al. 2017), and noninvasive 
assessment of ICP using the Vittamed device revealed no difference in ICP in subjects exposed 
to 3.5 hours of 12-degree HDT breathing either room air or 1% CO2 (Marshall-Goebel et al. 
2017a) or during 24 hours exposure to 12-degree HDT breathing either room air or 0.5% CO2 
(Strangman et al. 2017).  
d) Prolonged CO2 Exposure 
No blood gas measurements of arterial PCO2 have been measured in astronauts on ISS 
and only sparse measures of end-tidal PCO2 (PETCO2) have been reported as a surrogate. Prisk 
and colleagues reported PETCO2 levels in crewmembers during long-duration spaceflight 
(Expeditions 3 to 6) were 39.0 ± 3.9 mm Hg, which was no different from supine levels 
measured before (39.7 ± 3.1 mmHg) and after (38.5 ± 3.7 mmHg) spaceflight (Prisk et al. 2006). 
Importantly, standing PETCO2 levels were also measured before (36.7 ± 3.6 mmHg) and after 
spaceflight (35.5 ± 4.3 mmHg), highlighting the slight increase that occurs when transitioning 
from standing to supine due to the upward shift of the diaphragm and abdominal contents. A 
recent ISS experiment “BP Reg”, showed that PETCO2 was 42.1 ± 3.7 mmHg in 9 male subjects 
when ambient inspired PCO2 averaged 3.8 mm Hg, which was significantly greater than the 
preflight seated value of 36.0 ± 3.2 mmHg (Hughson et al. 2016b). These data are combined in 
Figure 27. 
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Law and colleagues recently reviewed ISS CO2 levels and de-identified astronaut private 
medical conference reports and reported an association between 7-day average CO2 
concentrations and headache incidence (Law et al. 2014). However, they found no association 
between CO2 levels and vision changes. From Expedition 2 through 31 the average 24-h CO2 
concentration was 3.4 mmHg and the 7-day average CO2 levels over a period from 2001 through 
2012 was similar (Figure 28).  
 
Prolonged exposure to a mild hypercapnic environment has been studied in a few 
subjects, although these subjects were lacking the headward fluid shift associated with 
spaceflight. Terrestrial exposure to 1.5% CO2 for 42 days led to an elevation in alveolar PCO2 of 
2-3 mmHg in 21 subjects and increased minute ventilation (VE) during the first few days of 
hypercapnia. With chronic CO2 exposure, VE decreased but remained elevated after the initial 23 
days of exposure (Schaefer et al. 1963). A similar pattern of increased VE followed by a return 
toward baseline occurred in 4 subjects exposed to 1.4% or 0.7% CO2 for 22 days, but because of 
the small number of subjects, variability during baseline conditions, and higher than expected 
baseline values, changes failed to reach statistical significance (Elliott et al. 1998). Additionally, 
subjects demonstrated a reduced ventilatory response to a 5% CO2 challenge during chronic low-
level CO2 exposure (Schaefer et al. 1963) and reduced VE during sustained elevations in PETCO2 
(Elliott et al. 1998). Together, these data suggest the early increase in ventilation during exposure 
to an elevated CO2 environment becomes blunted as chronic CO2 exposure progresses. However, 
Figure 27 End-tidal PCO2 measured pre-, in-, and postflight to the ISS. Data modified from Prisk et al. (2006) and 
Hughson et al. (2016). Values are means ± SD. 
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the increasing variability in arterialized PCO2 measured in these subjects throughout the chronic 
hypercapnic exposure (Sliwka et al. 1998) suggests variability in acclimatization between 
individuals. One contributing factor to the variability in ventilatory acclimatization to CO2 may 
be driven by ventilatory strategy and differences in tidal volume. Those with a high ventilatory 
response to 5% CO2 before chronic 1.5% CO2 exposure demonstrated a blunted ventilatory 
response to the 5% CO2 challenge at the conclusion of the 42 day exposure and a respiratory 
pattern characterized by a higher respiratory rate and lower tidal volume (Schaefer et al. 1963). 
Conversely, those with a mild ventilatory response to a 5% CO2 challenge demonstrated little 
change in ventilatory response after chronic CO2 exposure. Thus, while ventilatory response to 
CO2 appears to be blunted during prolonged CO2 exposures, the response may vary between 
individuals. Should changes in CO2 sensitivity after chronic CO2 exposure relate to SANS 
susceptibility, ventilatory response and/or strategy prior to spaceflight may provide an 
opportunity to predict SANS susceptibility. Whether the variability in ventilatory response to 
CO2 prior to spaceflight will predict differences in acclimatization to chronic CO2, cerebral 
vasculature regulation during or after spaceflight, or variability in SANS incidence remains 
unknown. 
 
Four subjects exposed to 0.7% and 1.2% CO2 for 23 days demonstrated an increase in 
middle cerebral artery blood flow velocity during the first few days of CO2 exposure, which then 
decreased yet remained elevated relative to pre-exposure levels (Sliwka et al. 1998). Because only 
Figure 28 Average partial pressure of CO2 in ambient air of the International Space Station. Vertical green bars 
represent time periods when ambient levels were targeted to remain below 4 mm Hg. Modified from Law et al. 
JOEM, 56:477-83, 2014. 
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4 subjects participated in this study, it is unclear if the increasing variability in cerebral blood flow 
velocity that occurred throughout the 23-day exposure resulted from differences in cerebral 
vascular reactivity or reflected the variability in resulting arterial PCO2. Unexpectedly, the 
elevated cerebral blood flow remained elevated for up to 5 days after returning to ambient air, 
suggesting a chronic adaptation to CO2 had in fact occurred. Cerebral blood flow velocity, 
cerebrovascular reactivity to CO2, and arterial blood gases will be measured before, during, and 
after 30 days of 6-degree HDT with a 0.5% CO2 environment and conclude data collection in 
December of 2017. Despite the reduction in cerebrovascular reactivity to CO2 after long-duration 
spaceflight (Zuj et al. 2012), no measures of CO2 sensitivity have been conducted during 
prolonged spaceflight when additional factors may be necessary to impair cerebral autoregulation 
and contribute to enhanced cerebral vasodilation. 
 
Intracranial pressure has never been measured in humans during chronic exposure to 
elevated levels of CO2. However, ICP in male Wistar rats exposed to 10% CO2 for 21 weeks was 
no different from ICP in control animals housed in room air for the same duration (5.9 ± 0.4 vs 
5.1 ± 0.4 mmHg, respectively) (Kondo et al. 1999). When the control animals were acutely 
exposed to 10% CO2 ICP increased to 9.9 mmHg, suggesting the chronic exposure led to an 
acclimatization. Additional experiments within this study pointed toward a blunting of nitric 
oxide-dependent vasodilation in response to the elevated arterial PCO2 levels for the acute 
increase and subsequent decrease in ICP with chronic hypercapnic exposure. Research targeted 
to conclude in 2018 is using the rat hind-limb unloading model to measure ICP and ocular 
outcomes in various groups of rats, including 1 group exposed to a mild hypercapnic 
environment  
 
3. Diet and Sodium 
Sodium, most commonly consumed as dietary sodium chloride (salt) is a required 
nutrient, used in numerous physiological functions, including the regulation of normal 
distribution of water between the various compartments of the human body (Scott M. Smith et al. 
2015). While the Institute of Medicine and the American Heart Association recommend 1500 mg 
of sodium per day as an adequate intake level (Appel et al. 2011; Susic and Frohlich 2012), most 
of the Western world’s population consumes a much higher amount; as an example, the average 
daily sodium intake in the U.S. is more than 3,400 mg (US Dept of Agriculture). Consumption of 
excessive salt has been linked to numerous adverse health effects, including hypertension, as 
well as pressure-independent pathologies such as increased risk for stroke, subclinical 
cardiovascular disease (left ventricular hypertrophy, ventricular fibrosis, diastolic dysfunction, 
arterial fibrosis leading to large elastic artery stiffness), fibrotic kidney damage, gastric cancer, 
and disordered mineral metabolism with increased urinary calcium excretion, potentially leading 
to osteoporosis. The increased non-pressure related fibrosis is due to increased oxidative stress 
and endothelial dysfunction in the setting of high sodium intake, leading to increased mitogenic 
responses that translate into fibrosis in the heart, kidneys, and arteries (Appel et al. 2011; Susic 
and Frohlich 2012). An acute increase in sodium intake has been shown to impair vascular 
endothelial function in young adults with normal blood pressure (Appel et al. 2011; Susic and 
Frohlich 2012), and it is has been shown that in middle-aged adults with elevated systolic blood 
pressure but no other health problems reducing sodium intake from moderate levels to less than 
1500 mg/d reduces large elastic artery stiffness (Appel et al. 2011). Sodium reduction decreases 
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pressure in both normotensive and hypertensive individuals, although the magnitude of this 
response is still unknown (Appel et al. 2011; Susic and Frohlich 2012). 
 
Foods prepared for spaceflight have always been high in sodium content, a consequence 
of the food preservation techniques. During the Skylab and Shuttle eras, as well as today in the 
ISS era, the average amount of sodium intake is 4-5 grams daily, with some individuals reported 
to consume as much a 7-10 grams daily (Scott M. Smith et al. 2015). Recent efforts at NASA 
have led to a reduction in the sodium content of many of these food items, leading to daily 
sodium intake of around 3000 mg/d (Lane et al. 2013).  
 
During real and simulated spaceflight, sodium homeostasis and blood sodium levels are 
maintained (Scott M. Smith et al. 2015). Over 90% of the dietary sodium in absorbed, so that 
increased sodium intake leads to an increase in sodium levels in the blood, followed by excretion 
of the excesses in the urine (Scott M. Smith et al. 2015). The concern with elevated sodium 
intake in the context of spaceflight is related to its potential impact on bone health and SANS. 
More specifically for SANS, the concern is that the sodium will contribute to elevation in arterial 
blood pressure and to non-pressure related elevations in arterial stiffness. In addition, increased 
sodium intake may induce an expansion of the extracellular fluid volume, which in combination 
with weightlessness-induced fluid shifts might worsen elevations in intracranial pressure.   
 
A link between increased ICP and altered sodium and water retention was suggested by a 
study in which 77% of IIH patients had evidence of peripheral edema and 80% had orthostatic 
retention of sodium and water (Friedman and Streeten 1998). Impaired saline and water load 
excretions in the upright posture were noted in IIH patients with orthostatic edema as compared 
values from lean and obese controls without IIH. However, the precise mechanisms linking 
orthostatic changes and IIH were not defined, and many IIH patients do not have these sodium 
and water abnormalities. Astronauts are well known to have orthostatic intolerance upon return 
to gravity after long-duration spaceflight, and the dietary sodium on orbit is also known to be in 
excess of 5 grams per day in some cases.  
 
4. Radiation 
The space radiation environment in low Earth orbit, where the ISS is located, exposes 
astronauts to higher levels of radiation compared to that found on the surface of the Earth, but the 
Earth’s magnetosphere provides substantial protection even in low Earth orbit. However, 
exploration class missions beyond the protection of Earth’s magnetosphere will expose 
astronauts to greater levels of radiation, in particular galactic cosmic radiation (GCR) (Hassler et 
al. 2014). Although it is unlikely, crew may also be exposed to higher doses during a solar 
particle event (SPE).    
 
Very high levels (20 Gy) of radiation exposure are reported to result in brain edema and 
neuro-inflammation, due to impaired brain-blood barrier (BBB) function (Yuan et al. 2003, 
2006; Bellone et al. 2016) and models suggest this may result in elevated intracranial pressure 
(Lakin et al. 2007). Some mini-pigs exposed to 2.5 Gy electron simulated solar particle event  
had higher CSF opening pressures 90-days after exposure (Sanzari et al. 2014). Preliminary data 
from Sprague-Dawley rats fed an iron-rich diet and exposed to 3 Gy spread over 16 days (37.5 
cGy per day every other day) showed greater oxidative stress in the retina and aortic vasculature, 
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suggesting cellular protection mechanisms may be overloaded by the combination of iron load 
and radiation exposure (Theriot et al. 2016). Published studies that demonstrate radiation induced 
alteration in blood-brain barrier used radiation doses much higher than those expected to occur 
during a nominal mission. Therefore, it is unclear if chronic low-dose, low-linear energy transfer 
(LET) radiation can alter the blood brain or retinal barriers and disrupt cognitive and visual 
function. In addition, it is unclear if high-LET radiation, the main components of GCR, affects 
tissues differently than the low-LET radiation typically used in experimental tests on the ground. 
 
E. Cardiovascular Adaptations 
1. Spaceflight-Induced Fluid Shift 
Spaceflight is known to cause a cephalad fluid shift secondary to the loss of the 
hydrostatic pressure gradient normally experienced on Earth. Moore and Thornton suggest a 
2000 mL shift from the legs to the upper body (Moore and Thornton 1987). Ground-based 
analogs of spaceflight, such as head-out water immersion and HDT bed rest, suggest that the 
fluid shift is between 700 to 3000 mL (Arborelius et al. 1972; Montgomery 1987; Moore and 
Thornton 1987). This fluid shift leads to transient increases in stroke volume (Lathers et al. 1989; 
Liu et al. 2012) and cardiac output (Norsk et al. 2006) and significant variability is likely across 
astronauts in the type and volume of the fluid shift experienced in spaceflight (Montgomery 
1987). While fluid shift seen in bed rest results in a reflex diuresis, the mechanisms of fluid 
redistribution are far less clear during spaceflight (Leach et al. 1996). 
 
The distribution of fluids in the body is influenced by the direction and magnitude of 
gravity and the resulting hydrostatic gradients. On Earth, standing up from a supine position in a 
gravity field imposes a substantial challenge to the human cardiovascular system. Due to the 
increase in hydrostatic pressure gradient acting along the length of the body, venous volume 
increases by approximately 500 mL (Rowell 1993). This redistribution of fluid from the central 
circulation is immediately detected by baroreceptors (pressure) and, in time, by volume 
(osmolarity) receptors, activating reflex responses to increase heart rate, contractility, and 
vascular resistance to maintain blood pressure. When astronauts enter the microgravity 
environment of spaceflight, the opposite effect occurs. It has been well documented that 
microgravity leads to a cephalad fluid shift in the absence of the hydrostatic pressure gradient 
(Thornton et al. 1977, 1987; Kas’ian et al. 1980; Moore and Thornton 1987; Kirsch et al. 1993). 
 
One of the first physiologic changes noted during the Apollo program was the decrease in 
plasma volume, exhibited by the decrease in weight of the crewmen (Leach et al. 1975). It was 
initially hypothesized that this decrease in plasma volume was a reflex response to a cephalad 
fluid shift, although the etiology of this plasma volume decrement was never clearly 
characterized. The time course of the plasma volume losses was unknown due to the lack of in-
flight measurements, but the degree of plasma volume loss was independent of the duration of 
the Apollo mission (Leach et al. 1975). 
 
Later, the cephalad fluid shift upon entry into microgravity was documented using 
anthropometric measures. Although pre- and postflight anthropometric changes lacked the ability 
to distinguish between changes in fluid status and tissue loss, it was assumed that the rapid 
recovery of anthropometric measures after flight represented fluid shifts and plasma volume 
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recovery; the more gradual recovery was presumed to result from lean tissue and fat mass 
accretion. Sixteen of 24 Apollo astronauts experienced a mean decrease in calf circumference of 
3% immediately after spaceflight that was not fully restored 5 days later, suggesting that the loss 
was a combination of fluid and muscle atrophy (Hoffler and Johnson 1975).  
 
Anthropometric observations made during the Skylab 2 and 3 missions demonstrated a 
decrease in thigh circumference, suggesting that these astronauts experienced a significant fluid 
shift and muscle atrophy during the course of their missions. More extensive circumferential 
measures were obtained during Skylab 4 (Thornton et al. 1977), when it was found that 
astronauts experience a rapid loss in leg volume early during their flight, too rapid to be 
explained by fat or lean tissue loss, but the change was consistent with the cephalic fluid shift 
that occurs during spaceflight. These measures were performed every 3 cm along the leg and the 
arm, around the neck, chest, abdomen, and hip (Figure 29). 
 
 
Figure 29 Circumference measures used to calculate volume of fluid shift during Skylab 4. 
 
Interestingly, there was little to no change in arm volume in these subjects from before to 
during flight and from during to after flight, suggesting that neither arm fluid volume nor tissue 
volume changed during the course of their mission (Figure 30). Furthermore, lower limb veins 
were not distended, whereas the veins of the upper body, including the jugular, temple and 
forehead veins were completely full and distended. It was hypothesized that intra and 
extravascular fluid shifts to above heart level had occurred and that increased transmural 
pressure led to cephalad edema (puffy face). 
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Anthropometric measurements of the thigh and calf also were obtained using stocking 
plethysmography in 11 astronauts during and after 5 early Shuttle flights (STS-7, 8, 51D, 51B, 
61B) (Thornton et al. 1977; Moore and Thornton 1987) (Figure 31). As expected, upon entry into 
microgravity, leg volume decreased by 12% and was believed to result from a rapid shift in fluid 
volume to the upper body, with confirmatory evidence in the form of photographs of puffy faces 
as well as reports of nasal congestion and “full headedness”. The total fluid shift was reported to 
Figure 30 Volume changes pre, in, and postflight from Skylab 4. 
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be 2 L, 1 L from each leg, with the majority of the volume coming from the thigh. Most of this 
fluid shift occurred in the first 6 to 10 hours after entering microgravity, followed by a 
subsequent slow negative decline or plateau. Similar to observations after Skylab missions, when 
measurements were repeated within 1.5 hours of landing while the astronauts were standing, the 
difference between pre and postflight leg volume was less than the measured loss during flight, 
amounting to only an average decrease in leg volume of 4%. The decreased volume upon landing 
was likely the combined result of lower plasma volume, decreased fat mass, and lower muscle 
mass. One week after Shuttle landing, leg volume still was 3% lower than before flight although 
plasma volume would have been recovered by this time. Using a similar method, Kas’ian et al. 
(Kas’ian et al. 1980) reported a decrease in leg volume of 6% to 7% within the first week of 
flight in 2 cosmonauts, which progressively decreased to 18% to 23% reduced leg volume by 
flight day 120 of the Salyut-6 mission. The absence of postflight tests makes interpretation of 
these volume changes difficult, as it is unclear how much of the volume loss was due to muscle 
atrophy.  
 
Figure 31 Schematic of leg plethysmograph and Dr. William Thornton making measurements on Commander 
Richard Truly on STS-8. Reproduced from Moore TP, et al. with permission of the Aerospace Medical Association. 
 
Kirsch et al. (Kirsch et al. 1993) used A-mode ultrasound to measure the spaceflight-
induced fluid shift in one cosmonaut on the Mir 1992 mission using interstitial thickness 
measures over the forehead and tibia. Measurements were obtained before flight (supine and 
head-down), 8 times during flight, and 7 days after the flight. Facial tissues swelled during the 
first 3 days of the mission. Tibial interstitial thickness was 20% less than before flight and 
remained low for the duration of the flight and immediately upon landing. Body weight did not 
fully recover within the first 4 days after landing, suggesting that only a portion of the interstitial 
thickness changes were fluid dependent.   
 
2. Plasma Volume Losses 
It is well documented that plasma volume decreases with spaceflight (Johnson et al. 
1977; Leach et al. 1996; Buckey et al. 1996b; Waters et al. 2002) although the exact mechanism 
of this plasma volume decrease is not completely understood. Red cell mass is decreased in 
spaceflight (Johnson et al. 1977; Udden et al. 1995; Alfrey et al. 1996) appropriately as a reflex 
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response to hemoconcentration after reduced plasma volume. Leach and coworkers initially 
reported that total body water is decreased after short-duration Shuttle flights (Leach et al. 1991), 
yet suggested that this may have been exaggerated by a space motion sickness-induced reduction 
in water intake. Several years later, they published the results of SLS-1 and SLS-2 studies in 
which they measured plasma volume, total body water, and extra and intracellular fluid volumes 
in 7 astronauts. In this report, Leach and coworkers reported that plasma and extracellular fluid 
volume were decreased, whereas total body water was unchanged, suggesting that the 
intracellular fluid volume was increased. This reduction occurred despite no report of natriuresis 
or diuresis, similar to results from Drummer et al. (Drummer et al. 1993). It is generally accepted 
that diuresis is not the cause of reduced plasma volume during spaceflight, but rather a 
combination of decreased water balance (i.e., reduced intake) and extravasation into intracellular 
and interstitial compartments (Norsk 2005). Leach et al. (Leach et al. 1996) reported a negative 
water balance and reduced total circulating protein in the astronauts. They suggested that a rapid 
filtration of protein out of the vascular space is responsible for the early plasma volume loss and 
a negative water balance perpetuates this hypovolemia. Norsk also reported a negative water 
balance during spaceflight, which is more pronounced than during bed rest (Norsk 2000).  
 
3. Central Venous Pressure (CVP) 
In the early days of the Shuttle era, the spaceflight-induced cephalad fluid shift was well-
known and assumed to cause an increase in CVP. Norsk et al. (Norsk et al. 1987) measured CVP 
in 14 subjects while seated upright during parabolic flight and determined only a slight (1.8 
mmHg) increase in CVP during short periods of weightlessness. When 7 subjects were studied in 
a separate parabolic flight study in which CVP was measured in the supine posture, Foldager and 
coworkers reported a decrease from 6.5 ± 1.3 during 1g to 5.0 ± 1.3 mmHg during 
weightlessness (Foldager et al. 1996). They were also able to measure CVP in one Spacelab D-2 
astronaut, and concluded that CVP in microgravity is close to or below measured values in 1-G 
supine position. Earlier, Kirsch and co-workers measured peripheral venous pressure in 4 
Spacelab-1 astronauts and suggested that these measures would be analogous to central venous 
pressure (Kirsch et al. 1984). All 4 astronauts were reported to have reductions in venous 
pressure measures; however, only data for 2 of the astronauts were reported. One astronaut was 
reported to experience a reduction in CVP, assumed to be equivalent to venous pressure 
measured peripherally, from 9.5 cm H2O (7 mmHg) on the day before flight to 6.5 and 2.6 cm 
H2O (4.8 and 2 mmHg) on the first and sixth days of flight, respectively. CVP in a second 
astronaut was reduced from 15.2 cm H2O (11.2 mmHg) on the day before flight to 6.5 and 7.7 
cm H2O (4.8 and 5.7 mmHg) on days 1 and 6 of flight, respectively (Kirsch et al. 1984). These 
findings were supported by two separate studies by Buckey et al. (Buckey et al. 1993, 1996a). 
The first report was from a Spacelab Life Sciences (SLS-1) flight in which CVP was measured 
before flight while seated and while in the launch position in the orbiter, during launch, and 
during the initial moments upon reaching microgravity. CVP increased from 5 to 6 cm H2O (3.7 
to 4.4 mmHg) while seated to 10 to 12 cm H2O (7.4 to 8.8 mmHg) in the launch position. It 
increased further during the launch, presumably from the Gx forces, to 15 to 17 cm H2O (11 to 
12.5 mmHg) before decreasing to 0 to minus 3 cm H2O (0 to minus 2.2 mmHg) upon entering 
microgravity (Figure 32). This reduction was rapid, occurring during the first minute of entering 
microgravity, and remained within 1 to 2 cm H2O (0.7 to 1.4 mmHg) until the catheter was 
removed (Buckey et al. 1993). Interestingly, heart size in this astronaut increased at the same 
time that CVP decreased. Similar results were obtained in a second report of 2 SLS-2 
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crewmembers (Buckey et al. 1996a). Mean CVP (2 SLS-2 crewmembers and 1 SLS-1 
crewmember) increased from 8.4 cm H2O (6.2 mmHg) before flight to 15 cm H2O (11 mmHg) in 
the launch position, to 2.5 cm H2O (1.8 mmHg) after 10 minutes in microgravity. Cardiac filling 
was increased, despite the reduction in CVP, suggesting that effective filling pressure was 
elevated due to the reduced transmural pressure applied from the lungs and abdominal organs in 
weightlessness.  
 
 
 
Videbaek and coworkers tested this hypothesis by measuring central venous pressure, 
esophageal pressure (EP – a surrogate of intrathoracic pressure) and atrial distension in 7 men 
during parabolic flight (Videbaek and Norsk 1997). The CVP during the microgravity period of 
parabolic flight decreased from 5.8 ± 1.5 to 4.5 ± 1.1 mmHg and esophageal pressure decreased 
from 1.5 ± 1.6 to -4.1 ± 1.7 mmHg. Left atrial diameter increased from 26.8 ± 1.2 mm to 30.4 ± 
0.7 mm. Despite the decrease in CVP, the left atrial filling pressure was elevated (as 
demonstrated by left atrial distension). Videbaek suggests that the difference in CVP and EP 
results in an increased transmural central venous pressure, which explains the increased cardiac 
filling despite the reduced CVP. Furthermore, they report increased left ventricular end diastolic 
volume, stroke volume, and cardiac output, likely the result of the chest wall changing shape and 
expanding in the absence of gravity. White and Blomqvist used a 3-compartment cardiovascular 
model to simulate the relaxation of the chest in microgravity (White and Blomqvist 1998). Their 
results indicate that relaxation of the chest would increase the transmural filling pressure of the 
heart, increase left ventricular end diastolic volume, stroke volume, and cardiac output, similar to 
Figure 32 CVP tracing from two SLS-2 astronauts showing the decrease in CVP upon exposure to microgravity 8.5 
minutes post-launch. Reproduced from Buckey JC Jr, et al. with permission from The American Physiological 
Society, obtained via Copyright Clearance Center, Inc.  
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the results obtained by Videbaek in parabolic flight. Prisk et al. (Prisk et al. 1993) also reported 
elevated stroke volume and cardiac output in 4 SLS-1 astronauts.  
 
4. Transcapillary Fluid Pressure  
Kirsch et al. (Kirsch et al. 1993) were one of the first to clearly show interstitial swelling 
in the forehead during flight, which supports the many anecdotal reports of puffy faces, sinus 
congestion, and feeling of a full head during spaceflight. However, little evidence exists of 
filtration into the extravascular space in the head and neck during spaceflight. Using a ground-
based analog of 10-degree HDT, Diridollou and coworkers (Diridollou et al. 2000), showed that 
after 24 hours subjects presented with forehead interstitial swelling similar to that seen by Kirsch 
(Kirsch et al. 1993). Linnarsson et al. (Linnarsson et al. 1985) used tetrapolar bioimpedance to 
measure segmental fluid shifts during 7-degree HDT bed rest. The authors suggest that the initial 
interstitial swelling is a result of a rapid blood shift, which is detected as a plasma volume 
expansion and is followed by a more gradual extravascular shift from the legs over the course of 
2 hours. Bioimpedance detected extravascular volume leaving the thigh and the calf, but not 
entering the chest, suggesting that this volume was being absorbed into the vascular space. This 
would result in a transient decrease in plasma oncotic pressure. This is supported by a study by 
Hsieh et al. (Hsieh et al. 1998) who reported an initial decreased oncotic pressure in the time 
frame reported by Linnarsson (Linnarsson et al. 1985), but this ultimately resulted in an elevated 
colloid osmotic pressure. Similarly, Parazynski et al. (Parazynski et al. 1991) reported an initial 
decrease in colloid oncotic pressure from 21.5 ± 1.5 mmHg to 18.1 ± 1.9 mmHg within the first 
4 hours of HDT. They suggest that this decrease in plasma oncotic pressure is a result of the 
change from filtration to absorption in the capillary beds below the heart. This colloid oncotic 
pressure is thought to gradually return to baseline and is described by the Starling-Landis 
equation  
 
The Starling-Landis equation describes fluid movement in the microvasculature: 
 
𝐽𝑣 = 𝐾𝑓[(𝑃𝑐 − 𝑃𝑖) − 𝜎(𝜋𝑐 − 𝜋𝑖)] 
 
𝐽𝑣 = 𝑁𝑒𝑡 𝑓𝑙𝑢𝑖𝑑 𝑚𝑜𝑣𝑒𝑚𝑒𝑛𝑡  
𝐾𝑓 = 𝐹𝑖𝑙𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡   
𝑃𝑐 = 𝐶𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 𝑓𝑙𝑢𝑖𝑑 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒  
𝑃𝑖 = 𝐼𝑛𝑡𝑒𝑟𝑠𝑡𝑖𝑡𝑖𝑎𝑙 𝑓𝑙𝑢𝑖𝑑 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒  
𝜎 = 𝑅𝑒𝑓𝑙𝑒𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡  
𝜋𝑐 = 𝐶𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 𝑜𝑛𝑐𝑜𝑡𝑖𝑐 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒  
𝜋𝑖 = 𝐼𝑛𝑡𝑒𝑟𝑠𝑡𝑖𝑡𝑖𝑎𝑙 𝑜𝑛𝑐𝑜𝑡𝑖𝑐 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒  
 
Fluid movement into or out of the capillaries is dependent on the hydrostatic pressure 
drop (Pc – Pi) minus the colloid osmotic pressure drop (πc – πi). The filtration coefficient (Kf) 
takes into account the permeability of the capillary membranes to water, which is dependent on 
surface area and hydrostatic conductance. The reflection coefficient (σ) is used to correct for the 
fact that not all plasma proteins are effective in retaining water, and is different in various 
vascular beds.  
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Parazynski et al., were the first to quantify all 4 Starling-Landis pressures during HDT 
(Parazynski et al. 1991). They measured upper body capillary and interstitial fluid pressures, as 
well as plasma and tissue oncotic pressures in 7 men during 8 hours of 6-degree HDT. Capillary 
fluid pressure increased from 27.7 ± 1.5 mmHg to 33.9 ± 1.7 mmHg at the end of bed rest, while 
interstitial fluid pressure did not change significantly (Figure 33). Although plasma oncotic 
pressure initially decreased, it returned to baseline by the end of 8 hours of bed rest. 
Subcutaneous and intramuscular colloid osmotic pressure in the face and neck did not change. 
Parazynski and coworkers suggest that the significantly elevated net Transcapillary pressure 
gradient in the head and neck is the reason for cephalic edema during bed rest and spaceflight. 
They further suggest that capillaries above the heart may be more permeable to protein filtration 
than those below the heart, similar to the results by Leach et al. (Leach et al. 1996). Hargens 
measured interstitial pressure in the lower leg muscles and subcutaneous tissues and reported a 
decrease in tissue pressure of 7.4 and 4.4 mmHg, respectively (Hargens 1983). He also 
hypothesized that lower leg vascular absorption results in decreased vascular oncotic pressure 
and, coupled with increased cephalic capillary pressure, results in filtration in the upper body. 
Several years later, in a separate review, Hargens further postulated that the reduced tissue 
weight in microgravity results in lower interstitial fluid pressure, further shifting the Starling 
balance to net filtration during spaceflight (Hargens and Watenpaugh 1996). 
 
 
Figure 33 Capillary (left) and interstitial fluid pressure (right) during 8 hours of HDT bed rest. Capillary pressure is 
significantly elevated and interstitial fluid pressure does not significantly change. Reproduced from Parazynski et al. 
with permission from The American Physiological Society, obtained via Copyright Clearance Center, Inc. 
 
Cephalad edema may be further exacerbated in spaceflight by changes in microvascular 
water permeability. In a lumped parameter cardiovascular model, Lakin et al. (Lakin et al. 2007) 
postulated that cerebral fluid filtration is increased if the space between endothelial cells of the 
cerebral blood vessels is increased. This would be possible in spaceflight if the gravity-induced 
hydrostatic pressure gradients in the cerebral interstitium were removed. They also suggest that 
radiation exposure during spaceflight may alter endothelial protein structure such that cells 
shrink, increasing permeability between cell junctions. Christ et al. (Christ et al. 2001) showed 
that fluid filtration capacity (capillary permeability) is increased during long-duration bed rest, 
and this may be enhance in the presence of free O2 radicals and activated leukocytes, such as 
during exposure to spaceflight radiation and other oxidative stressors.  
 
Risk of Spaceflight Associated Neuro-ocular Syndrome (SANS) 
75 
 
Diedrich et al. (Diedrich et al. 2007) summarizes the current model of spaceflight-
induced fluid volume changes (Figure 34). Exposure to microgravity causes a cephalad fluid 
shift secondary to the removal of the hydrostatic pressure gradient. CVP is reduced due to 
expansion of the chest and decreased pressure from tissue and organs. This reduction in tissue 
compression likely plays a role in extravasation of fluid, resulting in overall reduced plasma 
volume and cephalic edema. 
 
 
Figure 34 Flow diagram of predicted blood and fluid volume changes during spaceflight. Reproduced from 
Diedrich A, et al. with permission of Wolters Kluwer Health, obtained via RightsLink. 
 
5. Arterial and Venous Resistance 
Brief exposures to weightlessness during parabolic flight induces increased cardiac 
dimensions, cardiac output, and stroke volume (Caiani et al. 2006). Elevated cardiac output and 
stroke volume persist during short-duration space flight; the highest values are recorded early in 
the mission but still remaining above preflight standing values after a week of weightlessness 
(Prisk et al. 1993). Furthermore, Norsk et al. (Norsk et al. 2015) reported an increased cardiac 
output and decreased vascular resistance during 24 h recordings of 8 male astronauts on the ISS 
ISS after 3 to 6 months of spaceflight. Despite no significant change in common carotid artery 
and femoral artery diameter during 4 to 6 months of spaceflight, common carotid artery flow 
increased during the first month, but decreased to preflight levels by 3 to 6 months of spaceflight. 
However, there was no change in femoral artery flow (Arbeille et al. 2001).   
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Given the distensibility of the veins, changes in hydrostatic pressures during HDT bed 
rest and spaceflight are expected to result in changes in venous dimensions. While HDT results 
in jugular vein distension and smaller femoral vein area (Arbeille et al. 2001), this is not the case 
in spaceflight. Herault et al. (Herault et al. 2000) and Arbeille et al. (Arbeille et al. 2001) 
reported significant engorgement of the jugular and femoral veins during spaceflight and veins 
remained distended by as much as 40% after 6 months of spaceflight (Figure 35). 
Figure 35 Divergent vein diameter responses between HDT bed rest (panel A) and spaceflight (panel B). The panels 
show percentage change of the preflight values, measured at 1h, and days 4-5, 7, 15, 21, 28 and 42 during HDT, 
and at days 1 and 2-4, weeks 1 and 2-3, and months 3 and 5-6 during spaceflight. The jugular vein is distended in 
both real and simulated microgravity, while the femoral vein is only distended in real microgravity. Ajv - Jugular 
vein cross-sectional area. Afv - Femoral vein cross sectional area. * P<0.05, significantly different from preflight or 
pre-HDT values. Reproduced from Arbeille P, and others with permission of Springer-Verlag, obtained via 
Copyright Clearance Center, Inc.  
 
Jugular vein distension upon entry into weightlessness may result from either increased 
venous pressure or increased transmural pressure. While increased transmural pressure plays a 
role in atrial filling during weightlessness, the weight of the tissue overlying the jugular vein 
likely is small in comparison.  Recently, Martin et al. (Martin et al. 2016) reported that venous 
pressure measured non-invasively in the internal jugular vein, the primary vein draining the 
cranium, is elevated during parabolic flight to levels similar to those observed during 20 degree 
HDT. While limitations to the measurement technique (compression sonography) and the model 
(parabolic flight) exist, these data in combination with distended jugular vein dimensions are 
suggestive of venous congestion in the head and upper torso secondary to the cephalad fluid 
shift. Brief exposures to reduced gravity by free fall and parabolic flight also have been reported 
to increase jugular vein pressures in rats (Gotoh et al. 2004; Tanaka et al. 2005). Whether this 
acute response of jugular vein pressure plays a role in jugular vein distension and ocular 
structural changes during prolonged weightlessness has yet to be tested.  
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6. Vascular Adaptations to Spaceflight 
Normal blood vessel function is necessary for sustaining and adapting to the metabolic 
demands of individual organs. To meet the blood flow requirements of organs and local tissue 
beds, arteries and veins must be able to respond rapidly to diverse physical and chemical signals 
by changing either vessel caliber (diameter) or altering the density of the vascular network. 
Several factors regulate how vessels respond to modifications in demand including humoral, 
neural, and autoregulatory. Importantly, changes to any of these systems such as in response to 
chronic activation from environmental stimuli or injury may result in impaired vascular control 
and contribute to numerous pathologies. 
 
Medical data from as early as the Mercury and Gemini missions indicate that exposure to 
microgravity results in cardiovascular deconditioning that presents as orthostatic intolerance 
upon return to Earth's gravity (Berry 1968). While many researchers agree that the space-related 
deconditioning is likely triggered by a headward fluid shift and a reduced plasma volume, a 
preponderance of evidence indicates that the loss of vascular control, indicated by lower 
peripheral resistance and increased blood pooling in the lower limbs, is a primary mechanism for 
postflight orthostatic hypotension and is independent of volume status (Blomqvist et al. 1994; 
Buckey et al. 1996b; Fritsch-Yelle et al. 1996; Baisch et al. 2000; Watenpaugh et al. 2001; 
Waters et al. 2002). For example, flight data from both Buckey (Buckey et al. 1996b) and 
Fritsch-Yelle et al. (Fritsch-Yelle et al. 1996) demonstrated that astronauts who finished a 
postflight stand test, compared to those who became presyncopal, had a significantly greater 
vasoconstrictor response with higher total peripheral resistance. Fritsch-Yelle et al. suggested 
that the lower level of peripheral resistance, associated with an increased incidence of postflight 
orthostatic hypotension, is likely due to a smaller postflight increase in circulating levels of 
norepinephrine and is less likely related to volume status as there were no differences in plasma 
volume levels between presyncopal and nonpresyncopal subjects. Ground-based studies using 
HDT bed rest to simulate microgravity overwhelmingly confirm a significant relation between 
orthostatic intolerance and a decreased vasoconstrictor response that is evidenced by increased 
lower limb venous compliance (Convertino et al. 1989; Buckey et al. 1990, 1992; Bleeker et al. 
2004).  
 
Along similar lines of thought, differences between astronauts who become presyncopal 
and those that are nonpresyncopal on landing day may provide additional insight into the effects 
of spaceflight that might contribute to in-flight vision changes. Specifically, Tuday et al. (Tuday 
et al. 2007) observed that although vascular compliance, calculated as stroke volume divided by 
pulse pressure, was not different between the astronaut groups before flight, vascular compliance 
was lower in the nonpresyncopal astronauts than in the presyncopal astronauts on landing day. 
Perhaps increased stiffness may reflect remodeling of the vascular wall, including increased 
collagen: elastin ratio, collagen cross-linking, and modifications of the vascular matrix. Although 
this response to spaceflight may be to protect against postflight orthostatic intolerance, assuming 
that the decrease in vascular compliance is similar across all vessels in the body, then perhaps 
these observed changes may be suggestive of changes in the cerebrovasculature. However, using 
the hind-limb suspension model in rats, Tuday et al. (Tuday et al. 2007) provided some of the 
first ground-based experimental evidence demonstrating that a reduction in large artery 
hydrostatic forces results in greater vessel distention and is accompanied by an impaired 
vasoconstrictor response to the sympathetic neurotransmitter norepinephrine. Since then, 
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considerable attention has been focused on understanding the mechanisms that underlie many of 
the microgravity-induced vascular adaptations in relation to orthostatic intolerance. Much of this 
data has recently been reviewed in-depth by Zhang, who reported that changes in arterial 
compliance were a local effect resulting from regional changes in blood pressures. A number of 
other probable explanations may include, a reduced adrenergic receptor sensitivity (Waters et al. 
2005), less vasoconstrictor reserve (Convertino 1999; Fu et al. 2004), and an enhanced flow-
dependent vasodilator response (Bonnin et al. 2001). 
 
The effects of sex on postflight orthostatic tolerance, or the ability to regulate blood 
pressure during standing or upright tilt, may be of interest in the investigation of SANS as men 
appear better able to maintain blood pressure during orthostatic challenges than women, and men 
also seem to be more susceptible to vision changes during long-duration spaceflight. However, 
as noted by Fritsch-Yelle et al. (Fritsch-Yelle et al. 1996), differences in postflight orthostatic 
tolerance in the astronaut population may be the result of selection bias. That is, the large 
majority of astronauts who did not experience orthostatic intolerance on landing day were career 
military pilots or had high performance aircraft training (Fritsch-Yelle et al. 1996; Lee et al. 
1999). To further illustrate this potential bias, the study with the highest incidence of orthostatic 
intolerance also has the highest proportion of payload specialists (Buckey et al. 1996b). 
 
Recently, 2 studies in ISS astronauts demonstrated local structural and functional changes 
in the carotid artery in response to 4 to 6 months of spaceflight. First, Arbeille et al. (Arbeille et 
al. 2015) observed that carotid artery intima-media thickness increased ~12% in 8 astronauts (2 
women) by the end of their mission, with significantly increased thickness observed as early as 2 
weeks after launch. It was presumed that these results were not an artifact of measurements 
conducted in space by non-experts (astronauts) because the increased carotid intima-media 
thickness persisted when measurements were repeated by the investigators ~4 days after landing. 
Similarly intima-media thickness increased in the femoral artery during the spaceflight in these 
subjects, although there was no pre- to postflight thickening observed after landing. Similar 
results were obtained from 6 participants of the MARS 500 mission; intima-media thickening in 
the carotid and femoral arteries increased although the subjects were  not exposed to 
weightlessness (Arbeille et al. 2014), suggesting that other factors such as increased oxidative 
stress and altered glucose metabolism may play a significant role in these spaceflight-induced 
structural adaptations. At this time, however, it is not possible to discern the nature of the 
increase intima-media thickness in humans from sonographic measures used to measure carotid 
intima-media thickness, although data from Zhang et al. (Zhang et al. 1996) and Mao et al. (Mao 
et al. 1999) in rats during hindlimb suspension are suggestive of smooth muscle hyperplasia. 
Although this thickening in rats is reversible after cessation of hindlimb suspension, there 
currently are no such recovery measures in astronauts. 
 
Along with carotid artery structural adaptations, there appear to be corresponding 
changes in carotid artery function. Hughson et al. (Hughson et al. 2016a) reported that carotid 
stiffness was increased and distensibility decreased from before to after flight in 8 astronauts (4 
men, 4 women) after 6-month ISS missions. Additionally, pulse wave transit times were 
decreased, as measured by the time from the R-wave to onset of pressure wave in the foot and in 
the ankle. These data are suggestive of local adaptations in neck and torso as well as systemic 
effects. Similarly, arterial compliance, calculated from the ratio of resting stroke volume divided 
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by pulse pressure, had been previously reported by Tuday et al. (Tuday et al. 2007) to decrease 
on landing day after Space Shuttle missions. While biomarkers of oxidative stress and 
inflammation were not consistently affected from before to after flight in ISS astronauts, resting 
insulin, glycalated albumin, and a calculated index of insulin resistance (Homeostatic model 
assessment, HOMA) were elevated after landing (Hughson et al. 2016a). Functional changes 
may result from the structural adaptations described previously, but the impact of the neuro-
humoral environment in the postflight period, including changes in sympathetic and 
parasympathetic control, may also be a contributing factor (Baevsky et al. 2007; Hughson et al. 
2012).    
 
7. Radiation Effects on Vascular Function 
Our present level of knowledge of the vascular effects of radiation, in particular space-
like radiation, greatly lags behind that of the microgravity-related vascular alterations. Until 
recently, the majority of evidence suggesting radiation-induced changes in vascular function was 
substantiated only by epidemiologic studies such as those reporting data on cardiovascular 
disease rates in the Hiroshima/Nagasaki atomic bomb survivors (Preston et al. 2003) or the 
similar findings from the Chernobyl emergency workers (Ivanov et al. 2001). The vascular 
effects of exposure to radiation are generally focused around cardiovascular disease progression, 
most notably atherothrombotic vascular disease. Radiation is thought to produce damaging 
cellular effects either directly (Menendez et al. 1998; Kolesnick and Fuks 2003; Tishkin et al. 
2007) or indirectly (Bourlier et al. 1998; Soloviev et al. 2003; Soucy et al. 2007; Simone et al. 
2009). Several studies suggest that exposure to radiation impairs endothelial function, shifting 
the regulatory balance towards increased vasoconstriction through impairment in the nitric oxide 
pathway (Suvorava et al. 2006; Soucy et al. 2007, 2009). Although a healthy endothelium is 
primarily associated with maintaining normal vascular function through the production and 
secretion of several vasoactive substances such as nitric oxide, the endothelium is also a selective 
permeable barrier that regulates the exchange of fluids and blood constituents (such as plasma 
proteins and cells) between the circulation and the surrounding tissues. The impaired trafficking 
of substances from the intravascular space to the extracellular region could have significant 
implications on the delivery of nutrients and fluid distribution to surrounding tissues and organs. 
In addition, questions remain as to whether the vascular effects of exposure to microgravity and 
space-like radiation will be additive, contributing to an even greater pathogenesis, or whether the 
increase in vascular compliance resulting from the microgravity-induced deconditioning will be 
offset by the increase in vasoconstrictor tone due to impairment in the nitric oxide pathway. 
 
8. Cerebral and Ocular Circulation 
Although it is often overlooked, decrease in cerebral perfusion is critically important in 
the development of orthostatic intolerance. In general, cerebral blood flow is well protected 
against systemic changes in pressure or flow without compromising the high demands of brain 
tissue. However, with a reduction in central volume from both a decrease in plasma volume and 
blood pooling in the lower limbs, it is reasonable to assume that cerebral blood flow may be 
impacted after spaceflight. 
 
Blood flow to the brain is supplied by the 2 carotid and 2 vertebral arteries that 
communicate with each other through the arterial anastomoses that form the circle of Willis. 
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Under normal conditions the circle of Willis acts only to communicate need and not as a central 
station where supply is mixed and then delivered to the smaller collateral circulations (Hodes et 
al. 1947; Wellens et al. 1975). Three pairs of arteries form the circle of Willis and feed specific 
regions of the brain, the anterior, middle, and posterior cerebral arteries. Extending beyond the 
larger arteries are dense networks of capillaries where nutrient exchange takes place with a 2 to 3 
fold greater density in the gray compared with white matter. The blood is collected and drained 
by 2 systems of veins, including the deep venous system within the brain and the internal jugular 
and other veins outside of the skull. Circulation within the skull is unique in that it is tightly 
regulated by the blood-brain barrier and is therefore protected against ionic and humoral factors. 
The cerebral vasculature undergoes fine adjustments primarily through autoregulatory processes 
such that under normal healthy conditions on Earth the cerebral blood vessels have an intrinsic 
ability to keep blood flow constant over a wide range of arterial blood pressure levels via 
myogenic, metabolic, and tissue pressure mechanisms. 
 
Data indicate that upon entry into space, the mean arterial pressure in the head increases 
from approximately 70 mm Hg to 100 mm Hg. The higher cerebral perfusion pressure in turn 
leads to elevations in both cerebral artery and capillary blood flow, which contribute to 
elevations in ICP (Hargens and Watenpaugh 1996). It is widely believed that the product of these 
microgravity-induced alterations in perfusion pressures and blood flow and elevations in ICP 
contribute over time to pronounced changes in cerebral responsiveness (Buckey et al. 1996b). 
However, a number of studies suggest that cerebral blood flow is lower in response to spaceflight 
and head-down bed rest (Kawai et al. 1993; Bassett et al. 1993; Fritsch-Yelle et al. 1996). 
Specifically, Kawai et al. (Kawai et al. 1993) demonstrated that after 24 hours of HDT bed rest 
peak cerebral blood flow velocity was significantly lower compared to before HDT and 
remained lower up to 6 hours after HDT (Figure 36). These differences in the literature highlight 
the need for additional research in this area. 
 
Figure 36 The time course of mean cerebral blood flow velocity in subjects after 24-hours HDT bed rest. 
Reproduced from Kawai Y, et al. with permission from The American Physiological Society, obtained via Copyright 
Clearance Center, Inc. 
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Controversy exists as to whether regulation of blood flow is altered in response to stress 
(such as, moving from a supine to a standing position), or whether lower blood flow is simply a 
factor of hypovolemia. Data  from Fritsch-Yelle et al. (Fritsch-Yelle et al. 1996) do not support a 
change in regulation;   blood flow velocity was measured in the middle cerebral artery using 
ultrasound and no difference was found in tilt response between presyncopal and nonpresyncopal 
astronauts. In another study that measured cerebral blood flow, velocities, and beat-to-beat 
changes in arterial pressure, static autoregulation was not impaired after 16 days in space and, 
moreover, dynamic regulation (changes occurring during stress) was actually improved (Iwasaki 
et al. 2007). Interestingly, Greaves et al. (Greaves et al. 2007) also reported improved 
autoregulation in a set of subjects who participated in 60 days of HDT bed rest. Taken together, 
these data and recent findings from Jeong and colleagues (Jeong et al. 2012) suggest that 
autoregulation is in fact not impaired and that the alterations in blood flow after spaceflight are 
related to volume status. 
 
Recent work using phase-contrast MRI demonstrated that total blood flow through the 
internal carotid and vertebral arteries decreased after 4.5 hours of 6°, 12°, and 18° HDT 
compared to supine levels (Marshall-Goebel et al. 2016). At 12° HDT internal jugular venous 
area increased and outflow decreased, suggesting increased venous resistance. The addition of 
1% CO2 to the inspired air increased both arterial inflow and venous outflow. 
 
Evidence from several ground-based studies using the rat hind-limb tail suspension 
model suggests that the reduction in cerebral blood flow is associated with a decrease in 
autoregulation caused by alterations in cerebral arterial structure and function. Indeed, data from 
Geary et al. (Geary et al. 1998) and Wilkerson et al. (Wilkerson et al. 2002, 2005) indicate that 
myogenic tone and vascular resistance is increased during hind-limb suspension, and that the 
difference in tone (suspended versus control rats) is related to changes in nitric-oxide-mediated 
vasodilation. Interestingly, the overall functional consequence of increased tone appears to lead 
to reduced blood flow, and the stimulus does not appear to be an increase in arterial pressure but 
rather increases in transmural pressure caused by the elevation in the extravascular pressure in 
the cranium (Wilkerson et al. 2002). 
 
However, as noted previously, data from similar investigations on cerebral autoregulation 
in humans during spaceflight do not corroborate the findings in the ground-based analogs. This 
lack of corroboration between spaceflight and ground-based analogs is in line with evidence 
from modeling steady-state ICP differences between HDT bed rest and long-duration 
microgravity exposure (Stevens et al. 2005). It was concluded that ICP should be less in crew 
exposed to actual microgravity compared to subjects in long-term HDT (Stevens et al. 2005). 
The reason for the profound differences in findings for spaceflight and ground analogs of 
spaceflight remains unclear; however, it has been speculated that the central volume shift in 
fluid, and subsequent redistribution of fluid between compartments and tissues is not comparable 
in these two conditions. 
 
9. Lymphatics 
Well-regulated lymph function is critical for maintaining normal tissue fluid volume and 
pressure. The lymphatic system collects excess interstitial fluid and transports this fluid back to 
the blood through the thoracic duct (Koh et al. 2005). Distal to the thoracic duct, lymph is 
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pumped against gravity; however, proximal to the duct lymph drains by the aide of gravity. 
Typically, 8 to 12 liters of interstitial fluid are produced daily by transcapillary fluid filtration 
and transported through the lymphatic vasculature.   
 
Cervical lymphatics in the nasal submucosa at the cribriform plate can absorb 
cerebrospinal fluid (Boulton et al. 1999; Johnston 2003; Koh et al. 2005). In addition, lymphatics 
about spinal nerve subarachnoid spaces collect CSF to varying degrees (Koh et al. 2005). 
 
Because lymph pressures are low (0-20 cm H2O), lymphatic vessels are particularly 
sensitive to changes in hydrostatic and tissue pressures, which are altered with gravitational 
changes. It is known that lymphatics from different regions of the body adapt to their regional 
pressure and flow environments (Gashev et al. 2004). For example, 2 weeks of simulated 
microgravity in rats causes a potent inhibition of pressure/stretch stimulated pumping in all types 
of lymphatic vessels (Gashev et al. 2006). The largest pump flow inhibition was found in 
cervical lymphatics during simulated microgravity (Gashev et al. 2006). These lymphatics use 
cephalic to thoracic hydrostatic pressure gradient to generate lymph flow. Tracer studies suggest 
that CSF and extracranial lymph compartments are linked physiologically because tracers 
injected into the cranial cerebrospinal fluid later enter lymphatic vessels in the head and neck 
region (Koh et al. 2005). Animal studies (rat, dog, rabbit, and sheep) demonstrate that a large 
percentage (50%) of the CSF is cleared by the cervical and extracranial lymphatics (Boulton et 
al. 1999; Koh et al. 2005). In addition, silicon rubber tracer injected into the subarachnoid space 
of humans produced extensive infiltration into the lymphatic network adjacent to the extracranial 
surface of the cribriform plate and optic nerve (Johnston 2003; Koh et al. 2005). An increase in 
ICP resulted in greater levels of CSF tracer in the optic nerve and deep cervical lymph nodes 
(McComb et al. 1982). In fact, ligation of the cervical lymphatics result in edema of the brain 
and protein accumulation (Casley-Smith et al. 1976, 1978). However, it is unclear how impaired 
lymphatic function may contribute to vision impairment. 
 
10. Glymphatics 
The central nervous system does not contain traditional lymphatic vasculature. Recent 
data demonstrate that CSF moves within the periarterial space, providing a continuous pathway 
of interstitial fluid exchange (Iliff et al. 2012). Transport of water from the periarterial space into 
the brain parenchyma is facilitated by AQP4 water channels expressed in the membrane of 
astrocytes (Iliff et al. 2012, 2013) which “push” the brain parenchyma interstitial fluid into the 
perivenous space. From this perivenous space, the interstitial fluid can then empty into the 
cervical lymphatic system  (Johnston et al. 2004; Murtha et al. 2014). Moreover, this movement 
of periarterial CSF into and about the brain parenchyma was associated with movement of 
solutes to the perivenous sites (Iliff et al. 2012). Data suggest that lipids and lipoproteins greater 
than 1 kDa are localized to the perivascular space of the brain, and astrocytes release carrier 
proteins, thus the glymphatic pathway provides a route for lipid distribution. Rodent data suggest 
that the glymphatic pathways become enhanced during sleep, evidenced by the change in volume 
fraction of interstitial space of 14% during wake and 23% during sleep (Xie et al. 2013). Posture 
may play an additional role in the ability for the glymphatic system to clear waste during sleep. 
When rats are in the prone position, in which the head is most similar to the upright position and 
mimicking the awake state posture, glymphatic transport was a state of “retention”, whereas, 
lateral and supine positions improved glymphatic transport (Lee et al. 2015). In addition, 
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norepinephrine may neuro-modulate the enhancement of the glymphatic system during sleep 
(Berridge and Waterhouse 2003).   
 
It remains to be determined if and how a spaceflight-induced glymphatic dysfunction 
might play a role in the spaceflight-induced vision impairment. Denniston and Keane proposed 
that the paravascular system of the retina may be critical in retinal disease. Tracer studies 
indicate that similar “glymphatic” fluid pathways exist near the paravascular space around the 
central retinal artery and vein, but not in the lumen of the vessel itself. Sakamoto et al. proposed 
that the fluid communication zone occurs in the paravascular space around the branches of 
central retinal artery from the subarachnoid space to the optic nerve at the internal limiting 
membrane (Sakamoto et al. 2010). It remains unclear how this communication zone could be 
disrupted during spaceflight, however, as discussed above the TLPG and associated forces on 
this region may impact fluid communication from the retina to the optic nerve. 
 
F. Structural Brain Changes 
It is unknown if SANS is localized to the eye or if structural changes in the brain should 
be considered in describing the pathophysiology of SANS. Recent analysis of MRI data collected 
pre- and post-bed rest in 5 male and 3 female subjects suggests the brain may change (Roberts et 
al. 2015), but the physiological significance of these changes remains to be demonstrated. After 
42 to 90 days of 6° head-down tilt bed rest there was a significant inferior-to-superior 
displacement of the brain by an average 0.36 ± 15 mm and the brain tended to rotate in left-right 
axis by 0.28 ± 0.34 degrees, as compared to values obtained pre bed rest. Ventricular volume 
changes from pre- to post-bed rest were seen in some subjects, but due to the large variability 
between individuals a change in ventricular volume for the group as a whole was not statistically 
significance. However, these authors suggested an association between brain rotation and percent 
change in ventricle volume. Moreover, there was a significant increase in both gray and white 
matter density at the brain vertex. While this study was limited to a small number of subjects and 
variable bedrest duration, these data suggest that head-down tilt bed rest may induce brain 
structure changes that could impact CSF flow and cerebral venous outflow pathways.  
 
Recent retrospective analysis of 3 Tesla T2-weighted brain MRIs collected before and 
after spaceflight suggests brain anatomical changes develop during long-duration, but not short-
duration spaceflight (Roberts et al. 2017). Cine clips of matched pre- and post-flight images of 
18 astronauts revealed narrowing of the central sulcus, enlargement of the ventricular system 
(lateral, third, and fourth ventricles), and a more frequent upward shift of the brain in long-
duration (n=12) compared to short-duration (n=6) fliers. These authors hypothesize that the 
upward shift of the brain results in crowding of the vertex, obstruction of CSF and venous 
outflow, and results in elevation of ICP. Because only 3 astronauts in this cohort presented with 
optic disc edema, additional data are needed to understand if a relationship exists between SANS 
symptoms and brain structural changes. Indeed, further research is needed to explore this 
hypothesis and determine if these structural changes that appear in long-duration crewmembers 
represent pathological findings or are subclinical findings from exposure to prolonged 
weightlessness and resolve with time after return to a 1g environment. 
 
It remains unknown if the structural changes and movement of the brain within the skull 
following bed rest or spaceflight result in alterations to venous outflow from the brain. MRI 
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venography evaluation may provide some information about venous compression and stenosis. 
Some potential compressive zones have also been proposed as possibly relevant in contributing 
to the venous congestion in microgravity (Wiener 2012).  
 
G. Sex 
The incidence of SANS findings appears to be higher in male astronauts than in female 
astronauts, although the total number of female astronauts that have flown long-duration 
missions to the ISS remains low. During parabolic flight, Lawley, et al. measured ICP through 
the Ommaya reservoir of 5 male and 3 female subjects providing an opportunity to speculate on 
possible sex differences in the regulation of ICP. In this study, ICP during weightlessness was 
closer to the estimated 24 hour average ICP on Earth for the female subjects than it was for the 
male subjects. This suggests these female subjects experienced a greater translaminar pressure 
gradient in the posterior direction. Whether this difference between sexes occurs in astronauts 
during spaceflight and helps protect against the stimuli causing globe flattening is unknown and 
this hypothesis requires further investigation. 
 
VII. CONCLUSIONS AND FORWARD WORK 
Efforts by NASA to collect significant amounts of medical data on astronauts before, 
during, and after spaceflight have helped define the prevalence of ocular structural and functional 
changes that develop, while simultaneously investigating possible mechanisms, predictive risk 
profiles, and potential countermeasures. To date, 24 individual United States and partner agency 
astronauts have demonstrated one or more of the following signs: optic disc edema, globe 
flattening, choroidal folds, cotton wool spots, and/or change in refractive error. Based on the 
different number of individuals tested for each of these signs, 37 to 51% of long-duration 
crewmembers demonstrate one or more SANS findings. The inability to replicate SANS findings 
during bed rest, the most prevalent analog of spaceflight, has limited our ability to test various 
hypotheses on the ground. However, future planned bed rest studies include additional 
spaceflight-stressors such as elevated ambient CO2, as well as possible relief of a headward fluid 
shift using artificial gravity during prolonged bed rest. 
 
The initial leading hypothesis for the SANS risk was that long-duration spaceflight led to 
an increase in ICP that was transmitted to the posterior globe, leading to globe flattening, optic 
disc edema, and refractive error changes in some, but not all astronauts. However, no direct 
measure of ICP has been conducted during long-duration spaceflight to confirm or refute this 
hypothesis. Lawley et al. obtained direct measurements of ICP from a small number of subjects 
during short-duration weightlessness (~20 sec) in parabolic flight (Lawley et al. 2017), which 
provided some of the first evidence in humans to suggest that ICP may not be pathologically 
elevated. This study also provided insight into the role of exercise with and without a Valsalva 
maneuver, 24-hrs of bed rest, and the simple action of lifting the head during bed rest which may 
explain the lack of SANS signs during bed rest studies. Future work also needs to confirm if the 
few case studies reporting postflight lumbar puncture opening pressure truly represent elevated 
ICP by conducting preflight lumbar punctures for the appropriate within-subject comparison.  
 
The data by Lawley (Lawley et al. 2017), in combination with the case study of the 
astronaut who completed a second spaceflight (Mader et al. 2013), and the number of SANS 
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signs that present asymmetrically between eyes (Mader et al. 2017) suggest that the underlying 
mechanism may involve the posterior globe, optic nerve, and/or tissue pressure and anatomy 
localized around the orbit. This hypothesis should be given greater investigative interest than it 
has previously received. As more optical coherence tomography images (which provide the most 
detailed and quantitative assessment of the posterior globe) are collected, we will develop a 
better understanding of the spatial and temporal time course of structural ocular changes. 
 
Despite only partial understanding of the mechanisms or risk factors that contribute to the 
development of SANS, research into in-flight countermeasure development needs to be 
simultaneously investigated while we still have use of the ISS. Targeting the venous system that 
drains the head, the lymphatic system, and possible changes in cerebral spinal fluid all represent 
areas of research for possible countermeasure development or areas that may provide 
mechanistic insight that have not been fully investigated thus far. Studies are currently underway 
to investigate the use of devices that redistribute fluids distally, including Braslet thigh cuffs, a 
modified version of the Kaatsu system, an impedance threshold device, artificial gravity, and a 
lower body negative pressure device. 
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IX. LIST OF ACRYONYMS 
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AQP  Aquaporin 
CCFP  Cochlear and Cerebral Fluid Pressure 
ChT  Total choroid surface area 
CO2  Carbon dioxide 
CPG  Clinical practice guidelines 
CSF  Cerebral spinal fluid 
CVP  Central venous pressure 
EJVP  External jugular venous pressure 
EVA  Extra vehicular activity 
HDT  Head-down tilt 
ICP  Intracranial pressure 
IIH  Idiopathic intracranial hypertension 
IJVP  Internal jugular venous pressure 
IOP  Intraocular pressure 
LP  Lamina cribrosa 
MRI  Magnetic resonance imaging 
MRV  Magnetic resonance venogram 
NFL  Nerve fiber layer 
OA  Ophthalmic artery 
OAE  Otoacoustic emission 
OCT  Optical coherence tomography 
ON  Optic nerve 
ONH  Optic nerve head 
ONS  Optic nerve sheath 
ONSD  Optic nerve sheath diameter 
POAG  Primary open angle Glaucoma 
RNFL  Retinal nerve fiber layer 
RPE  Retinal pigment epithelium 
SMS  Space motion sickness 
SSP  Sagittal sinus pressure 
SVP  Spontaneous venous pulsations 
VF  Visual field  
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